{"idB": "749647_12_item7_p30_s2", "idA": "749647_11_item7_p11_s2", "sentA": "Of those policies, we believe that the policies discussed below may involve a higher degree of judgment and may be more critical to an accurate reflection of our financial condition and results of operations.", "sentB": "The equity financing transactions in 2011 raised approximately $58 million in gross proceeds, significantly strengthening our financial condition.", "type": 1, "words": ["<tag1>", "Of", "those", "policies,", "we", "believe", "that", "the", "policies", "discussed", "below", "may", "involve", "a", "higher", "degree", "of", "judgment", "and", "may", "be", "more", "critical", "to", "an", "accurate", "reflection", "of", "our", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "The", "equity", "financing", "transactions", "in", "2011", "raised", "approximately", "$58", "million", "in", "gross", "proceeds,", "significantly", "strengthening", "our", "financial", "condition.", "<tag3>"], "wordsA": ["Of", "those", "policies,", "we", "believe", "that", "the", "policies", "discussed", "below", "may", "involve", "a", "higher", "degree", "of", "judgment", "and", "may", "be", "more", "critical", "to", "an", "accurate", "reflection", "of", "our", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["The", "equity", "financing", "transactions", "in", "2011", "raised", "approximately", "$58", "million", "in", "gross", "proceeds,", "significantly", "strengthening", "our", "financial", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p52_s1", "idA": "749647_11_item7_p12_s1", "sentA": "The stock options generally expire 10 years from the date of grant.", "sentB": "The CEFF terminated automatically on the date on which SCVB purchased the entire commitment amount under the CEFF.", "type": 1, "words": ["<tag1>", "The", "stock", "options", "generally", "expire", "10", "years", "from", "the", "date", "of", "grant.", "<tag2>", "The", "CEFF", "terminated", "automatically", "on", "the", "date", "on", "which", "SCVB", "purchased", "the", "entire", "commitment", "amount", "under", "the", "CEFF.", "<tag3>"], "wordsA": ["The", "stock", "options", "generally", "expire", "10", "years", "from", "the", "date", "of", "grant."], "wordsB": ["The", "CEFF", "terminated", "automatically", "on", "the", "date", "on", "which", "SCVB", "purchased", "the", "entire", "commitment", "amount", "under", "the", "CEFF."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p48_s2", "idA": "749647_11_item7_p13_s0", "sentA": "Stock option awards vest upon terms determined by the Board of Directors.", "sentB": "These maximum share and beneficial ownership limitations were not able to be waived by the parties.", "type": 1, "words": ["<tag1>", "Stock", "option", "awards", "vest", "upon", "terms", "determined", "by", "the", "Board", "of", "Directors.", "<tag2>", "These", "maximum", "share", "and", "beneficial", "ownership", "limitations", "were", "not", "able", "to", "be", "waived", "by", "the", "parties.", "<tag3>"], "wordsA": ["Stock", "option", "awards", "vest", "upon", "terms", "determined", "by", "the", "Board", "of", "Directors."], "wordsB": ["These", "maximum", "share", "and", "beneficial", "ownership", "limitations", "were", "not", "able", "to", "be", "waived", "by", "the", "parties."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p15_s1", "idA": "749647_11_item7_p15_s1", "sentA": "The model is also sensitive to changes in assumptions, which can materially affect the fair value estimate.", "sentB": "This standard allows us to establish modeling assumptions as to expected stock price volatility, option terms, forfeiture and dividend rates, which directly impact estimated fair value as determined.", "type": 1, "words": ["<tag1>", "The", "model", "is", "also", "sensitive", "to", "changes", "in", "assumptions,", "which", "can", "materially", "affect", "the", "fair", "value", "estimate.", "<tag2>", "This", "standard", "allows", "us", "to", "establish", "modeling", "assumptions", "as", "to", "expected", "stock", "price", "volatility,", "option", "terms,", "forfeiture", "and", "dividend", "rates,", "which", "directly", "impact", "estimated", "fair", "value", "as", "determined.", "<tag3>"], "wordsA": ["The", "model", "is", "also", "sensitive", "to", "changes", "in", "assumptions,", "which", "can", "materially", "affect", "the", "fair", "value", "estimate."], "wordsB": ["This", "standard", "allows", "us", "to", "establish", "modeling", "assumptions", "as", "to", "expected", "stock", "price", "volatility,", "option", "terms,", "forfeiture", "and", "dividend", "rates,", "which", "directly", "impact", "estimated", "fair", "value", "as", "determined."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p5_s2", "idA": "749647_11_item7_p16_s0", "sentA": "Expected volatilities utilized in the model are based on historical volatility of the Company s stock price.", "sentB": "The second trigger was the occurrence of 190 progression-free survival (PFS) events in the study population.", "type": 1, "words": ["<tag1>", "Expected", "volatilities", "utilized", "in", "the", "model", "are", "based", "on", "historical", "volatility", "of", "the", "Company", "s", "stock", "price.", "<tag2>", "The", "second", "trigger", "was", "the", "occurrence", "of", "190", "progression-free", "survival", "(PFS)", "events", "in", "the", "study", "population.", "<tag3>"], "wordsA": ["Expected", "volatilities", "utilized", "in", "the", "model", "are", "based", "on", "historical", "volatility", "of", "the", "Company", "s", "stock", "price."], "wordsB": ["The", "second", "trigger", "was", "the", "occurrence", "of", "190", "progression-free", "survival", "(PFS)", "events", "in", "the", "study", "population."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p5_s1", "idA": "749647_11_item7_p18_s0", "sentA": "We review our financial reporting and disclosure practices and accounting policies on an ongoing basis to ensure that our financial reporting and disclosure system provides accurate and transparent information relative to the current economic and business environment.", "sentB": "The target enrollment figure is designed to ensure that the study s primary end point, progression-free survival, can be achieved with adequate statistical power, and is one of two triggers for an interim efficacy analysis by the study s DMC.", "type": 1, "words": ["<tag1>", "We", "review", "our", "financial", "reporting", "and", "disclosure", "practices", "and", "accounting", "policies", "on", "an", "ongoing", "basis", "to", "ensure", "that", "our", "financial", "reporting", "and", "disclosure", "system", "provides", "accurate", "and", "transparent", "information", "relative", "to", "the", "current", "economic", "and", "business", "environment.", "<tag2>", "The", "target", "enrollment", "figure", "is", "designed", "to", "ensure", "that", "the", "study", "s", "primary", "end", "point,", "progression-free", "survival,", "can", "be", "achieved", "with", "adequate", "statistical", "power,", "and", "is", "one", "of", "two", "triggers", "for", "an", "interim", "efficacy", "analysis", "by", "the", "study", "s", "DMC.", "<tag3>"], "wordsA": ["We", "review", "our", "financial", "reporting", "and", "disclosure", "practices", "and", "accounting", "policies", "on", "an", "ongoing", "basis", "to", "ensure", "that", "our", "financial", "reporting", "and", "disclosure", "system", "provides", "accurate", "and", "transparent", "information", "relative", "to", "the", "current", "economic", "and", "business", "environment."], "wordsB": ["The", "target", "enrollment", "figure", "is", "designed", "to", "ensure", "that", "the", "study", "s", "primary", "end", "point,", "progression-free", "survival,", "can", "be", "achieved", "with", "adequate", "statistical", "power,", "and", "is", "one", "of", "two", "triggers", "for", "an", "interim", "efficacy", "analysis", "by", "the", "study", "s", "DMC."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p22_s1", "idA": "749647_11_item7_p21_s2", "sentA": "This increase is related to milestone payments, investigator grants and monitoring costs associated with the increase in patient enrollment in the HEAT study during 2010.", "sentB": "We continue to carefully monitor operating costs and focus our efforts and financial resources on completing enrollment and patient follow-up in the Phase III HEAT study.", "type": 1, "words": ["<tag1>", "This", "increase", "is", "related", "to", "milestone", "payments,", "investigator", "grants", "and", "monitoring", "costs", "associated", "with", "the", "increase", "in", "patient", "enrollment", "in", "the", "HEAT", "study", "during", "2010.", "<tag2>", "We", "continue", "to", "carefully", "monitor", "operating", "costs", "and", "focus", "our", "efforts", "and", "financial", "resources", "on", "completing", "enrollment", "and", "patient", "follow-up", "in", "the", "Phase", "III", "HEAT", "study.", "<tag3>"], "wordsA": ["This", "increase", "is", "related", "to", "milestone", "payments,", "investigator", "grants", "and", "monitoring", "costs", "associated", "with", "the", "increase", "in", "patient", "enrollment", "in", "the", "HEAT", "study", "during", "2010."], "wordsB": ["We", "continue", "to", "carefully", "monitor", "operating", "costs", "and", "focus", "our", "efforts", "and", "financial", "resources", "on", "completing", "enrollment", "and", "patient", "follow-up", "in", "the", "Phase", "III", "HEAT", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p5_s0", "idA": "749647_11_item7_p21_s2", "sentA": "This increase is related to milestone payments, investigator grants and monitoring costs associated with the increase in patient enrollment in the HEAT study during 2010.", "sentB": "In August 2011, we announced that we had reached our preplanned enrollment objective of 600 patients in the pivotal Phase III HEAT study.", "type": 1, "words": ["<tag1>", "This", "increase", "is", "related", "to", "milestone", "payments,", "investigator", "grants", "and", "monitoring", "costs", "associated", "with", "the", "increase", "in", "patient", "enrollment", "in", "the", "HEAT", "study", "during", "2010.", "<tag2>", "In", "August", "2011,", "we", "announced", "that", "we", "had", "reached", "our", "preplanned", "enrollment", "objective", "of", "600", "patients", "in", "the", "pivotal", "Phase", "III", "HEAT", "study.", "<tag3>"], "wordsA": ["This", "increase", "is", "related", "to", "milestone", "payments,", "investigator", "grants", "and", "monitoring", "costs", "associated", "with", "the", "increase", "in", "patient", "enrollment", "in", "the", "HEAT", "study", "during", "2010."], "wordsB": ["In", "August", "2011,", "we", "announced", "that", "we", "had", "reached", "our", "preplanned", "enrollment", "objective", "of", "600", "patients", "in", "the", "pivotal", "Phase", "III", "HEAT", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p6_s1", "idA": "749647_11_item7_p21_s2", "sentA": "This increase is related to milestone payments, investigator grants and monitoring costs associated with the increase in patient enrollment in the HEAT study during 2010.", "sentB": "The HEAT study has enrolled a sufficient number to support registrational filings in South Korea and Taiwan, two important markets for ThermoDox .", "type": 1, "words": ["<tag1>", "This", "increase", "is", "related", "to", "milestone", "payments,", "investigator", "grants", "and", "monitoring", "costs", "associated", "with", "the", "increase", "in", "patient", "enrollment", "in", "the", "HEAT", "study", "during", "2010.", "<tag2>", "The", "HEAT", "study", "has", "enrolled", "a", "sufficient", "number", "to", "support", "registrational", "filings", "in", "South", "Korea", "and", "Taiwan,", "two", "important", "markets", "for", "ThermoDox", ".", "<tag3>"], "wordsA": ["This", "increase", "is", "related", "to", "milestone", "payments,", "investigator", "grants", "and", "monitoring", "costs", "associated", "with", "the", "increase", "in", "patient", "enrollment", "in", "the", "HEAT", "study", "during", "2010."], "wordsB": ["The", "HEAT", "study", "has", "enrolled", "a", "sufficient", "number", "to", "support", "registrational", "filings", "in", "South", "Korea", "and", "Taiwan,", "two", "important", "markets", "for", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p8_s1", "idA": "749647_11_item7_p21_s2", "sentA": "This increase is related to milestone payments, investigator grants and monitoring costs associated with the increase in patient enrollment in the HEAT study during 2010.", "sentB": "The HEAT study has enrolled a sufficient number to support registrational filings in South Korea and Taiwan, two important markets for ThermoDox .", "type": 1, "words": ["<tag1>", "This", "increase", "is", "related", "to", "milestone", "payments,", "investigator", "grants", "and", "monitoring", "costs", "associated", "with", "the", "increase", "in", "patient", "enrollment", "in", "the", "HEAT", "study", "during", "2010.", "<tag2>", "The", "HEAT", "study", "has", "enrolled", "a", "sufficient", "number", "to", "support", "registrational", "filings", "in", "South", "Korea", "and", "Taiwan,", "two", "important", "markets", "for", "ThermoDox", ".", "<tag3>"], "wordsA": ["This", "increase", "is", "related", "to", "milestone", "payments,", "investigator", "grants", "and", "monitoring", "costs", "associated", "with", "the", "increase", "in", "patient", "enrollment", "in", "the", "HEAT", "study", "during", "2010."], "wordsB": ["The", "HEAT", "study", "has", "enrolled", "a", "sufficient", "number", "to", "support", "registrational", "filings", "in", "South", "Korea", "and", "Taiwan,", "two", "important", "markets", "for", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p55_s2", "idA": "749647_11_item7_p21_s6", "sentA": "Also included in these production costs are $0.2 million associated with the acceleration of Company s commercial manufacturing strategy.", "sentB": "The lease has a term of 66 months and provides for 6 months rent free, with the first monthly rent payment of approximately $23,000 due in April 2012.", "type": 1, "words": ["<tag1>", "Also", "included", "in", "these", "production", "costs", "are", "$0.2", "million", "associated", "with", "the", "acceleration", "of", "Company", "s", "commercial", "manufacturing", "strategy.", "<tag2>", "The", "lease", "has", "a", "term", "of", "66", "months", "and", "provides", "for", "6", "months", "rent", "free,", "with", "the", "first", "monthly", "rent", "payment", "of", "approximately", "$23,000", "due", "in", "April", "2012.", "<tag3>"], "wordsA": ["Also", "included", "in", "these", "production", "costs", "are", "$0.2", "million", "associated", "with", "the", "acceleration", "of", "Company", "s", "commercial", "manufacturing", "strategy."], "wordsB": ["The", "lease", "has", "a", "term", "of", "66", "months", "and", "provides", "for", "6", "months", "rent", "free,", "with", "the", "first", "monthly", "rent", "payment", "of", "approximately", "$23,000", "due", "in", "April", "2012."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p7_s2", "idA": "749647_11_item7_p22_s2", "sentA": "The amortization of the indemnity reserve was $1.1 million in 2009.", "sentB": "A total of 380 events of progression are required to reach the planned final analysis of the study.", "type": 1, "words": ["<tag1>", "The", "amortization", "of", "the", "indemnity", "reserve", "was", "$1.1", "million", "in", "2009.", "<tag2>", "A", "total", "of", "380", "events", "of", "progression", "are", "required", "to", "reach", "the", "planned", "final", "analysis", "of", "the", "study.", "<tag3>"], "wordsA": ["The", "amortization", "of", "the", "indemnity", "reserve", "was", "$1.1", "million", "in", "2009."], "wordsB": ["A", "total", "of", "380", "events", "of", "progression", "are", "required", "to", "reach", "the", "planned", "final", "analysis", "of", "the", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p7_s1", "idA": "749647_11_item7_p24_s3", "sentA": "At the time of the retention of the collateral, its value increased by $0.2 million which was recorded in other income.", "sentB": "The DMC evaluated data from 613 patients in its review, which was conducted following the realization of 219 progression-free survival (PFS) events within the study population.", "type": 1, "words": ["<tag1>", "At", "the", "time", "of", "the", "retention", "of", "the", "collateral,", "its", "value", "increased", "by", "$0.2", "million", "which", "was", "recorded", "in", "other", "income.", "<tag2>", "The", "DMC", "evaluated", "data", "from", "613", "patients", "in", "its", "review,", "which", "was", "conducted", "following", "the", "realization", "of", "219", "progression-free", "survival", "(PFS)", "events", "within", "the", "study", "population.", "<tag3>"], "wordsA": ["At", "the", "time", "of", "the", "retention", "of", "the", "collateral,", "its", "value", "increased", "by", "$0.2", "million", "which", "was", "recorded", "in", "other", "income."], "wordsB": ["The", "DMC", "evaluated", "data", "from", "613", "patients", "in", "its", "review,", "which", "was", "conducted", "following", "the", "realization", "of", "219", "progression-free", "survival", "(PFS)", "events", "within", "the", "study", "population."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p6_s2", "idA": "749647_11_item7_p27_s0", "sentA": "The Company reported an income tax expense of $0.8 million in 2007 representing the alternative minimum tax due as a result of the gain on the sale of the medical device assets.", "sentB": "Continued enrollment will not affect the timing of the planned interim analysis, and has the potential to reduce the timeline of the final data read out, though we can not guarantee such a result.", "type": 1, "words": ["<tag1>", "The", "Company", "reported", "an", "income", "tax", "expense", "of", "$0.8", "million", "in", "2007", "representing", "the", "alternative", "minimum", "tax", "due", "as", "a", "result", "of", "the", "gain", "on", "the", "sale", "of", "the", "medical", "device", "assets.", "<tag2>", "Continued", "enrollment", "will", "not", "affect", "the", "timing", "of", "the", "planned", "interim", "analysis,", "and", "has", "the", "potential", "to", "reduce", "the", "timeline", "of", "the", "final", "data", "read", "out,", "though", "we", "can", "not", "guarantee", "such", "a", "result.", "<tag3>"], "wordsA": ["The", "Company", "reported", "an", "income", "tax", "expense", "of", "$0.8", "million", "in", "2007", "representing", "the", "alternative", "minimum", "tax", "due", "as", "a", "result", "of", "the", "gain", "on", "the", "sale", "of", "the", "medical", "device", "assets."], "wordsB": ["Continued", "enrollment", "will", "not", "affect", "the", "timing", "of", "the", "planned", "interim", "analysis,", "and", "has", "the", "potential", "to", "reduce", "the", "timeline", "of", "the", "final", "data", "read", "out,", "though", "we", "can", "not", "guarantee", "such", "a", "result."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p8_s2", "idA": "749647_11_item7_p27_s0", "sentA": "The Company reported an income tax expense of $0.8 million in 2007 representing the alternative minimum tax due as a result of the gain on the sale of the medical device assets.", "sentB": "Continued enrollment will not affect the timing of the planned interim analysis, and has the potential to reduce the timeline of the final data read out, though we can not guarantee such a result.", "type": 1, "words": ["<tag1>", "The", "Company", "reported", "an", "income", "tax", "expense", "of", "$0.8", "million", "in", "2007", "representing", "the", "alternative", "minimum", "tax", "due", "as", "a", "result", "of", "the", "gain", "on", "the", "sale", "of", "the", "medical", "device", "assets.", "<tag2>", "Continued", "enrollment", "will", "not", "affect", "the", "timing", "of", "the", "planned", "interim", "analysis,", "and", "has", "the", "potential", "to", "reduce", "the", "timeline", "of", "the", "final", "data", "read", "out,", "though", "we", "can", "not", "guarantee", "such", "a", "result.", "<tag3>"], "wordsA": ["The", "Company", "reported", "an", "income", "tax", "expense", "of", "$0.8", "million", "in", "2007", "representing", "the", "alternative", "minimum", "tax", "due", "as", "a", "result", "of", "the", "gain", "on", "the", "sale", "of", "the", "medical", "device", "assets."], "wordsB": ["Continued", "enrollment", "will", "not", "affect", "the", "timing", "of", "the", "planned", "interim", "analysis,", "and", "has", "the", "potential", "to", "reduce", "the", "timeline", "of", "the", "final", "data", "read", "out,", "though", "we", "can", "not", "guarantee", "such", "a", "result."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p55_s3", "idA": "749647_11_item7_p27_s1", "sentA": "In December 2009, the Company filed for a refund of that tax pursuant to Revenue Procedure 2009-52 and recorded a tax benefit in that amount.", "sentB": "Also, as required by the lease, the Company provided Brandywine with an irrevocable and unconditional standby letter of credit for $250,000, which the Company secured with an escrow deposit at its banking institution of this same amount.", "type": 1, "words": ["<tag1>", "In", "December", "2009,", "the", "Company", "filed", "for", "a", "refund", "of", "that", "tax", "pursuant", "to", "Revenue", "Procedure", "2009-52", "and", "recorded", "a", "tax", "benefit", "in", "that", "amount.", "<tag2>", "Also,", "as", "required", "by", "the", "lease,", "the", "Company", "provided", "Brandywine", "with", "an", "irrevocable", "and", "unconditional", "standby", "letter", "of", "credit", "for", "$250,000,", "which", "the", "Company", "secured", "with", "an", "escrow", "deposit", "at", "its", "banking", "institution", "of", "this", "same", "amount.", "<tag3>"], "wordsA": ["In", "December", "2009,", "the", "Company", "filed", "for", "a", "refund", "of", "that", "tax", "pursuant", "to", "Revenue", "Procedure", "2009-52", "and", "recorded", "a", "tax", "benefit", "in", "that", "amount."], "wordsB": ["Also,", "as", "required", "by", "the", "lease,", "the", "Company", "provided", "Brandywine", "with", "an", "irrevocable", "and", "unconditional", "standby", "letter", "of", "credit", "for", "$250,000,", "which", "the", "Company", "secured", "with", "an", "escrow", "deposit", "at", "its", "banking", "institution", "of", "this", "same", "amount."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p15_s2", "idA": "749647_11_item7_p2_s2", "sentA": "The promise of this drug technology is to maximize efficacy while minimizing side effects common to cancer treatments.", "sentB": "Our practice is to utilize reasonable and supportable assumptions which are reviewed with the board and its appropriate committee.", "type": 1, "words": ["<tag1>", "The", "promise", "of", "this", "drug", "technology", "is", "to", "maximize", "efficacy", "while", "minimizing", "side", "effects", "common", "to", "cancer", "treatments.", "<tag2>", "Our", "practice", "is", "to", "utilize", "reasonable", "and", "supportable", "assumptions", "which", "are", "reviewed", "with", "the", "board", "and", "its", "appropriate", "committee.", "<tag3>"], "wordsA": ["The", "promise", "of", "this", "drug", "technology", "is", "to", "maximize", "efficacy", "while", "minimizing", "side", "effects", "common", "to", "cancer", "treatments."], "wordsB": ["Our", "practice", "is", "to", "utilize", "reasonable", "and", "supportable", "assumptions", "which", "are", "reviewed", "with", "the", "board", "and", "its", "appropriate", "committee."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p13_s0", "idA": "749647_11_item7_p33_s0", "sentA": "At December 31, 2010, the Company had cash, cash equivalents and short term investments of $1.5 million.", "sentB": "We believe that our cash and investment resources of $30.5 million on hand at December 31, 2011 are sufficient to fund operations into the second half of 2013.", "type": 1, "words": ["<tag1>", "At", "December", "31,", "2010,", "the", "Company", "had", "cash,", "cash", "equivalents", "and", "short", "term", "investments", "of", "$1.5", "million.", "<tag2>", "We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$30.5", "million", "on", "hand", "at", "December", "31,", "2011", "are", "sufficient", "to", "fund", "operations", "into", "the", "second", "half", "of", "2013.", "<tag3>"], "wordsA": ["At", "December", "31,", "2010,", "the", "Company", "had", "cash,", "cash", "equivalents", "and", "short", "term", "investments", "of", "$1.5", "million."], "wordsB": ["We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$30.5", "million", "on", "hand", "at", "December", "31,", "2011", "are", "sufficient", "to", "fund", "operations", "into", "the", "second", "half", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p31_s0", "idA": "749647_11_item7_p33_s0", "sentA": "At December 31, 2010, the Company had cash, cash equivalents and short term investments of $1.5 million.", "sentB": "We believe that our cash and investment resources of $30.5 million on hand at December 31, 2011 are sufficient to fund operations into the second half of 2013.", "type": 1, "words": ["<tag1>", "At", "December", "31,", "2010,", "the", "Company", "had", "cash,", "cash", "equivalents", "and", "short", "term", "investments", "of", "$1.5", "million.", "<tag2>", "We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$30.5", "million", "on", "hand", "at", "December", "31,", "2011", "are", "sufficient", "to", "fund", "operations", "into", "the", "second", "half", "of", "2013.", "<tag3>"], "wordsA": ["At", "December", "31,", "2010,", "the", "Company", "had", "cash,", "cash", "equivalents", "and", "short", "term", "investments", "of", "$1.5", "million."], "wordsB": ["We", "believe", "that", "our", "cash", "and", "investment", "resources", "of", "$30.5", "million", "on", "hand", "at", "December", "31,", "2011", "are", "sufficient", "to", "fund", "operations", "into", "the", "second", "half", "of", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p55_s0", "idA": "749647_11_item7_p37_s0", "sentA": "In January 2011, the Company completed a registered offering of $5.1 million of convertible preferred stock and common stock warrants.", "sentB": "On July 21, 2011, the Company executed a lease with Brandywine Operating Partnership, L.P. (Brandywine), a Delaware limited partnership for a 10,870 square foot premises located in Lawrenceville, New Jersey.", "type": 1, "words": ["<tag1>", "In", "January", "2011,", "the", "Company", "completed", "a", "registered", "offering", "of", "$5.1", "million", "of", "convertible", "preferred", "stock", "and", "common", "stock", "warrants.", "<tag2>", "On", "July", "21,", "2011,", "the", "Company", "executed", "a", "lease", "with", "Brandywine", "Operating", "Partnership,", "L.P.", "(Brandywine),", "a", "Delaware", "limited", "partnership", "for", "a", "10,870", "square", "foot", "premises", "located", "in", "Lawrenceville,", "New", "Jersey.", "<tag3>"], "wordsA": ["In", "January", "2011,", "the", "Company", "completed", "a", "registered", "offering", "of", "$5.1", "million", "of", "convertible", "preferred", "stock", "and", "common", "stock", "warrants."], "wordsB": ["On", "July", "21,", "2011,", "the", "Company", "executed", "a", "lease", "with", "Brandywine", "Operating", "Partnership,", "L.P.", "(Brandywine),", "a", "Delaware", "limited", "partnership", "for", "a", "10,870", "square", "foot", "premises", "located", "in", "Lawrenceville,", "New", "Jersey."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p7_s0", "idA": "749647_11_item7_p37_s0", "sentA": "In January 2011, the Company completed a registered offering of $5.1 million of convertible preferred stock and common stock warrants.", "sentB": "In November 2011, we announced that the independent Data Monitoring Committee (DMC) for our Phase III HEAT Study, had completed a planned interim analysis for safety, efficacy and futility and unanimously recommended that the study continue to its final analysis as planned.", "type": 1, "words": ["<tag1>", "In", "January", "2011,", "the", "Company", "completed", "a", "registered", "offering", "of", "$5.1", "million", "of", "convertible", "preferred", "stock", "and", "common", "stock", "warrants.", "<tag2>", "In", "November", "2011,", "we", "announced", "that", "the", "independent", "Data", "Monitoring", "Committee", "(DMC)", "for", "our", "Phase", "III", "HEAT", "Study,", "had", "completed", "a", "planned", "interim", "analysis", "for", "safety,", "efficacy", "and", "futility", "and", "unanimously", "recommended", "that", "the", "study", "continue", "to", "its", "final", "analysis", "as", "planned.", "<tag3>"], "wordsA": ["In", "January", "2011,", "the", "Company", "completed", "a", "registered", "offering", "of", "$5.1", "million", "of", "convertible", "preferred", "stock", "and", "common", "stock", "warrants."], "wordsB": ["In", "November", "2011,", "we", "announced", "that", "the", "independent", "Data", "Monitoring", "Committee", "(DMC)", "for", "our", "Phase", "III", "HEAT", "Study,", "had", "completed", "a", "planned", "interim", "analysis", "for", "safety,", "efficacy", "and", "futility", "and", "unanimously", "recommended", "that", "the", "study", "continue", "to", "its", "final", "analysis", "as", "planned."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p52_s0", "idA": "749647_11_item7_p41_s0", "sentA": "We currently estimate we will use approximately $15 to $16 million of cash in 2011.", "sentB": "Availability under the CEFF was exhausted during the second quarter of 2011.", "type": 1, "words": ["<tag1>", "We", "currently", "estimate", "we", "will", "use", "approximately", "$15", "to", "$16", "million", "of", "cash", "in", "2011.", "<tag2>", "Availability", "under", "the", "CEFF", "was", "exhausted", "during", "the", "second", "quarter", "of", "2011.", "<tag3>"], "wordsA": ["We", "currently", "estimate", "we", "will", "use", "approximately", "$15", "to", "$16", "million", "of", "cash", "in", "2011."], "wordsB": ["Availability", "under", "the", "CEFF", "was", "exhausted", "during", "the", "second", "quarter", "of", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p49_s0", "idA": "749647_11_item7_p5_s0", "sentA": "As of March 22, 2011, we have sold 1,339,774 shares of our common stock to the Purchaser pursuant to the CEFF for aggregate net proceeds of $3,073,328 including 583,132 shares that were sold on December 30, 2010 for aggregate net proceeds of $1,125,670 and 275,855 shares that were sold on March 16, 2011 for aggregate net proceeds of $588,793.", "sentB": "During 2011, we completed three draws and sales to SCBV under the CEFF as follows:", "type": 1, "words": ["<tag1>", "As", "of", "March", "22,", "2011,", "we", "have", "sold", "1,339,774", "shares", "of", "our", "common", "stock", "to", "the", "Purchaser", "pursuant", "to", "the", "CEFF", "for", "aggregate", "net", "proceeds", "of", "$3,073,328", "including", "583,132", "shares", "that", "were", "sold", "on", "December", "30,", "2010", "for", "aggregate", "net", "proceeds", "of", "$1,125,670", "and", "275,855", "shares", "that", "were", "sold", "on", "March", "16,", "2011", "for", "aggregate", "net", "proceeds", "of", "$588,793.", "<tag2>", "During", "2011,", "we", "completed", "three", "draws", "and", "sales", "to", "SCBV", "under", "the", "CEFF", "as", "follows:", "<tag3>"], "wordsA": ["As", "of", "March", "22,", "2011,", "we", "have", "sold", "1,339,774", "shares", "of", "our", "common", "stock", "to", "the", "Purchaser", "pursuant", "to", "the", "CEFF", "for", "aggregate", "net", "proceeds", "of", "$3,073,328", "including", "583,132", "shares", "that", "were", "sold", "on", "December", "30,", "2010", "for", "aggregate", "net", "proceeds", "of", "$1,125,670", "and", "275,855", "shares", "that", "were", "sold", "on", "March", "16,", "2011", "for", "aggregate", "net", "proceeds", "of", "$588,793."], "wordsB": ["During", "2011,", "we", "completed", "three", "draws", "and", "sales", "to", "SCBV", "under", "the", "CEFF", "as", "follows:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item7_p55_s4", "idA": "749647_11_item7_p9_s0", "sentA": "Concurrent with the issuance and sale of the Units, the Company issued a warrant (the Placement Agent Warrant ) to purchase up to 350 shares of Preferred Stock at an exercise price of $1,000 per whole share of Preferred Stock to Dominick Dominick LLC, as placement agent.", "sentB": "The standby letter of credit will be reduced by $50,000 on each of the 19 th , 31 st and 43 rd months from the initial term, with the remaining $100,000 amount remaining until the lease term has expired.", "type": 1, "words": ["<tag1>", "Concurrent", "with", "the", "issuance", "and", "sale", "of", "the", "Units,", "the", "Company", "issued", "a", "warrant", "(the", "Placement", "Agent", "Warrant", ")", "to", "purchase", "up", "to", "350", "shares", "of", "Preferred", "Stock", "at", "an", "exercise", "price", "of", "$1,000", "per", "whole", "share", "of", "Preferred", "Stock", "to", "Dominick", "Dominick", "LLC,", "as", "placement", "agent.", "<tag2>", "The", "standby", "letter", "of", "credit", "will", "be", "reduced", "by", "$50,000", "on", "each", "of", "the", "19", "th", ",", "31", "st", "and", "43", "rd", "months", "from", "the", "initial", "term,", "with", "the", "remaining", "$100,000", "amount", "remaining", "until", "the", "lease", "term", "has", "expired.", "<tag3>"], "wordsA": ["Concurrent", "with", "the", "issuance", "and", "sale", "of", "the", "Units,", "the", "Company", "issued", "a", "warrant", "(the", "Placement", "Agent", "Warrant", ")", "to", "purchase", "up", "to", "350", "shares", "of", "Preferred", "Stock", "at", "an", "exercise", "price", "of", "$1,000", "per", "whole", "share", "of", "Preferred", "Stock", "to", "Dominick", "Dominick", "LLC,", "as", "placement", "agent."], "wordsB": ["The", "standby", "letter", "of", "credit", "will", "be", "reduced", "by", "$50,000", "on", "each", "of", "the", "19", "th", ",", "31", "st", "and", "43", "rd", "months", "from", "the", "initial", "term,", "with", "the", "remaining", "$100,000", "amount", "remaining", "until", "the", "lease", "term", "has", "expired."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p9_s2", "idA": "749647_12_item7_p12_s0", "sentA": "As a result of these equity transactions, the Company collectively raised $58.0 million in gross proceeds by issuing approximately 19.7 million shares of our common stock and warrants to purchase approximately 10.6 million shares of our common stock.", "sentB": "The future of these activities will be part of our strategic planning as we analyze the data announced on January 31, 2013 and will affect our partnership with Hisun described below.", "type": 1, "words": ["<tag1>", "As", "a", "result", "of", "these", "equity", "transactions,", "the", "Company", "collectively", "raised", "$58.0", "million", "in", "gross", "proceeds", "by", "issuing", "approximately", "19.7", "million", "shares", "of", "our", "common", "stock", "and", "warrants", "to", "purchase", "approximately", "10.6", "million", "shares", "of", "our", "common", "stock.", "<tag2>", "The", "future", "of", "these", "activities", "will", "be", "part", "of", "our", "strategic", "planning", "as", "we", "analyze", "the", "data", "announced", "on", "January", "31,", "2013", "and", "will", "affect", "our", "partnership", "with", "Hisun", "described", "below.", "<tag3>"], "wordsA": ["As", "a", "result", "of", "these", "equity", "transactions,", "the", "Company", "collectively", "raised", "$58.0", "million", "in", "gross", "proceeds", "by", "issuing", "approximately", "19.7", "million", "shares", "of", "our", "common", "stock", "and", "warrants", "to", "purchase", "approximately", "10.6", "million", "shares", "of", "our", "common", "stock."], "wordsB": ["The", "future", "of", "these", "activities", "will", "be", "part", "of", "our", "strategic", "planning", "as", "we", "analyze", "the", "data", "announced", "on", "January", "31,", "2013", "and", "will", "affect", "our", "partnership", "with", "Hisun", "described", "below."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p24_s2", "idA": "749647_12_item7_p14_s2", "sentA": "Of those policies, we believe that the policies discussed below may involve a higher degree of judgment and may be more critical to an accurate reflection of our financial condition and results of operations.", "sentB": "The aggregate loan amount may be advanced in two tranches of $5 million each.", "type": 1, "words": ["<tag1>", "Of", "those", "policies,", "we", "believe", "that", "the", "policies", "discussed", "below", "may", "involve", "a", "higher", "degree", "of", "judgment", "and", "may", "be", "more", "critical", "to", "an", "accurate", "reflection", "of", "our", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "The", "aggregate", "loan", "amount", "may", "be", "advanced", "in", "two", "tranches", "of", "$5", "million", "each.", "<tag3>"], "wordsA": ["Of", "those", "policies,", "we", "believe", "that", "the", "policies", "discussed", "below", "may", "involve", "a", "higher", "degree", "of", "judgment", "and", "may", "be", "more", "critical", "to", "an", "accurate", "reflection", "of", "our", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["The", "aggregate", "loan", "amount", "may", "be", "advanced", "in", "two", "tranches", "of", "$5", "million", "each."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p67_s2", "idA": "749647_12_item7_p14_s2", "sentA": "Of those policies, we believe that the policies discussed below may involve a higher degree of judgment and may be more critical to an accurate reflection of our financial condition and results of operations.", "sentB": "The aggregate loan amount may be advanced in two tranches of $5 million each.", "type": 1, "words": ["<tag1>", "Of", "those", "policies,", "we", "believe", "that", "the", "policies", "discussed", "below", "may", "involve", "a", "higher", "degree", "of", "judgment", "and", "may", "be", "more", "critical", "to", "an", "accurate", "reflection", "of", "our", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "The", "aggregate", "loan", "amount", "may", "be", "advanced", "in", "two", "tranches", "of", "$5", "million", "each.", "<tag3>"], "wordsA": ["Of", "those", "policies,", "we", "believe", "that", "the", "policies", "discussed", "below", "may", "involve", "a", "higher", "degree", "of", "judgment", "and", "may", "be", "more", "critical", "to", "an", "accurate", "reflection", "of", "our", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["The", "aggregate", "loan", "amount", "may", "be", "advanced", "in", "two", "tranches", "of", "$5", "million", "each."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p7_s4", "idA": "749647_12_item7_p14_s2", "sentA": "Of those policies, we believe that the policies discussed below may involve a higher degree of judgment and may be more critical to an accurate reflection of our financial condition and results of operations.", "sentB": "We expect that the strength of our balance sheet will afford us the opportunity to evaluate our future development plans.", "type": 1, "words": ["<tag1>", "Of", "those", "policies,", "we", "believe", "that", "the", "policies", "discussed", "below", "may", "involve", "a", "higher", "degree", "of", "judgment", "and", "may", "be", "more", "critical", "to", "an", "accurate", "reflection", "of", "our", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "We", "expect", "that", "the", "strength", "of", "our", "balance", "sheet", "will", "afford", "us", "the", "opportunity", "to", "evaluate", "our", "future", "development", "plans.", "<tag3>"], "wordsA": ["Of", "those", "policies,", "we", "believe", "that", "the", "policies", "discussed", "below", "may", "involve", "a", "higher", "degree", "of", "judgment", "and", "may", "be", "more", "critical", "to", "an", "accurate", "reflection", "of", "our", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["We", "expect", "that", "the", "strength", "of", "our", "balance", "sheet", "will", "afford", "us", "the", "opportunity", "to", "evaluate", "our", "future", "development", "plans."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p24_s4", "idA": "749647_12_item7_p16_s1", "sentA": "As part of the process, the Company reviews the selection, application and communication of critical accounting policies and financial disclosures.", "sentB": "On January 31, 2013, the Company announced it did not meet the primary endpoint of the HEAT study, therefore the second tranche will not be drawn down.", "type": 1, "words": ["<tag1>", "As", "part", "of", "the", "process,", "the", "Company", "reviews", "the", "selection,", "application", "and", "communication", "of", "critical", "accounting", "policies", "and", "financial", "disclosures.", "<tag2>", "On", "January", "31,", "2013,", "the", "Company", "announced", "it", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study,", "therefore", "the", "second", "tranche", "will", "not", "be", "drawn", "down.", "<tag3>"], "wordsA": ["As", "part", "of", "the", "process,", "the", "Company", "reviews", "the", "selection,", "application", "and", "communication", "of", "critical", "accounting", "policies", "and", "financial", "disclosures."], "wordsB": ["On", "January", "31,", "2013,", "the", "Company", "announced", "it", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study,", "therefore", "the", "second", "tranche", "will", "not", "be", "drawn", "down."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p67_s4", "idA": "749647_12_item7_p16_s1", "sentA": "As part of the process, the Company reviews the selection, application and communication of critical accounting policies and financial disclosures.", "sentB": "On January 31, 2013, the Company announced it did not meet the primary endpoint of the HEAT study, therefore the Term B Loan will not be drawn down.", "type": 1, "words": ["<tag1>", "As", "part", "of", "the", "process,", "the", "Company", "reviews", "the", "selection,", "application", "and", "communication", "of", "critical", "accounting", "policies", "and", "financial", "disclosures.", "<tag2>", "On", "January", "31,", "2013,", "the", "Company", "announced", "it", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study,", "therefore", "the", "Term", "B", "Loan", "will", "not", "be", "drawn", "down.", "<tag3>"], "wordsA": ["As", "part", "of", "the", "process,", "the", "Company", "reviews", "the", "selection,", "application", "and", "communication", "of", "critical", "accounting", "policies", "and", "financial", "disclosures."], "wordsB": ["On", "January", "31,", "2013,", "the", "Company", "announced", "it", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study,", "therefore", "the", "Term", "B", "Loan", "will", "not", "be", "drawn", "down."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p14_s1", "idA": "749647_12_item7_p17_s0", "sentA": "The preparation of our financial statements in conformity with accounting principles generally accepted in the United States requires that our management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.", "sentB": "Hisun agreed to pay us an additional $5.0 million within sixty days after the signing of the exclusive option agreement if it has not been terminated within such time period.", "type": 1, "words": ["<tag1>", "The", "preparation", "of", "our", "financial", "statements", "in", "conformity", "with", "accounting", "principles", "generally", "accepted", "in", "the", "United", "States", "requires", "that", "our", "management", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period.", "<tag2>", "Hisun", "agreed", "to", "pay", "us", "an", "additional", "$5.0", "million", "within", "sixty", "days", "after", "the", "signing", "of", "the", "exclusive", "option", "agreement", "if", "it", "has", "not", "been", "terminated", "within", "such", "time", "period.", "<tag3>"], "wordsA": ["The", "preparation", "of", "our", "financial", "statements", "in", "conformity", "with", "accounting", "principles", "generally", "accepted", "in", "the", "United", "States", "requires", "that", "our", "management", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period."], "wordsB": ["Hisun", "agreed", "to", "pay", "us", "an", "additional", "$5.0", "million", "within", "sixty", "days", "after", "the", "signing", "of", "the", "exclusive", "option", "agreement", "if", "it", "has", "not", "been", "terminated", "within", "such", "time", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p29_s2", "idA": "749647_12_item7_p17_s0", "sentA": "The preparation of our financial statements in conformity with accounting principles generally accepted in the United States requires that our management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.", "sentB": "Hisun agreed to pay us an additional $5 million within sixty days after the signing of the exclusive option agreement if it has not been terminated within such time period.", "type": 1, "words": ["<tag1>", "The", "preparation", "of", "our", "financial", "statements", "in", "conformity", "with", "accounting", "principles", "generally", "accepted", "in", "the", "United", "States", "requires", "that", "our", "management", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period.", "<tag2>", "Hisun", "agreed", "to", "pay", "us", "an", "additional", "$5", "million", "within", "sixty", "days", "after", "the", "signing", "of", "the", "exclusive", "option", "agreement", "if", "it", "has", "not", "been", "terminated", "within", "such", "time", "period.", "<tag3>"], "wordsA": ["The", "preparation", "of", "our", "financial", "statements", "in", "conformity", "with", "accounting", "principles", "generally", "accepted", "in", "the", "United", "States", "requires", "that", "our", "management", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period."], "wordsB": ["Hisun", "agreed", "to", "pay", "us", "an", "additional", "$5", "million", "within", "sixty", "days", "after", "the", "signing", "of", "the", "exclusive", "option", "agreement", "if", "it", "has", "not", "been", "terminated", "within", "such", "time", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p8_s0", "idA": "749647_12_item7_p17_s1", "sentA": "We review our estimates and the methods by which they are determined on an ongoing basis.", "sentB": "The timing and the outcome of clinical results is extremely difficult to predict.", "type": 1, "words": ["<tag1>", "We", "review", "our", "estimates", "and", "the", "methods", "by", "which", "they", "are", "determined", "on", "an", "ongoing", "basis.", "<tag2>", "The", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict.", "<tag3>"], "wordsA": ["We", "review", "our", "estimates", "and", "the", "methods", "by", "which", "they", "are", "determined", "on", "an", "ongoing", "basis."], "wordsB": ["The", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p25_s0", "idA": "749647_12_item7_p18_s0", "sentA": "Comparison of Fiscal Year Ended December 31, 2011 and Fiscal Year Ended December 31, 2010.", "sentB": "The Term A Loan is scheduled to mature on October 15, 2015.", "type": 1, "words": ["<tag1>", "Comparison", "of", "Fiscal", "Year", "Ended", "December", "31,", "2011", "and", "Fiscal", "Year", "Ended", "December", "31,", "2010.", "<tag2>", "The", "Term", "A", "Loan", "is", "scheduled", "to", "mature", "on", "October", "15,", "2015.", "<tag3>"], "wordsA": ["Comparison", "of", "Fiscal", "Year", "Ended", "December", "31,", "2011", "and", "Fiscal", "Year", "Ended", "December", "31,", "2010."], "wordsB": ["The", "Term", "A", "Loan", "is", "scheduled", "to", "mature", "on", "October", "15,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p68_s0", "idA": "749647_12_item7_p18_s0", "sentA": "Comparison of Fiscal Year Ended December 31, 2011 and Fiscal Year Ended December 31, 2010.", "sentB": "The Term A Loan is scheduled to mature on October 15, 2015.", "type": 1, "words": ["<tag1>", "Comparison", "of", "Fiscal", "Year", "Ended", "December", "31,", "2011", "and", "Fiscal", "Year", "Ended", "December", "31,", "2010.", "<tag2>", "The", "Term", "A", "Loan", "is", "scheduled", "to", "mature", "on", "October", "15,", "2015.", "<tag3>"], "wordsA": ["Comparison", "of", "Fiscal", "Year", "Ended", "December", "31,", "2011", "and", "Fiscal", "Year", "Ended", "December", "31,", "2010."], "wordsB": ["The", "Term", "A", "Loan", "is", "scheduled", "to", "mature", "on", "October", "15,", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p14_s0", "idA": "749647_12_item7_p19_s0", "sentA": "In the first quarter of 2011, we recognized $2 million in licensing revenue after amending our development, product supply and commercialization agreement for ThermoDox with Yakult Honsha Co. to provide for accelerated payments of up to $4 million in future milestone payments, including $2 million that was paid to us on January 12, 2011, in exchange for a reduction in product approval milestones that we may receive in the future under the Yakult Agreement.", "sentB": "On January 18, 2013, we also entered into an exclusive option agreement with Hisun, terminable at any time by Hisun, under which we granted Hisun an option to enter into an exclusive license agreement with us for the manufacturing and commercialization of ThermoDox with respect to all indications in the China territory under the terms and conditions set forth in the exclusive option agreement and other customary terms and conditions to be set forth in the license agreement, if any.", "type": 1, "words": ["<tag1>", "In", "the", "first", "quarter", "of", "2011,", "we", "recognized", "$2", "million", "in", "licensing", "revenue", "after", "amending", "our", "development,", "product", "supply", "and", "commercialization", "agreement", "for", "ThermoDox", "with", "Yakult", "Honsha", "Co.", "to", "provide", "for", "accelerated", "payments", "of", "up", "to", "$4", "million", "in", "future", "milestone", "payments,", "including", "$2", "million", "that", "was", "paid", "to", "us", "on", "January", "12,", "2011,", "in", "exchange", "for", "a", "reduction", "in", "product", "approval", "milestones", "that", "we", "may", "receive", "in", "the", "future", "under", "the", "Yakult", "Agreement.", "<tag2>", "On", "January", "18,", "2013,", "we", "also", "entered", "into", "an", "exclusive", "option", "agreement", "with", "Hisun,", "terminable", "at", "any", "time", "by", "Hisun,", "under", "which", "we", "granted", "Hisun", "an", "option", "to", "enter", "into", "an", "exclusive", "license", "agreement", "with", "us", "for", "the", "manufacturing", "and", "commercialization", "of", "ThermoDox", "with", "respect", "to", "all", "indications", "in", "the", "China", "territory", "under", "the", "terms", "and", "conditions", "set", "forth", "in", "the", "exclusive", "option", "agreement", "and", "other", "customary", "terms", "and", "conditions", "to", "be", "set", "forth", "in", "the", "license", "agreement,", "if", "any.", "<tag3>"], "wordsA": ["In", "the", "first", "quarter", "of", "2011,", "we", "recognized", "$2", "million", "in", "licensing", "revenue", "after", "amending", "our", "development,", "product", "supply", "and", "commercialization", "agreement", "for", "ThermoDox", "with", "Yakult", "Honsha", "Co.", "to", "provide", "for", "accelerated", "payments", "of", "up", "to", "$4", "million", "in", "future", "milestone", "payments,", "including", "$2", "million", "that", "was", "paid", "to", "us", "on", "January", "12,", "2011,", "in", "exchange", "for", "a", "reduction", "in", "product", "approval", "milestones", "that", "we", "may", "receive", "in", "the", "future", "under", "the", "Yakult", "Agreement."], "wordsB": ["On", "January", "18,", "2013,", "we", "also", "entered", "into", "an", "exclusive", "option", "agreement", "with", "Hisun,", "terminable", "at", "any", "time", "by", "Hisun,", "under", "which", "we", "granted", "Hisun", "an", "option", "to", "enter", "into", "an", "exclusive", "license", "agreement", "with", "us", "for", "the", "manufacturing", "and", "commercialization", "of", "ThermoDox", "with", "respect", "to", "all", "indications", "in", "the", "China", "territory", "under", "the", "terms", "and", "conditions", "set", "forth", "in", "the", "exclusive", "option", "agreement", "and", "other", "customary", "terms", "and", "conditions", "to", "be", "set", "forth", "in", "the", "license", "agreement,", "if", "any."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p29_s1", "idA": "749647_12_item7_p19_s0", "sentA": "In the first quarter of 2011, we recognized $2 million in licensing revenue after amending our development, product supply and commercialization agreement for ThermoDox with Yakult Honsha Co. to provide for accelerated payments of up to $4 million in future milestone payments, including $2 million that was paid to us on January 12, 2011, in exchange for a reduction in product approval milestones that we may receive in the future under the Yakult Agreement.", "sentB": "On January 18, 2013, we also entered into an exclusive option agreement with Hisun, terminable at any time by Hisun, under which we granted Hisun an option to enter into an exclusive license agreement with us for the manufacturing and commercialization of ThermoDox with respect to all indications in the China territory under the terms and conditions set forth in the exclusive option agreement and other customary terms and conditions to be set forth in the license agreement, if any.", "type": 1, "words": ["<tag1>", "In", "the", "first", "quarter", "of", "2011,", "we", "recognized", "$2", "million", "in", "licensing", "revenue", "after", "amending", "our", "development,", "product", "supply", "and", "commercialization", "agreement", "for", "ThermoDox", "with", "Yakult", "Honsha", "Co.", "to", "provide", "for", "accelerated", "payments", "of", "up", "to", "$4", "million", "in", "future", "milestone", "payments,", "including", "$2", "million", "that", "was", "paid", "to", "us", "on", "January", "12,", "2011,", "in", "exchange", "for", "a", "reduction", "in", "product", "approval", "milestones", "that", "we", "may", "receive", "in", "the", "future", "under", "the", "Yakult", "Agreement.", "<tag2>", "On", "January", "18,", "2013,", "we", "also", "entered", "into", "an", "exclusive", "option", "agreement", "with", "Hisun,", "terminable", "at", "any", "time", "by", "Hisun,", "under", "which", "we", "granted", "Hisun", "an", "option", "to", "enter", "into", "an", "exclusive", "license", "agreement", "with", "us", "for", "the", "manufacturing", "and", "commercialization", "of", "ThermoDox", "with", "respect", "to", "all", "indications", "in", "the", "China", "territory", "under", "the", "terms", "and", "conditions", "set", "forth", "in", "the", "exclusive", "option", "agreement", "and", "other", "customary", "terms", "and", "conditions", "to", "be", "set", "forth", "in", "the", "license", "agreement,", "if", "any.", "<tag3>"], "wordsA": ["In", "the", "first", "quarter", "of", "2011,", "we", "recognized", "$2", "million", "in", "licensing", "revenue", "after", "amending", "our", "development,", "product", "supply", "and", "commercialization", "agreement", "for", "ThermoDox", "with", "Yakult", "Honsha", "Co.", "to", "provide", "for", "accelerated", "payments", "of", "up", "to", "$4", "million", "in", "future", "milestone", "payments,", "including", "$2", "million", "that", "was", "paid", "to", "us", "on", "January", "12,", "2011,", "in", "exchange", "for", "a", "reduction", "in", "product", "approval", "milestones", "that", "we", "may", "receive", "in", "the", "future", "under", "the", "Yakult", "Agreement."], "wordsB": ["On", "January", "18,", "2013,", "we", "also", "entered", "into", "an", "exclusive", "option", "agreement", "with", "Hisun,", "terminable", "at", "any", "time", "by", "Hisun,", "under", "which", "we", "granted", "Hisun", "an", "option", "to", "enter", "into", "an", "exclusive", "license", "agreement", "with", "us", "for", "the", "manufacturing", "and", "commercialization", "of", "ThermoDox", "with", "respect", "to", "all", "indications", "in", "the", "China", "territory", "under", "the", "terms", "and", "conditions", "set", "forth", "in", "the", "exclusive", "option", "agreement", "and", "other", "customary", "terms", "and", "conditions", "to", "be", "set", "forth", "in", "the", "license", "agreement,", "if", "any."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p6_s1", "idA": "749647_12_item7_p19_s0", "sentA": "In the first quarter of 2011, we recognized $2 million in licensing revenue after amending our development, product supply and commercialization agreement for ThermoDox with Yakult Honsha Co. to provide for accelerated payments of up to $4 million in future milestone payments, including $2 million that was paid to us on January 12, 2011, in exchange for a reduction in product approval milestones that we may receive in the future under the Yakult Agreement.", "sentB": "In the trial, ThermoDox was well-tolerated with no unexpected serious adverse events.", "type": 1, "words": ["<tag1>", "In", "the", "first", "quarter", "of", "2011,", "we", "recognized", "$2", "million", "in", "licensing", "revenue", "after", "amending", "our", "development,", "product", "supply", "and", "commercialization", "agreement", "for", "ThermoDox", "with", "Yakult", "Honsha", "Co.", "to", "provide", "for", "accelerated", "payments", "of", "up", "to", "$4", "million", "in", "future", "milestone", "payments,", "including", "$2", "million", "that", "was", "paid", "to", "us", "on", "January", "12,", "2011,", "in", "exchange", "for", "a", "reduction", "in", "product", "approval", "milestones", "that", "we", "may", "receive", "in", "the", "future", "under", "the", "Yakult", "Agreement.", "<tag2>", "In", "the", "trial,", "ThermoDox", "was", "well-tolerated", "with", "no", "unexpected", "serious", "adverse", "events.", "<tag3>"], "wordsA": ["In", "the", "first", "quarter", "of", "2011,", "we", "recognized", "$2", "million", "in", "licensing", "revenue", "after", "amending", "our", "development,", "product", "supply", "and", "commercialization", "agreement", "for", "ThermoDox", "with", "Yakult", "Honsha", "Co.", "to", "provide", "for", "accelerated", "payments", "of", "up", "to", "$4", "million", "in", "future", "milestone", "payments,", "including", "$2", "million", "that", "was", "paid", "to", "us", "on", "January", "12,", "2011,", "in", "exchange", "for", "a", "reduction", "in", "product", "approval", "milestones", "that", "we", "may", "receive", "in", "the", "future", "under", "the", "Yakult", "Agreement."], "wordsB": ["In", "the", "trial,", "ThermoDox", "was", "well-tolerated", "with", "no", "unexpected", "serious", "adverse", "events."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p87_s1", "idA": "749647_12_item7_p19_s0", "sentA": "In the first quarter of 2011, we recognized $2 million in licensing revenue after amending our development, product supply and commercialization agreement for ThermoDox with Yakult Honsha Co. to provide for accelerated payments of up to $4 million in future milestone payments, including $2 million that was paid to us on January 12, 2011, in exchange for a reduction in product approval milestones that we may receive in the future under the Yakult Agreement.", "sentB": "This lease obligation has thirty monthly payments of $5,651 through February 2014.", "type": 1, "words": ["<tag1>", "In", "the", "first", "quarter", "of", "2011,", "we", "recognized", "$2", "million", "in", "licensing", "revenue", "after", "amending", "our", "development,", "product", "supply", "and", "commercialization", "agreement", "for", "ThermoDox", "with", "Yakult", "Honsha", "Co.", "to", "provide", "for", "accelerated", "payments", "of", "up", "to", "$4", "million", "in", "future", "milestone", "payments,", "including", "$2", "million", "that", "was", "paid", "to", "us", "on", "January", "12,", "2011,", "in", "exchange", "for", "a", "reduction", "in", "product", "approval", "milestones", "that", "we", "may", "receive", "in", "the", "future", "under", "the", "Yakult", "Agreement.", "<tag2>", "This", "lease", "obligation", "has", "thirty", "monthly", "payments", "of", "$5,651", "through", "February", "2014.", "<tag3>"], "wordsA": ["In", "the", "first", "quarter", "of", "2011,", "we", "recognized", "$2", "million", "in", "licensing", "revenue", "after", "amending", "our", "development,", "product", "supply", "and", "commercialization", "agreement", "for", "ThermoDox", "with", "Yakult", "Honsha", "Co.", "to", "provide", "for", "accelerated", "payments", "of", "up", "to", "$4", "million", "in", "future", "milestone", "payments,", "including", "$2", "million", "that", "was", "paid", "to", "us", "on", "January", "12,", "2011,", "in", "exchange", "for", "a", "reduction", "in", "product", "approval", "milestones", "that", "we", "may", "receive", "in", "the", "future", "under", "the", "Yakult", "Agreement."], "wordsB": ["This", "lease", "obligation", "has", "thirty", "monthly", "payments", "of", "$5,651", "through", "February", "2014."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p21_s0", "idA": "749647_12_item7_p19_s1", "sentA": "We had no licensing revenue for the year ended December 31, 2010.", "sentB": "The primary study endpoint for the ABLATE study is based on one year local tumor recurrence, with secondary endpoints of time to progression and overall survival.", "type": 1, "words": ["<tag1>", "We", "had", "no", "licensing", "revenue", "for", "the", "year", "ended", "December", "31,", "2010.", "<tag2>", "The", "primary", "study", "endpoint", "for", "the", "ABLATE", "study", "is", "based", "on", "one", "year", "local", "tumor", "recurrence,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival.", "<tag3>"], "wordsA": ["We", "had", "no", "licensing", "revenue", "for", "the", "year", "ended", "December", "31,", "2010."], "wordsB": ["The", "primary", "study", "endpoint", "for", "the", "ABLATE", "study", "is", "based", "on", "one", "year", "local", "tumor", "recurrence,", "with", "secondary", "endpoints", "of", "time", "to", "progression", "and", "overall", "survival."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p15_s0", "idA": "749647_12_item7_p20_s2", "sentA": "This increase is primarily the result of costs for investigator grants, monitoring costs and milestone payments associated with higher patient enrollment levels for the Phase III HEAT study.", "sentB": "The exclusive option agreement contemplated payments of an upfront license fee, milestone payments and royalties to Celsion if the exclusive license agreement were entered into.", "type": 1, "words": ["<tag1>", "This", "increase", "is", "primarily", "the", "result", "of", "costs", "for", "investigator", "grants,", "monitoring", "costs", "and", "milestone", "payments", "associated", "with", "higher", "patient", "enrollment", "levels", "for", "the", "Phase", "III", "HEAT", "study.", "<tag2>", "The", "exclusive", "option", "agreement", "contemplated", "payments", "of", "an", "upfront", "license", "fee,", "milestone", "payments", "and", "royalties", "to", "Celsion", "if", "the", "exclusive", "license", "agreement", "were", "entered", "into.", "<tag3>"], "wordsA": ["This", "increase", "is", "primarily", "the", "result", "of", "costs", "for", "investigator", "grants,", "monitoring", "costs", "and", "milestone", "payments", "associated", "with", "higher", "patient", "enrollment", "levels", "for", "the", "Phase", "III", "HEAT", "study."], "wordsB": ["The", "exclusive", "option", "agreement", "contemplated", "payments", "of", "an", "upfront", "license", "fee,", "milestone", "payments", "and", "royalties", "to", "Celsion", "if", "the", "exclusive", "license", "agreement", "were", "entered", "into."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p10_s2", "idA": "749647_12_item7_p21_s0", "sentA": "In 2011, we initiated a Phase II study of ThermoDox in combination with radiofrequency ablation (RFA) for the treatment of colorectal liver metastases (CRLM).", "sentB": "We will repay Hisun for the aggregate amount of these development costs and fees commencing on the successful completion of three registrational batches of ThermoDox .", "type": 1, "words": ["<tag1>", "In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "radiofrequency", "ablation", "(RFA)", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(CRLM).", "<tag2>", "We", "will", "repay", "Hisun", "for", "the", "aggregate", "amount", "of", "these", "development", "costs", "and", "fees", "commencing", "on", "the", "successful", "completion", "of", "three", "registrational", "batches", "of", "ThermoDox", ".", "<tag3>"], "wordsA": ["In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "radiofrequency", "ablation", "(RFA)", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(CRLM)."], "wordsB": ["We", "will", "repay", "Hisun", "for", "the", "aggregate", "amount", "of", "these", "development", "costs", "and", "fees", "commencing", "on", "the", "successful", "completion", "of", "three", "registrational", "batches", "of", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p12_s0", "idA": "749647_12_item7_p21_s0", "sentA": "In 2011, we initiated a Phase II study of ThermoDox in combination with radiofrequency ablation (RFA) for the treatment of colorectal liver metastases (CRLM).", "sentB": "The agreement is initially limited to a percentage of the production requirements of ThermoDox in the China territory with Hisun retaining an option for additional global supply after local regulatory approval in the China territory.", "type": 1, "words": ["<tag1>", "In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "radiofrequency", "ablation", "(RFA)", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(CRLM).", "<tag2>", "The", "agreement", "is", "initially", "limited", "to", "a", "percentage", "of", "the", "production", "requirements", "of", "ThermoDox", "in", "the", "China", "territory", "with", "Hisun", "retaining", "an", "option", "for", "additional", "global", "supply", "after", "local", "regulatory", "approval", "in", "the", "China", "territory.", "<tag3>"], "wordsA": ["In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "radiofrequency", "ablation", "(RFA)", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(CRLM)."], "wordsB": ["The", "agreement", "is", "initially", "limited", "to", "a", "percentage", "of", "the", "production", "requirements", "of", "ThermoDox", "in", "the", "China", "territory", "with", "Hisun", "retaining", "an", "option", "for", "additional", "global", "supply", "after", "local", "regulatory", "approval", "in", "the", "China", "territory."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p22_s0", "idA": "749647_12_item7_p21_s1", "sentA": "Costs associated with the Company s CRLM trial were $0.3 million in 2011.", "sentB": "The DIGNITY study has opened for enrollment with the activation of three clinical sites.", "type": 1, "words": ["<tag1>", "Costs", "associated", "with", "the", "Company", "s", "CRLM", "trial", "were", "$0.3", "million", "in", "2011.", "<tag2>", "The", "DIGNITY", "study", "has", "opened", "for", "enrollment", "with", "the", "activation", "of", "three", "clinical", "sites.", "<tag3>"], "wordsA": ["Costs", "associated", "with", "the", "Company", "s", "CRLM", "trial", "were", "$0.3", "million", "in", "2011."], "wordsB": ["The", "DIGNITY", "study", "has", "opened", "for", "enrollment", "with", "the", "activation", "of", "three", "clinical", "sites."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p12_s1", "idA": "749647_12_item7_p21_s2", "sentA": "Costs associated with the production of Thermodox trials increased to $4.3 million in 2011 compared to $2.9 million in the same period of 2010 primarily due to ongoing progress towards developing our commercial manufacturing capabilities for ThermoDox .", "sentB": "In addition, Hisun will collaborate with us in relation to the regulatory approval activities for ThermoDox with the China State Food and Drug Administration (SFDA).", "type": 1, "words": ["<tag1>", "Costs", "associated", "with", "the", "production", "of", "Thermodox", "trials", "increased", "to", "$4.3", "million", "in", "2011", "compared", "to", "$2.9", "million", "in", "the", "same", "period", "of", "2010", "primarily", "due", "to", "ongoing", "progress", "towards", "developing", "our", "commercial", "manufacturing", "capabilities", "for", "ThermoDox", ".", "<tag2>", "In", "addition,", "Hisun", "will", "collaborate", "with", "us", "in", "relation", "to", "the", "regulatory", "approval", "activities", "for", "ThermoDox", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(SFDA).", "<tag3>"], "wordsA": ["Costs", "associated", "with", "the", "production", "of", "Thermodox", "trials", "increased", "to", "$4.3", "million", "in", "2011", "compared", "to", "$2.9", "million", "in", "the", "same", "period", "of", "2010", "primarily", "due", "to", "ongoing", "progress", "towards", "developing", "our", "commercial", "manufacturing", "capabilities", "for", "ThermoDox", "."], "wordsB": ["In", "addition,", "Hisun", "will", "collaborate", "with", "us", "in", "relation", "to", "the", "regulatory", "approval", "activities", "for", "ThermoDox", "with", "the", "China", "State", "Food", "and", "Drug", "Administration", "(SFDA)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p13_s0", "idA": "749647_12_item7_p29_s0", "sentA": "The process of developing and commercializing ThermoDox requires significant research and development work and clinical trial studies, as well as significant manufacturing and process development efforts.", "sentB": "On January 18, 2013, we broadened our relationship with Hisun by entering into a technology development contract with Hisun, pursuant to which Hisun paid us a non-refundable research and development fee of $5.0 million to support our development of ThermoDox and we will provide research data and other technical support in relation to a regulatory filing by Hisun with the SFDA for approval of ThermoDox for manufacturing and sale in the China territory.", "type": 1, "words": ["<tag1>", "The", "process", "of", "developing", "and", "commercializing", "ThermoDox", "requires", "significant", "research", "and", "development", "work", "and", "clinical", "trial", "studies,", "as", "well", "as", "significant", "manufacturing", "and", "process", "development", "efforts.", "<tag2>", "On", "January", "18,", "2013,", "we", "broadened", "our", "relationship", "with", "Hisun", "by", "entering", "into", "a", "technology", "development", "contract", "with", "Hisun,", "pursuant", "to", "which", "Hisun", "paid", "us", "a", "non-refundable", "research", "and", "development", "fee", "of", "$5.0", "million", "to", "support", "our", "development", "of", "ThermoDox", "and", "we", "will", "provide", "research", "data", "and", "other", "technical", "support", "in", "relation", "to", "a", "regulatory", "filing", "by", "Hisun", "with", "the", "SFDA", "for", "approval", "of", "ThermoDox", "for", "manufacturing", "and", "sale", "in", "the", "China", "territory.", "<tag3>"], "wordsA": ["The", "process", "of", "developing", "and", "commercializing", "ThermoDox", "requires", "significant", "research", "and", "development", "work", "and", "clinical", "trial", "studies,", "as", "well", "as", "significant", "manufacturing", "and", "process", "development", "efforts."], "wordsB": ["On", "January", "18,", "2013,", "we", "broadened", "our", "relationship", "with", "Hisun", "by", "entering", "into", "a", "technology", "development", "contract", "with", "Hisun,", "pursuant", "to", "which", "Hisun", "paid", "us", "a", "non-refundable", "research", "and", "development", "fee", "of", "$5.0", "million", "to", "support", "our", "development", "of", "ThermoDox", "and", "we", "will", "provide", "research", "data", "and", "other", "technical", "support", "in", "relation", "to", "a", "regulatory", "filing", "by", "Hisun", "with", "the", "SFDA", "for", "approval", "of", "ThermoDox", "for", "manufacturing", "and", "sale", "in", "the", "China", "territory."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p73_s0", "idA": "749647_12_item7_p29_s0", "sentA": "The process of developing and commercializing ThermoDox requires significant research and development work and clinical trial studies, as well as significant manufacturing and process development efforts.", "sentB": "On January 18, 2013, we entered into a technology development contract with Hisun, pursuant to which Hisun paid us a non-refundable research and development fee of $5 million to support our development of ThermoDox and we will provide research data and other technical support in relation to a regulatory filing by Hisun for approval of ThermoDox for manufacturing and sale in mainland China, Hong Kong and Macau.", "type": 1, "words": ["<tag1>", "The", "process", "of", "developing", "and", "commercializing", "ThermoDox", "requires", "significant", "research", "and", "development", "work", "and", "clinical", "trial", "studies,", "as", "well", "as", "significant", "manufacturing", "and", "process", "development", "efforts.", "<tag2>", "On", "January", "18,", "2013,", "we", "entered", "into", "a", "technology", "development", "contract", "with", "Hisun,", "pursuant", "to", "which", "Hisun", "paid", "us", "a", "non-refundable", "research", "and", "development", "fee", "of", "$5", "million", "to", "support", "our", "development", "of", "ThermoDox", "and", "we", "will", "provide", "research", "data", "and", "other", "technical", "support", "in", "relation", "to", "a", "regulatory", "filing", "by", "Hisun", "for", "approval", "of", "ThermoDox", "for", "manufacturing", "and", "sale", "in", "mainland", "China,", "Hong", "Kong", "and", "Macau.", "<tag3>"], "wordsA": ["The", "process", "of", "developing", "and", "commercializing", "ThermoDox", "requires", "significant", "research", "and", "development", "work", "and", "clinical", "trial", "studies,", "as", "well", "as", "significant", "manufacturing", "and", "process", "development", "efforts."], "wordsB": ["On", "January", "18,", "2013,", "we", "entered", "into", "a", "technology", "development", "contract", "with", "Hisun,", "pursuant", "to", "which", "Hisun", "paid", "us", "a", "non-refundable", "research", "and", "development", "fee", "of", "$5", "million", "to", "support", "our", "development", "of", "ThermoDox", "and", "we", "will", "provide", "research", "data", "and", "other", "technical", "support", "in", "relation", "to", "a", "regulatory", "filing", "by", "Hisun", "for", "approval", "of", "ThermoDox", "for", "manufacturing", "and", "sale", "in", "mainland", "China,", "Hong", "Kong", "and", "Macau."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p7_s5", "idA": "749647_12_item7_p29_s0", "sentA": "The process of developing and commercializing ThermoDox requires significant research and development work and clinical trial studies, as well as significant manufacturing and process development efforts.", "sentB": "However, as demonstrated by the HEAT study results announced on January 31, 2013, drug research and development is an inherently uncertain process and there is a high risk of failure at every stage prior to approval.", "type": 1, "words": ["<tag1>", "The", "process", "of", "developing", "and", "commercializing", "ThermoDox", "requires", "significant", "research", "and", "development", "work", "and", "clinical", "trial", "studies,", "as", "well", "as", "significant", "manufacturing", "and", "process", "development", "efforts.", "<tag2>", "However,", "as", "demonstrated", "by", "the", "HEAT", "study", "results", "announced", "on", "January", "31,", "2013,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval.", "<tag3>"], "wordsA": ["The", "process", "of", "developing", "and", "commercializing", "ThermoDox", "requires", "significant", "research", "and", "development", "work", "and", "clinical", "trial", "studies,", "as", "well", "as", "significant", "manufacturing", "and", "process", "development", "efforts."], "wordsB": ["However,", "as", "demonstrated", "by", "the", "HEAT", "study", "results", "announced", "on", "January", "31,", "2013,", "drug", "research", "and", "development", "is", "an", "inherently", "uncertain", "process", "and", "there", "is", "a", "high", "risk", "of", "failure", "at", "every", "stage", "prior", "to", "approval."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p39_s0", "idA": "749647_12_item7_p29_s1", "sentA": "We expect these activities, together with our general and administrative expenses to result in significant operating losses for the foreseeable future.", "sentB": "However, our future capital requirements will depend upon numerous unpredictable factors, including, without limitation, the cost, timing and outcomes of clinical studies and regulatory reviews of our proprietary drug candidates, our efforts to implement new collaborations, licenses and strategic transactions, general and administrative expenses, capital expenditures and other uses of cash.", "type": 1, "words": ["<tag1>", "We", "expect", "these", "activities,", "together", "with", "our", "general", "and", "administrative", "expenses", "to", "result", "in", "significant", "operating", "losses", "for", "the", "foreseeable", "future.", "<tag2>", "However,", "our", "future", "capital", "requirements", "will", "depend", "upon", "numerous", "unpredictable", "factors,", "including,", "without", "limitation,", "the", "cost,", "timing", "and", "outcomes", "of", "clinical", "studies", "and", "regulatory", "reviews", "of", "our", "proprietary", "drug", "candidates,", "our", "efforts", "to", "implement", "new", "collaborations,", "licenses", "and", "strategic", "transactions,", "general", "and", "administrative", "expenses,", "capital", "expenditures", "and", "other", "uses", "of", "cash.", "<tag3>"], "wordsA": ["We", "expect", "these", "activities,", "together", "with", "our", "general", "and", "administrative", "expenses", "to", "result", "in", "significant", "operating", "losses", "for", "the", "foreseeable", "future."], "wordsB": ["However,", "our", "future", "capital", "requirements", "will", "depend", "upon", "numerous", "unpredictable", "factors,", "including,", "without", "limitation,", "the", "cost,", "timing", "and", "outcomes", "of", "clinical", "studies", "and", "regulatory", "reviews", "of", "our", "proprietary", "drug", "candidates,", "our", "efforts", "to", "implement", "new", "collaborations,", "licenses", "and", "strategic", "transactions,", "general", "and", "administrative", "expenses,", "capital", "expenditures", "and", "other", "uses", "of", "cash."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p80_s1", "idA": "749647_12_item7_p29_s1", "sentA": "We expect these activities, together with our general and administrative expenses to result in significant operating losses for the foreseeable future.", "sentB": "However, our future capital requirements will depend upon numerous unpredictable factors, including, without limitation, the cost, timing and outcomes of clinical studies and regulatory reviews of our proprietary drug candidates, our efforts to implement new collaborations, licenses and strategic transactions, general and administrative expenses, capital expenditures and other uses of cash.", "type": 1, "words": ["<tag1>", "We", "expect", "these", "activities,", "together", "with", "our", "general", "and", "administrative", "expenses", "to", "result", "in", "significant", "operating", "losses", "for", "the", "foreseeable", "future.", "<tag2>", "However,", "our", "future", "capital", "requirements", "will", "depend", "upon", "numerous", "unpredictable", "factors,", "including,", "without", "limitation,", "the", "cost,", "timing", "and", "outcomes", "of", "clinical", "studies", "and", "regulatory", "reviews", "of", "our", "proprietary", "drug", "candidates,", "our", "efforts", "to", "implement", "new", "collaborations,", "licenses", "and", "strategic", "transactions,", "general", "and", "administrative", "expenses,", "capital", "expenditures", "and", "other", "uses", "of", "cash.", "<tag3>"], "wordsA": ["We", "expect", "these", "activities,", "together", "with", "our", "general", "and", "administrative", "expenses", "to", "result", "in", "significant", "operating", "losses", "for", "the", "foreseeable", "future."], "wordsB": ["However,", "our", "future", "capital", "requirements", "will", "depend", "upon", "numerous", "unpredictable", "factors,", "including,", "without", "limitation,", "the", "cost,", "timing", "and", "outcomes", "of", "clinical", "studies", "and", "regulatory", "reviews", "of", "our", "proprietary", "drug", "candidates,", "our", "efforts", "to", "implement", "new", "collaborations,", "licenses", "and", "strategic", "transactions,", "general", "and", "administrative", "expenses,", "capital", "expenditures", "and", "other", "uses", "of", "cash."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p10_s3", "idA": "749647_12_item7_p30_s1", "sentA": "At December 31, 2010, we had total current assets of $2.0 million (including cash, cash equivalents and short term investments of $1.5 million) and current liabilities of $6.8 million, resulting in a working capital deficit of $4.8 million.", "sentB": "The batches are expected to be successfully produced in mid-2013, and repayment of the development costs will occur at any time on or prior to the fourth year anniversary of the signing of the agreement, which we expect in total to be approximately $2.0 million.", "type": 1, "words": ["<tag1>", "At", "December", "31,", "2010,", "we", "had", "total", "current", "assets", "of", "$2.0", "million", "(including", "cash,", "cash", "equivalents", "and", "short", "term", "investments", "of", "$1.5", "million)", "and", "current", "liabilities", "of", "$6.8", "million,", "resulting", "in", "a", "working", "capital", "deficit", "of", "$4.8", "million.", "<tag2>", "The", "batches", "are", "expected", "to", "be", "successfully", "produced", "in", "mid-2013,", "and", "repayment", "of", "the", "development", "costs", "will", "occur", "at", "any", "time", "on", "or", "prior", "to", "the", "fourth", "year", "anniversary", "of", "the", "signing", "of", "the", "agreement,", "which", "we", "expect", "in", "total", "to", "be", "approximately", "$2.0", "million.", "<tag3>"], "wordsA": ["At", "December", "31,", "2010,", "we", "had", "total", "current", "assets", "of", "$2.0", "million", "(including", "cash,", "cash", "equivalents", "and", "short", "term", "investments", "of", "$1.5", "million)", "and", "current", "liabilities", "of", "$6.8", "million,", "resulting", "in", "a", "working", "capital", "deficit", "of", "$4.8", "million."], "wordsB": ["The", "batches", "are", "expected", "to", "be", "successfully", "produced", "in", "mid-2013,", "and", "repayment", "of", "the", "development", "costs", "will", "occur", "at", "any", "time", "on", "or", "prior", "to", "the", "fourth", "year", "anniversary", "of", "the", "signing", "of", "the", "agreement,", "which", "we", "expect", "in", "total", "to", "be", "approximately", "$2.0", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p18_s2", "idA": "749647_12_item7_p33_s0", "sentA": "We will require additional capital to develop our product candidates through clinical development, manufacturing, and commercialization.", "sentB": "This early phase clinical study is being finalized and will require approval from a local ethics committee.", "type": 1, "words": ["<tag1>", "We", "will", "require", "additional", "capital", "to", "develop", "our", "product", "candidates", "through", "clinical", "development,", "manufacturing,", "and", "commercialization.", "<tag2>", "This", "early", "phase", "clinical", "study", "is", "being", "finalized", "and", "will", "require", "approval", "from", "a", "local", "ethics", "committee.", "<tag3>"], "wordsA": ["We", "will", "require", "additional", "capital", "to", "develop", "our", "product", "candidates", "through", "clinical", "development,", "manufacturing,", "and", "commercialization."], "wordsB": ["This", "early", "phase", "clinical", "study", "is", "being", "finalized", "and", "will", "require", "approval", "from", "a", "local", "ethics", "committee."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p19_s1", "idA": "749647_12_item7_p38_s2", "sentA": "As a result, 839 shares of convertible preferred stock which were outstanding at the time, were converted into 349,582 shares of our common stock.", "sentB": "The studies are being conducted at the University of Washington (UW) School of Medicine.", "type": 1, "words": ["<tag1>", "As", "a", "result,", "839", "shares", "of", "convertible", "preferred", "stock", "which", "were", "outstanding", "at", "the", "time,", "were", "converted", "into", "349,582", "shares", "of", "our", "common", "stock.", "<tag2>", "The", "studies", "are", "being", "conducted", "at", "the", "University", "of", "Washington", "(UW)", "School", "of", "Medicine.", "<tag3>"], "wordsA": ["As", "a", "result,", "839", "shares", "of", "convertible", "preferred", "stock", "which", "were", "outstanding", "at", "the", "time,", "were", "converted", "into", "349,582", "shares", "of", "our", "common", "stock."], "wordsB": ["The", "studies", "are", "being", "conducted", "at", "the", "University", "of", "Washington", "(UW)", "School", "of", "Medicine."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p18_s1", "idA": "749647_12_item7_p41_s5", "sentA": "Concurrent with the issuance and sale of the units, the Company entered into a registration rights agreement with the investors that required the Company to file a registration statement with the Securities and Exchange Commission covering the resale by the investors of the common stock and the shares of common stock issuable upon exercise of the warrants, which registration statement became effective on June 24, 2011.", "sentB": "The trial, which is supported by the National Institute for Health Research Oxford Biomedical Research Centre, will be carried out as a multidisciplinary collaboration between us, the Oxford University Institute of Biomedical Engineering and the Oxford University Hospitals NHS Trust.", "type": 1, "words": ["<tag1>", "Concurrent", "with", "the", "issuance", "and", "sale", "of", "the", "units,", "the", "Company", "entered", "into", "a", "registration", "rights", "agreement", "with", "the", "investors", "that", "required", "the", "Company", "to", "file", "a", "registration", "statement", "with", "the", "Securities", "and", "Exchange", "Commission", "covering", "the", "resale", "by", "the", "investors", "of", "the", "common", "stock", "and", "the", "shares", "of", "common", "stock", "issuable", "upon", "exercise", "of", "the", "warrants,", "which", "registration", "statement", "became", "effective", "on", "June", "24,", "2011.", "<tag2>", "The", "trial,", "which", "is", "supported", "by", "the", "National", "Institute", "for", "Health", "Research", "Oxford", "Biomedical", "Research", "Centre,", "will", "be", "carried", "out", "as", "a", "multidisciplinary", "collaboration", "between", "us,", "the", "Oxford", "University", "Institute", "of", "Biomedical", "Engineering", "and", "the", "Oxford", "University", "Hospitals", "NHS", "Trust.", "<tag3>"], "wordsA": ["Concurrent", "with", "the", "issuance", "and", "sale", "of", "the", "units,", "the", "Company", "entered", "into", "a", "registration", "rights", "agreement", "with", "the", "investors", "that", "required", "the", "Company", "to", "file", "a", "registration", "statement", "with", "the", "Securities", "and", "Exchange", "Commission", "covering", "the", "resale", "by", "the", "investors", "of", "the", "common", "stock", "and", "the", "shares", "of", "common", "stock", "issuable", "upon", "exercise", "of", "the", "warrants,", "which", "registration", "statement", "became", "effective", "on", "June", "24,", "2011."], "wordsB": ["The", "trial,", "which", "is", "supported", "by", "the", "National", "Institute", "for", "Health", "Research", "Oxford", "Biomedical", "Research", "Centre,", "will", "be", "carried", "out", "as", "a", "multidisciplinary", "collaboration", "between", "us,", "the", "Oxford", "University", "Institute", "of", "Biomedical", "Engineering", "and", "the", "Oxford", "University", "Hospitals", "NHS", "Trust."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p22_s2", "idA": "749647_12_item7_p43_s1", "sentA": "The Company received gross proceeds of $222,336 from the exercise of these warrants.", "sentB": "The continuation of these studies will be subject to a detailed analysis of the data from the HEAT study to assess the future strategic value of our product pipeline and research and development priorities.", "type": 1, "words": ["<tag1>", "The", "Company", "received", "gross", "proceeds", "of", "$222,336", "from", "the", "exercise", "of", "these", "warrants.", "<tag2>", "The", "continuation", "of", "these", "studies", "will", "be", "subject", "to", "a", "detailed", "analysis", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "our", "product", "pipeline", "and", "research", "and", "development", "priorities.", "<tag3>"], "wordsA": ["The", "Company", "received", "gross", "proceeds", "of", "$222,336", "from", "the", "exercise", "of", "these", "warrants."], "wordsB": ["The", "continuation", "of", "these", "studies", "will", "be", "subject", "to", "a", "detailed", "analysis", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "our", "product", "pipeline", "and", "research", "and", "development", "priorities."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p27_s2", "idA": "749647_12_item7_p43_s1", "sentA": "The Company received gross proceeds of $222,336 from the exercise of these warrants.", "sentB": "The Company was also obligated to pay other customary facility fees for a credit facility of this size and type.", "type": 1, "words": ["<tag1>", "The", "Company", "received", "gross", "proceeds", "of", "$222,336", "from", "the", "exercise", "of", "these", "warrants.", "<tag2>", "The", "Company", "was", "also", "obligated", "to", "pay", "other", "customary", "facility", "fees", "for", "a", "credit", "facility", "of", "this", "size", "and", "type.", "<tag3>"], "wordsA": ["The", "Company", "received", "gross", "proceeds", "of", "$222,336", "from", "the", "exercise", "of", "these", "warrants."], "wordsB": ["The", "Company", "was", "also", "obligated", "to", "pay", "other", "customary", "facility", "fees", "for", "a", "credit", "facility", "of", "this", "size", "and", "type."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p70_s2", "idA": "749647_12_item7_p43_s1", "sentA": "The Company received gross proceeds of $222,336 from the exercise of these warrants.", "sentB": "The Company was also obligated to pay other customary facility fees for a credit facility of this size and type.", "type": 1, "words": ["<tag1>", "The", "Company", "received", "gross", "proceeds", "of", "$222,336", "from", "the", "exercise", "of", "these", "warrants.", "<tag2>", "The", "Company", "was", "also", "obligated", "to", "pay", "other", "customary", "facility", "fees", "for", "a", "credit", "facility", "of", "this", "size", "and", "type.", "<tag3>"], "wordsA": ["The", "Company", "received", "gross", "proceeds", "of", "$222,336", "from", "the", "exercise", "of", "these", "warrants."], "wordsB": ["The", "Company", "was", "also", "obligated", "to", "pay", "other", "customary", "facility", "fees", "for", "a", "credit", "facility", "of", "this", "size", "and", "type."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p33_s3", "idA": "749647_12_item7_p44_s3", "sentA": "The Company received gross proceeds from the offering of approximately $13.0 million, before deducting placement agent fees and offering expenses.", "sentB": "The Company also agreed to reimburse Cantor for legal fees and disbursements, not to exceed $50,000 in the aggregate, in connection with entering into the ATM Agreement.", "type": 1, "words": ["<tag1>", "The", "Company", "received", "gross", "proceeds", "from", "the", "offering", "of", "approximately", "$13.0", "million,", "before", "deducting", "placement", "agent", "fees", "and", "offering", "expenses.", "<tag2>", "The", "Company", "also", "agreed", "to", "reimburse", "Cantor", "for", "legal", "fees", "and", "disbursements,", "not", "to", "exceed", "$50,000", "in", "the", "aggregate,", "in", "connection", "with", "entering", "into", "the", "ATM", "Agreement.", "<tag3>"], "wordsA": ["The", "Company", "received", "gross", "proceeds", "from", "the", "offering", "of", "approximately", "$13.0", "million,", "before", "deducting", "placement", "agent", "fees", "and", "offering", "expenses."], "wordsB": ["The", "Company", "also", "agreed", "to", "reimburse", "Cantor", "for", "legal", "fees", "and", "disbursements,", "not", "to", "exceed", "$50,000", "in", "the", "aggregate,", "in", "connection", "with", "entering", "into", "the", "ATM", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p76_s3", "idA": "749647_12_item7_p44_s3", "sentA": "The Company received gross proceeds from the offering of approximately $13.0 million, before deducting placement agent fees and offering expenses.", "sentB": "The Company also agreed to reimburse Cantor for legal fees and disbursements, not to exceed $50,000 in the aggregate, in connection with entering into the ATM Agreement.", "type": 1, "words": ["<tag1>", "The", "Company", "received", "gross", "proceeds", "from", "the", "offering", "of", "approximately", "$13.0", "million,", "before", "deducting", "placement", "agent", "fees", "and", "offering", "expenses.", "<tag2>", "The", "Company", "also", "agreed", "to", "reimburse", "Cantor", "for", "legal", "fees", "and", "disbursements,", "not", "to", "exceed", "$50,000", "in", "the", "aggregate,", "in", "connection", "with", "entering", "into", "the", "ATM", "Agreement.", "<tag3>"], "wordsA": ["The", "Company", "received", "gross", "proceeds", "from", "the", "offering", "of", "approximately", "$13.0", "million,", "before", "deducting", "placement", "agent", "fees", "and", "offering", "expenses."], "wordsB": ["The", "Company", "also", "agreed", "to", "reimburse", "Cantor", "for", "legal", "fees", "and", "disbursements,", "not", "to", "exceed", "$50,000", "in", "the", "aggregate,", "in", "connection", "with", "entering", "into", "the", "ATM", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p24_s1", "idA": "749647_12_item7_p47_s0", "sentA": "Each warrant to purchase shares of the Company s common stock has an exercise price of $2.36 per share, for total potential additional proceeds to the Company of up to approximately $7.5 million upon exercise of the warrants.", "sentB": "The Credit Agreement provides for a secured term loan of up to $10 million, with 50% of any loans to be funded by Oxford and 50% to be funded by Horizon.", "type": 1, "words": ["<tag1>", "Each", "warrant", "to", "purchase", "shares", "of", "the", "Company", "s", "common", "stock", "has", "an", "exercise", "price", "of", "$2.36", "per", "share,", "for", "total", "potential", "additional", "proceeds", "to", "the", "Company", "of", "up", "to", "approximately", "$7.5", "million", "upon", "exercise", "of", "the", "warrants.", "<tag2>", "The", "Credit", "Agreement", "provides", "for", "a", "secured", "term", "loan", "of", "up", "to", "$10", "million,", "with", "50%", "of", "any", "loans", "to", "be", "funded", "by", "Oxford", "and", "50%", "to", "be", "funded", "by", "Horizon.", "<tag3>"], "wordsA": ["Each", "warrant", "to", "purchase", "shares", "of", "the", "Company", "s", "common", "stock", "has", "an", "exercise", "price", "of", "$2.36", "per", "share,", "for", "total", "potential", "additional", "proceeds", "to", "the", "Company", "of", "up", "to", "approximately", "$7.5", "million", "upon", "exercise", "of", "the", "warrants."], "wordsB": ["The", "Credit", "Agreement", "provides", "for", "a", "secured", "term", "loan", "of", "up", "to", "$10", "million,", "with", "50%", "of", "any", "loans", "to", "be", "funded", "by", "Oxford", "and", "50%", "to", "be", "funded", "by", "Horizon."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p32_s2", "idA": "749647_12_item7_p47_s0", "sentA": "Each warrant to purchase shares of the Company s common stock has an exercise price of $2.36 per share, for total potential additional proceeds to the Company of up to approximately $7.5 million upon exercise of the warrants.", "sentB": "Subject to the terms and conditions of the ATM Agreement, Cantor will use commercially reasonable efforts, consistent with its normal trading and sales practices and applicable state and federal law, rules and regulations and the rules of The NASDAQ Capital Market, to sell ATM Shares from time to time based upon the Company s instructions, including any price, time or size limits or other customary parameters or conditions Celsion may impose.", "type": 1, "words": ["<tag1>", "Each", "warrant", "to", "purchase", "shares", "of", "the", "Company", "s", "common", "stock", "has", "an", "exercise", "price", "of", "$2.36", "per", "share,", "for", "total", "potential", "additional", "proceeds", "to", "the", "Company", "of", "up", "to", "approximately", "$7.5", "million", "upon", "exercise", "of", "the", "warrants.", "<tag2>", "Subject", "to", "the", "terms", "and", "conditions", "of", "the", "ATM", "Agreement,", "Cantor", "will", "use", "commercially", "reasonable", "efforts,", "consistent", "with", "its", "normal", "trading", "and", "sales", "practices", "and", "applicable", "state", "and", "federal", "law,", "rules", "and", "regulations", "and", "the", "rules", "of", "The", "NASDAQ", "Capital", "Market,", "to", "sell", "ATM", "Shares", "from", "time", "to", "time", "based", "upon", "the", "Company", "s", "instructions,", "including", "any", "price,", "time", "or", "size", "limits", "or", "other", "customary", "parameters", "or", "conditions", "Celsion", "may", "impose.", "<tag3>"], "wordsA": ["Each", "warrant", "to", "purchase", "shares", "of", "the", "Company", "s", "common", "stock", "has", "an", "exercise", "price", "of", "$2.36", "per", "share,", "for", "total", "potential", "additional", "proceeds", "to", "the", "Company", "of", "up", "to", "approximately", "$7.5", "million", "upon", "exercise", "of", "the", "warrants."], "wordsB": ["Subject", "to", "the", "terms", "and", "conditions", "of", "the", "ATM", "Agreement,", "Cantor", "will", "use", "commercially", "reasonable", "efforts,", "consistent", "with", "its", "normal", "trading", "and", "sales", "practices", "and", "applicable", "state", "and", "federal", "law,", "rules", "and", "regulations", "and", "the", "rules", "of", "The", "NASDAQ", "Capital", "Market,", "to", "sell", "ATM", "Shares", "from", "time", "to", "time", "based", "upon", "the", "Company", "s", "instructions,", "including", "any", "price,", "time", "or", "size", "limits", "or", "other", "customary", "parameters", "or", "conditions", "Celsion", "may", "impose."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p67_s1", "idA": "749647_12_item7_p47_s0", "sentA": "Each warrant to purchase shares of the Company s common stock has an exercise price of $2.36 per share, for total potential additional proceeds to the Company of up to approximately $7.5 million upon exercise of the warrants.", "sentB": "The Credit Agreement provides for a secured term loan of up to $10 million, with 50% of any loans to be funded by Oxford and 50% to be funded by Horizon.", "type": 1, "words": ["<tag1>", "Each", "warrant", "to", "purchase", "shares", "of", "the", "Company", "s", "common", "stock", "has", "an", "exercise", "price", "of", "$2.36", "per", "share,", "for", "total", "potential", "additional", "proceeds", "to", "the", "Company", "of", "up", "to", "approximately", "$7.5", "million", "upon", "exercise", "of", "the", "warrants.", "<tag2>", "The", "Credit", "Agreement", "provides", "for", "a", "secured", "term", "loan", "of", "up", "to", "$10", "million,", "with", "50%", "of", "any", "loans", "to", "be", "funded", "by", "Oxford", "and", "50%", "to", "be", "funded", "by", "Horizon.", "<tag3>"], "wordsA": ["Each", "warrant", "to", "purchase", "shares", "of", "the", "Company", "s", "common", "stock", "has", "an", "exercise", "price", "of", "$2.36", "per", "share,", "for", "total", "potential", "additional", "proceeds", "to", "the", "Company", "of", "up", "to", "approximately", "$7.5", "million", "upon", "exercise", "of", "the", "warrants."], "wordsB": ["The", "Credit", "Agreement", "provides", "for", "a", "secured", "term", "loan", "of", "up", "to", "$10", "million,", "with", "50%", "of", "any", "loans", "to", "be", "funded", "by", "Oxford", "and", "50%", "to", "be", "funded", "by", "Horizon."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p75_s2", "idA": "749647_12_item7_p47_s0", "sentA": "Each warrant to purchase shares of the Company s common stock has an exercise price of $2.36 per share, for total potential additional proceeds to the Company of up to approximately $7.5 million upon exercise of the warrants.", "sentB": "Subject to the terms and conditions of the ATM Agreement, Cantor will use commercially reasonable efforts, consistent with its normal trading and sales practices and applicable state and federal law, rules and regulations and the rules of The NASDAQ Capital Market, to sell ATM Shares from time to time based upon the Company s instructions, including any price, time or size limits or other customary parameters or conditions Celsion may impose.", "type": 1, "words": ["<tag1>", "Each", "warrant", "to", "purchase", "shares", "of", "the", "Company", "s", "common", "stock", "has", "an", "exercise", "price", "of", "$2.36", "per", "share,", "for", "total", "potential", "additional", "proceeds", "to", "the", "Company", "of", "up", "to", "approximately", "$7.5", "million", "upon", "exercise", "of", "the", "warrants.", "<tag2>", "Subject", "to", "the", "terms", "and", "conditions", "of", "the", "ATM", "Agreement,", "Cantor", "will", "use", "commercially", "reasonable", "efforts,", "consistent", "with", "its", "normal", "trading", "and", "sales", "practices", "and", "applicable", "state", "and", "federal", "law,", "rules", "and", "regulations", "and", "the", "rules", "of", "The", "NASDAQ", "Capital", "Market,", "to", "sell", "ATM", "Shares", "from", "time", "to", "time", "based", "upon", "the", "Company", "s", "instructions,", "including", "any", "price,", "time", "or", "size", "limits", "or", "other", "customary", "parameters", "or", "conditions", "Celsion", "may", "impose.", "<tag3>"], "wordsA": ["Each", "warrant", "to", "purchase", "shares", "of", "the", "Company", "s", "common", "stock", "has", "an", "exercise", "price", "of", "$2.36", "per", "share,", "for", "total", "potential", "additional", "proceeds", "to", "the", "Company", "of", "up", "to", "approximately", "$7.5", "million", "upon", "exercise", "of", "the", "warrants."], "wordsB": ["Subject", "to", "the", "terms", "and", "conditions", "of", "the", "ATM", "Agreement,", "Cantor", "will", "use", "commercially", "reasonable", "efforts,", "consistent", "with", "its", "normal", "trading", "and", "sales", "practices", "and", "applicable", "state", "and", "federal", "law,", "rules", "and", "regulations", "and", "the", "rules", "of", "The", "NASDAQ", "Capital", "Market,", "to", "sell", "ATM", "Shares", "from", "time", "to", "time", "based", "upon", "the", "Company", "s", "instructions,", "including", "any", "price,", "time", "or", "size", "limits", "or", "other", "customary", "parameters", "or", "conditions", "Celsion", "may", "impose."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p29_s0", "idA": "749647_12_item7_p47_s2", "sentA": "Concurrent with the issuance and sale of the units, the Company entered into a registration rights agreement with the investors that required the Company to file a registration statement with the Securities and Exchange Commission covering the resale by the investors of the common stock and the shares of common stock issuable upon exercise of the warrants, which registration statement became effective on February 8, 2011.", "sentB": "On January 18, 2013, we entered into a technology development contract with Hisun, pursuant to which Hisun paid us a non-refundable research and development fee of $5 million to support our development of ThermoDox and we will provide research data and other technical support in relation to a regulatory filing by Hisun with the SFDA for approval of ThermoDox for manufacturing and sale in mainland China, Hong Kong and Macau.", "type": 1, "words": ["<tag1>", "Concurrent", "with", "the", "issuance", "and", "sale", "of", "the", "units,", "the", "Company", "entered", "into", "a", "registration", "rights", "agreement", "with", "the", "investors", "that", "required", "the", "Company", "to", "file", "a", "registration", "statement", "with", "the", "Securities", "and", "Exchange", "Commission", "covering", "the", "resale", "by", "the", "investors", "of", "the", "common", "stock", "and", "the", "shares", "of", "common", "stock", "issuable", "upon", "exercise", "of", "the", "warrants,", "which", "registration", "statement", "became", "effective", "on", "February", "8,", "2011.", "<tag2>", "On", "January", "18,", "2013,", "we", "entered", "into", "a", "technology", "development", "contract", "with", "Hisun,", "pursuant", "to", "which", "Hisun", "paid", "us", "a", "non-refundable", "research", "and", "development", "fee", "of", "$5", "million", "to", "support", "our", "development", "of", "ThermoDox", "and", "we", "will", "provide", "research", "data", "and", "other", "technical", "support", "in", "relation", "to", "a", "regulatory", "filing", "by", "Hisun", "with", "the", "SFDA", "for", "approval", "of", "ThermoDox", "for", "manufacturing", "and", "sale", "in", "mainland", "China,", "Hong", "Kong", "and", "Macau.", "<tag3>"], "wordsA": ["Concurrent", "with", "the", "issuance", "and", "sale", "of", "the", "units,", "the", "Company", "entered", "into", "a", "registration", "rights", "agreement", "with", "the", "investors", "that", "required", "the", "Company", "to", "file", "a", "registration", "statement", "with", "the", "Securities", "and", "Exchange", "Commission", "covering", "the", "resale", "by", "the", "investors", "of", "the", "common", "stock", "and", "the", "shares", "of", "common", "stock", "issuable", "upon", "exercise", "of", "the", "warrants,", "which", "registration", "statement", "became", "effective", "on", "February", "8,", "2011."], "wordsB": ["On", "January", "18,", "2013,", "we", "entered", "into", "a", "technology", "development", "contract", "with", "Hisun,", "pursuant", "to", "which", "Hisun", "paid", "us", "a", "non-refundable", "research", "and", "development", "fee", "of", "$5", "million", "to", "support", "our", "development", "of", "ThermoDox", "and", "we", "will", "provide", "research", "data", "and", "other", "technical", "support", "in", "relation", "to", "a", "regulatory", "filing", "by", "Hisun", "with", "the", "SFDA", "for", "approval", "of", "ThermoDox", "for", "manufacturing", "and", "sale", "in", "mainland", "China,", "Hong", "Kong", "and", "Macau."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p19_s2", "idA": "749647_12_item7_p4_s1", "sentA": "Localized mild hyperthermia (greater than 40 degrees Celsius) releases the encapsulated doxorubicin from the liposome enabling high concentrations of doxorubicin to be deposited preferentially in a targeted tumor.", "sentB": "The UW research is expected to include animal models to confirm the ability of HIFU to target high concentrations of doxorubicin in proprietary pancreatic cancer cell lines and in vivo studies to assess the response to these tumors treated using ThermoDox with and without HIFU-induced hyperthermia.", "type": 1, "words": ["<tag1>", "Localized", "mild", "hyperthermia", "(greater", "than", "40", "degrees", "Celsius)", "releases", "the", "encapsulated", "doxorubicin", "from", "the", "liposome", "enabling", "high", "concentrations", "of", "doxorubicin", "to", "be", "deposited", "preferentially", "in", "a", "targeted", "tumor.", "<tag2>", "The", "UW", "research", "is", "expected", "to", "include", "animal", "models", "to", "confirm", "the", "ability", "of", "HIFU", "to", "target", "high", "concentrations", "of", "doxorubicin", "in", "proprietary", "pancreatic", "cancer", "cell", "lines", "and", "in", "vivo", "studies", "to", "assess", "the", "response", "to", "these", "tumors", "treated", "using", "ThermoDox", "with", "and", "without", "HIFU-induced", "hyperthermia.", "<tag3>"], "wordsA": ["Localized", "mild", "hyperthermia", "(greater", "than", "40", "degrees", "Celsius)", "releases", "the", "encapsulated", "doxorubicin", "from", "the", "liposome", "enabling", "high", "concentrations", "of", "doxorubicin", "to", "be", "deposited", "preferentially", "in", "a", "targeted", "tumor."], "wordsB": ["The", "UW", "research", "is", "expected", "to", "include", "animal", "models", "to", "confirm", "the", "ability", "of", "HIFU", "to", "target", "high", "concentrations", "of", "doxorubicin", "in", "proprietary", "pancreatic", "cancer", "cell", "lines", "and", "in", "vivo", "studies", "to", "assess", "the", "response", "to", "these", "tumors", "treated", "using", "ThermoDox", "with", "and", "without", "HIFU-induced", "hyperthermia."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p27_s1", "idA": "749647_12_item7_p51_s1", "sentA": "We registered the resale of the shares of common stock issued to SCBV pursuant to the CEFF under the Securities Act on a registration statement on Form S-1.", "sentB": "For an initial period extending for the Term A Loan through May 1, 2013, the Company is only required to make interest payments, after which the Company is required to make consecutive equal monthly payments of principle and interest to each lender as calculated pursuant to the Credit Agreement.", "type": 1, "words": ["<tag1>", "We", "registered", "the", "resale", "of", "the", "shares", "of", "common", "stock", "issued", "to", "SCBV", "pursuant", "to", "the", "CEFF", "under", "the", "Securities", "Act", "on", "a", "registration", "statement", "on", "Form", "S-1.", "<tag2>", "For", "an", "initial", "period", "extending", "for", "the", "Term", "A", "Loan", "through", "May", "1,", "2013,", "the", "Company", "is", "only", "required", "to", "make", "interest", "payments,", "after", "which", "the", "Company", "is", "required", "to", "make", "consecutive", "equal", "monthly", "payments", "of", "principle", "and", "interest", "to", "each", "lender", "as", "calculated", "pursuant", "to", "the", "Credit", "Agreement.", "<tag3>"], "wordsA": ["We", "registered", "the", "resale", "of", "the", "shares", "of", "common", "stock", "issued", "to", "SCBV", "pursuant", "to", "the", "CEFF", "under", "the", "Securities", "Act", "on", "a", "registration", "statement", "on", "Form", "S-1."], "wordsB": ["For", "an", "initial", "period", "extending", "for", "the", "Term", "A", "Loan", "through", "May", "1,", "2013,", "the", "Company", "is", "only", "required", "to", "make", "interest", "payments,", "after", "which", "the", "Company", "is", "required", "to", "make", "consecutive", "equal", "monthly", "payments", "of", "principle", "and", "interest", "to", "each", "lender", "as", "calculated", "pursuant", "to", "the", "Credit", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p70_s1", "idA": "749647_12_item7_p51_s1", "sentA": "We registered the resale of the shares of common stock issued to SCBV pursuant to the CEFF under the Securities Act on a registration statement on Form S-1.", "sentB": "For an initial period extending for the Term A Loan through May 1, 2013, the Company is only required to make interest payments, after which the Company is required to make consecutive equal monthly payments of principle and interest to each lender as calculated pursuant to the Credit Agreement.", "type": 1, "words": ["<tag1>", "We", "registered", "the", "resale", "of", "the", "shares", "of", "common", "stock", "issued", "to", "SCBV", "pursuant", "to", "the", "CEFF", "under", "the", "Securities", "Act", "on", "a", "registration", "statement", "on", "Form", "S-1.", "<tag2>", "For", "an", "initial", "period", "extending", "for", "the", "Term", "A", "Loan", "through", "May", "1,", "2013,", "the", "Company", "is", "only", "required", "to", "make", "interest", "payments,", "after", "which", "the", "Company", "is", "required", "to", "make", "consecutive", "equal", "monthly", "payments", "of", "principle", "and", "interest", "to", "each", "lender", "as", "calculated", "pursuant", "to", "the", "Credit", "Agreement.", "<tag3>"], "wordsA": ["We", "registered", "the", "resale", "of", "the", "shares", "of", "common", "stock", "issued", "to", "SCBV", "pursuant", "to", "the", "CEFF", "under", "the", "Securities", "Act", "on", "a", "registration", "statement", "on", "Form", "S-1."], "wordsB": ["For", "an", "initial", "period", "extending", "for", "the", "Term", "A", "Loan", "through", "May", "1,", "2013,", "the", "Company", "is", "only", "required", "to", "make", "interest", "payments,", "after", "which", "the", "Company", "is", "required", "to", "make", "consecutive", "equal", "monthly", "payments", "of", "principle", "and", "interest", "to", "each", "lender", "as", "calculated", "pursuant", "to", "the", "Credit", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p7_s1", "idA": "749647_12_item7_p51_s1", "sentA": "We registered the resale of the shares of common stock issued to SCBV pursuant to the CEFF under the Securities Act on a registration statement on Form S-1.", "sentB": "We plan to continue with related partnerships, such as our arrangement with Zhejiang Hisun Pharmaceutical Co. Ltd. (Hisun) described below, to the extent feasible.", "type": 1, "words": ["<tag1>", "We", "registered", "the", "resale", "of", "the", "shares", "of", "common", "stock", "issued", "to", "SCBV", "pursuant", "to", "the", "CEFF", "under", "the", "Securities", "Act", "on", "a", "registration", "statement", "on", "Form", "S-1.", "<tag2>", "We", "plan", "to", "continue", "with", "related", "partnerships,", "such", "as", "our", "arrangement", "with", "Zhejiang", "Hisun", "Pharmaceutical", "Co.", "Ltd.", "(Hisun)", "described", "below,", "to", "the", "extent", "feasible.", "<tag3>"], "wordsA": ["We", "registered", "the", "resale", "of", "the", "shares", "of", "common", "stock", "issued", "to", "SCBV", "pursuant", "to", "the", "CEFF", "under", "the", "Securities", "Act", "on", "a", "registration", "statement", "on", "Form", "S-1."], "wordsB": ["We", "plan", "to", "continue", "with", "related", "partnerships,", "such", "as", "our", "arrangement", "with", "Zhejiang", "Hisun", "Pharmaceutical", "Co.", "Ltd.", "(Hisun)", "described", "below,", "to", "the", "extent", "feasible."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p11_s0", "idA": "749647_12_item7_p52_s0", "sentA": "Availability under the CEFF was exhausted during the second quarter of 2011.", "sentB": "Hisun is also obligated to certain performance requirements under the agreement.", "type": 1, "words": ["<tag1>", "Availability", "under", "the", "CEFF", "was", "exhausted", "during", "the", "second", "quarter", "of", "2011.", "<tag2>", "Hisun", "is", "also", "obligated", "to", "certain", "performance", "requirements", "under", "the", "agreement.", "<tag3>"], "wordsA": ["Availability", "under", "the", "CEFF", "was", "exhausted", "during", "the", "second", "quarter", "of", "2011."], "wordsB": ["Hisun", "is", "also", "obligated", "to", "certain", "performance", "requirements", "under", "the", "agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p24_s3", "idA": "749647_12_item7_p52_s0", "sentA": "Availability under the CEFF was exhausted during the second quarter of 2011.", "sentB": "The first tranche (the Term A Loan ) was made available to the Company on June 27, 2012 and the second tranche (the Term B Loan ) was to be made available, if at all, during the period beginning on the date that the Company achieved positive data in its Phase III clinical trial of RFA and ThermoDox (the HEAT study) and ending on March 31, 2013.", "type": 1, "words": ["<tag1>", "Availability", "under", "the", "CEFF", "was", "exhausted", "during", "the", "second", "quarter", "of", "2011.", "<tag2>", "The", "first", "tranche", "(the", "Term", "A", "Loan", ")", "was", "made", "available", "to", "the", "Company", "on", "June", "27,", "2012", "and", "the", "second", "tranche", "(the", "Term", "B", "Loan", ")", "was", "to", "be", "made", "available,", "if", "at", "all,", "during", "the", "period", "beginning", "on", "the", "date", "that", "the", "Company", "achieved", "positive", "data", "in", "its", "Phase", "III", "clinical", "trial", "of", "RFA", "and", "ThermoDox", "(the", "HEAT", "study)", "and", "ending", "on", "March", "31,", "2013.", "<tag3>"], "wordsA": ["Availability", "under", "the", "CEFF", "was", "exhausted", "during", "the", "second", "quarter", "of", "2011."], "wordsB": ["The", "first", "tranche", "(the", "Term", "A", "Loan", ")", "was", "made", "available", "to", "the", "Company", "on", "June", "27,", "2012", "and", "the", "second", "tranche", "(the", "Term", "B", "Loan", ")", "was", "to", "be", "made", "available,", "if", "at", "all,", "during", "the", "period", "beginning", "on", "the", "date", "that", "the", "Company", "achieved", "positive", "data", "in", "its", "Phase", "III", "clinical", "trial", "of", "RFA", "and", "ThermoDox", "(the", "HEAT", "study)", "and", "ending", "on", "March", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p32_s1", "idA": "749647_12_item7_p52_s0", "sentA": "Availability under the CEFF was exhausted during the second quarter of 2011.", "sentB": "The Company is not obligated to sell any ATM Shares under the ATM Agreement.", "type": 1, "words": ["<tag1>", "Availability", "under", "the", "CEFF", "was", "exhausted", "during", "the", "second", "quarter", "of", "2011.", "<tag2>", "The", "Company", "is", "not", "obligated", "to", "sell", "any", "ATM", "Shares", "under", "the", "ATM", "Agreement.", "<tag3>"], "wordsA": ["Availability", "under", "the", "CEFF", "was", "exhausted", "during", "the", "second", "quarter", "of", "2011."], "wordsB": ["The", "Company", "is", "not", "obligated", "to", "sell", "any", "ATM", "Shares", "under", "the", "ATM", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p67_s3", "idA": "749647_12_item7_p52_s0", "sentA": "Availability under the CEFF was exhausted during the second quarter of 2011.", "sentB": "The first tranche (the Term A Loan ) was made available to the Company on June 27, 2012 and the second tranche (the Term B Loan ) was to be made available, if at all, during the period beginning on the date that the Company achieved positive data in its Phase III clinical trial of RFA and ThermoDox (the HEAT study) and ending on March 31, 2013.", "type": 1, "words": ["<tag1>", "Availability", "under", "the", "CEFF", "was", "exhausted", "during", "the", "second", "quarter", "of", "2011.", "<tag2>", "The", "first", "tranche", "(the", "Term", "A", "Loan", ")", "was", "made", "available", "to", "the", "Company", "on", "June", "27,", "2012", "and", "the", "second", "tranche", "(the", "Term", "B", "Loan", ")", "was", "to", "be", "made", "available,", "if", "at", "all,", "during", "the", "period", "beginning", "on", "the", "date", "that", "the", "Company", "achieved", "positive", "data", "in", "its", "Phase", "III", "clinical", "trial", "of", "RFA", "and", "ThermoDox", "(the", "HEAT", "study)", "and", "ending", "on", "March", "31,", "2013.", "<tag3>"], "wordsA": ["Availability", "under", "the", "CEFF", "was", "exhausted", "during", "the", "second", "quarter", "of", "2011."], "wordsB": ["The", "first", "tranche", "(the", "Term", "A", "Loan", ")", "was", "made", "available", "to", "the", "Company", "on", "June", "27,", "2012", "and", "the", "second", "tranche", "(the", "Term", "B", "Loan", ")", "was", "to", "be", "made", "available,", "if", "at", "all,", "during", "the", "period", "beginning", "on", "the", "date", "that", "the", "Company", "achieved", "positive", "data", "in", "its", "Phase", "III", "clinical", "trial", "of", "RFA", "and", "ThermoDox", "(the", "HEAT", "study)", "and", "ending", "on", "March", "31,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p75_s1", "idA": "749647_12_item7_p52_s0", "sentA": "Availability under the CEFF was exhausted during the second quarter of 2011.", "sentB": "The Company is not obligated to sell any ATM Shares under the ATM Agreement.", "type": 1, "words": ["<tag1>", "Availability", "under", "the", "CEFF", "was", "exhausted", "during", "the", "second", "quarter", "of", "2011.", "<tag2>", "The", "Company", "is", "not", "obligated", "to", "sell", "any", "ATM", "Shares", "under", "the", "ATM", "Agreement.", "<tag3>"], "wordsA": ["Availability", "under", "the", "CEFF", "was", "exhausted", "during", "the", "second", "quarter", "of", "2011."], "wordsB": ["The", "Company", "is", "not", "obligated", "to", "sell", "any", "ATM", "Shares", "under", "the", "ATM", "Agreement."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p89_s0", "idA": "749647_12_item7_p52_s1", "sentA": "The CEFF terminated automatically on the date on which SCVB purchased the entire commitment amount under the CEFF.", "sentB": "Following is a schedule of future principle payments due on the Credit Agreement as discussed above:", "type": 1, "words": ["<tag1>", "The", "CEFF", "terminated", "automatically", "on", "the", "date", "on", "which", "SCVB", "purchased", "the", "entire", "commitment", "amount", "under", "the", "CEFF.", "<tag2>", "Following", "is", "a", "schedule", "of", "future", "principle", "payments", "due", "on", "the", "Credit", "Agreement", "as", "discussed", "above:", "<tag3>"], "wordsA": ["The", "CEFF", "terminated", "automatically", "on", "the", "date", "on", "which", "SCVB", "purchased", "the", "entire", "commitment", "amount", "under", "the", "CEFF."], "wordsB": ["Following", "is", "a", "schedule", "of", "future", "principle", "payments", "due", "on", "the", "Credit", "Agreement", "as", "discussed", "above:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p7_s3", "idA": "749647_12_item7_p53_s0", "sentA": "We currently estimate we will use approximately $19 - $21 million of cash in 2012 to fund operations.", "sentB": "As we evaluate strategic alternatives, we will need to consider a number of factors, including investment in, or acquisition of, complementary businesses, technologies or products, possible capital raising transactions, partnering opportunities and working capital requirements.", "type": 1, "words": ["<tag1>", "We", "currently", "estimate", "we", "will", "use", "approximately", "$19", "-", "$21", "million", "of", "cash", "in", "2012", "to", "fund", "operations.", "<tag2>", "As", "we", "evaluate", "strategic", "alternatives,", "we", "will", "need", "to", "consider", "a", "number", "of", "factors,", "including", "investment", "in,", "or", "acquisition", "of,", "complementary", "businesses,", "technologies", "or", "products,", "possible", "capital", "raising", "transactions,", "partnering", "opportunities", "and", "working", "capital", "requirements.", "<tag3>"], "wordsA": ["We", "currently", "estimate", "we", "will", "use", "approximately", "$19", "-", "$21", "million", "of", "cash", "in", "2012", "to", "fund", "operations."], "wordsB": ["As", "we", "evaluate", "strategic", "alternatives,", "we", "will", "need", "to", "consider", "a", "number", "of", "factors,", "including", "investment", "in,", "or", "acquisition", "of,", "complementary", "businesses,", "technologies", "or", "products,", "possible", "capital", "raising", "transactions,", "partnering", "opportunities", "and", "working", "capital", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p10_s1", "idA": "749647_12_item7_p53_s6", "sentA": "The overall status of the economic climate could also result in the terms of any equity offering, debt financing, or alliance, license, or other arrangement being even less favorable to us and our stockholders than if the overall economic climate were stronger.", "sentB": "In accordance with the terms of the agreement, Hisun will be responsible for providing all of the technical and regulatory support services, including the costs of all technical transfer, registrational and bioequivalence studies, technical transfer costs, Celsion consultative support costs and the purchase of any necessary equipment and additional facility costs necessary to support capacity requirements for the manufacture of ThermoDox .", "type": 1, "words": ["<tag1>", "The", "overall", "status", "of", "the", "economic", "climate", "could", "also", "result", "in", "the", "terms", "of", "any", "equity", "offering,", "debt", "financing,", "or", "alliance,", "license,", "or", "other", "arrangement", "being", "even", "less", "favorable", "to", "us", "and", "our", "stockholders", "than", "if", "the", "overall", "economic", "climate", "were", "stronger.", "<tag2>", "In", "accordance", "with", "the", "terms", "of", "the", "agreement,", "Hisun", "will", "be", "responsible", "for", "providing", "all", "of", "the", "technical", "and", "regulatory", "support", "services,", "including", "the", "costs", "of", "all", "technical", "transfer,", "registrational", "and", "bioequivalence", "studies,", "technical", "transfer", "costs,", "Celsion", "consultative", "support", "costs", "and", "the", "purchase", "of", "any", "necessary", "equipment", "and", "additional", "facility", "costs", "necessary", "to", "support", "capacity", "requirements", "for", "the", "manufacture", "of", "ThermoDox", ".", "<tag3>"], "wordsA": ["The", "overall", "status", "of", "the", "economic", "climate", "could", "also", "result", "in", "the", "terms", "of", "any", "equity", "offering,", "debt", "financing,", "or", "alliance,", "license,", "or", "other", "arrangement", "being", "even", "less", "favorable", "to", "us", "and", "our", "stockholders", "than", "if", "the", "overall", "economic", "climate", "were", "stronger."], "wordsB": ["In", "accordance", "with", "the", "terms", "of", "the", "agreement,", "Hisun", "will", "be", "responsible", "for", "providing", "all", "of", "the", "technical", "and", "regulatory", "support", "services,", "including", "the", "costs", "of", "all", "technical", "transfer,", "registrational", "and", "bioequivalence", "studies,", "technical", "transfer", "costs,", "Celsion", "consultative", "support", "costs", "and", "the", "purchase", "of", "any", "necessary", "equipment", "and", "additional", "facility", "costs", "necessary", "to", "support", "capacity", "requirements", "for", "the", "manufacture", "of", "ThermoDox", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p29_s3", "idA": "749647_12_item7_p53_s6", "sentA": "The overall status of the economic climate could also result in the terms of any equity offering, debt financing, or alliance, license, or other arrangement being even less favorable to us and our stockholders than if the overall economic climate were stronger.", "sentB": "The exclusive option agreement contemplated payments of an upfront license fee, milestone payments and royalties to us if the exclusive license agreement were entered into.", "type": 1, "words": ["<tag1>", "The", "overall", "status", "of", "the", "economic", "climate", "could", "also", "result", "in", "the", "terms", "of", "any", "equity", "offering,", "debt", "financing,", "or", "alliance,", "license,", "or", "other", "arrangement", "being", "even", "less", "favorable", "to", "us", "and", "our", "stockholders", "than", "if", "the", "overall", "economic", "climate", "were", "stronger.", "<tag2>", "The", "exclusive", "option", "agreement", "contemplated", "payments", "of", "an", "upfront", "license", "fee,", "milestone", "payments", "and", "royalties", "to", "us", "if", "the", "exclusive", "license", "agreement", "were", "entered", "into.", "<tag3>"], "wordsA": ["The", "overall", "status", "of", "the", "economic", "climate", "could", "also", "result", "in", "the", "terms", "of", "any", "equity", "offering,", "debt", "financing,", "or", "alliance,", "license,", "or", "other", "arrangement", "being", "even", "less", "favorable", "to", "us", "and", "our", "stockholders", "than", "if", "the", "overall", "economic", "climate", "were", "stronger."], "wordsB": ["The", "exclusive", "option", "agreement", "contemplated", "payments", "of", "an", "upfront", "license", "fee,", "milestone", "payments", "and", "royalties", "to", "us", "if", "the", "exclusive", "license", "agreement", "were", "entered", "into."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p88_s0", "idA": "749647_12_item7_p53_s6", "sentA": "The overall status of the economic climate could also result in the terms of any equity offering, debt financing, or alliance, license, or other arrangement being even less favorable to us and our stockholders than if the overall economic climate were stronger.", "sentB": "Following is a summary of the future minimum payments required under leases that have initial or remaining lease terms of one year or more as of December 31, 2012:", "type": 1, "words": ["<tag1>", "The", "overall", "status", "of", "the", "economic", "climate", "could", "also", "result", "in", "the", "terms", "of", "any", "equity", "offering,", "debt", "financing,", "or", "alliance,", "license,", "or", "other", "arrangement", "being", "even", "less", "favorable", "to", "us", "and", "our", "stockholders", "than", "if", "the", "overall", "economic", "climate", "were", "stronger.", "<tag2>", "Following", "is", "a", "summary", "of", "the", "future", "minimum", "payments", "required", "under", "leases", "that", "have", "initial", "or", "remaining", "lease", "terms", "of", "one", "year", "or", "more", "as", "of", "December", "31,", "2012:", "<tag3>"], "wordsA": ["The", "overall", "status", "of", "the", "economic", "climate", "could", "also", "result", "in", "the", "terms", "of", "any", "equity", "offering,", "debt", "financing,", "or", "alliance,", "license,", "or", "other", "arrangement", "being", "even", "less", "favorable", "to", "us", "and", "our", "stockholders", "than", "if", "the", "overall", "economic", "climate", "were", "stronger."], "wordsB": ["Following", "is", "a", "summary", "of", "the", "future", "minimum", "payments", "required", "under", "leases", "that", "have", "initial", "or", "remaining", "lease", "terms", "of", "one", "year", "or", "more", "as", "of", "December", "31,", "2012:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p22_s1", "idA": "749647_12_item7_p55_s4", "sentA": "The standby letter of credit will be reduced by $50,000 on each of the 19 th , 31 st and 43 rd months from the initial term, with the remaining $100,000 amount remaining until the lease term has expired.", "sentB": "The primary study endpoint of the DIGNITY study is bioequivalence of the drug supplied by our second U.S. manufacturing site, with the secondary endpoint of tumor response based on RECIST criteria.", "type": 1, "words": ["<tag1>", "The", "standby", "letter", "of", "credit", "will", "be", "reduced", "by", "$50,000", "on", "each", "of", "the", "19", "th", ",", "31", "st", "and", "43", "rd", "months", "from", "the", "initial", "term,", "with", "the", "remaining", "$100,000", "amount", "remaining", "until", "the", "lease", "term", "has", "expired.", "<tag2>", "The", "primary", "study", "endpoint", "of", "the", "DIGNITY", "study", "is", "bioequivalence", "of", "the", "drug", "supplied", "by", "our", "second", "U.S.", "manufacturing", "site,", "with", "the", "secondary", "endpoint", "of", "tumor", "response", "based", "on", "RECIST", "criteria.", "<tag3>"], "wordsA": ["The", "standby", "letter", "of", "credit", "will", "be", "reduced", "by", "$50,000", "on", "each", "of", "the", "19", "th", ",", "31", "st", "and", "43", "rd", "months", "from", "the", "initial", "term,", "with", "the", "remaining", "$100,000", "amount", "remaining", "until", "the", "lease", "term", "has", "expired."], "wordsB": ["The", "primary", "study", "endpoint", "of", "the", "DIGNITY", "study", "is", "bioequivalence", "of", "the", "drug", "supplied", "by", "our", "second", "U.S.", "manufacturing", "site,", "with", "the", "secondary", "endpoint", "of", "tumor", "response", "based", "on", "RECIST", "criteria."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p33_s1", "idA": "749647_12_item7_p5_s2", "sentA": "The second trigger was the occurrence of 190 progression-free survival (PFS) events in the study population.", "sentB": "The ATM Agreement may be terminated by Cantor or Celsion at any time upon 10 days' notice to the other party, or by Cantor at any time in certain circumstances, including the occurrence of a material adverse change in Celsion.", "type": 1, "words": ["<tag1>", "The", "second", "trigger", "was", "the", "occurrence", "of", "190", "progression-free", "survival", "(PFS)", "events", "in", "the", "study", "population.", "<tag2>", "The", "ATM", "Agreement", "may", "be", "terminated", "by", "Cantor", "or", "Celsion", "at", "any", "time", "upon", "10", "days'", "notice", "to", "the", "other", "party,", "or", "by", "Cantor", "at", "any", "time", "in", "certain", "circumstances,", "including", "the", "occurrence", "of", "a", "material", "adverse", "change", "in", "Celsion.", "<tag3>"], "wordsA": ["The", "second", "trigger", "was", "the", "occurrence", "of", "190", "progression-free", "survival", "(PFS)", "events", "in", "the", "study", "population."], "wordsB": ["The", "ATM", "Agreement", "may", "be", "terminated", "by", "Cantor", "or", "Celsion", "at", "any", "time", "upon", "10", "days'", "notice", "to", "the", "other", "party,", "or", "by", "Cantor", "at", "any", "time", "in", "certain", "circumstances,", "including", "the", "occurrence", "of", "a", "material", "adverse", "change", "in", "Celsion."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p76_s1", "idA": "749647_12_item7_p5_s2", "sentA": "The second trigger was the occurrence of 190 progression-free survival (PFS) events in the study population.", "sentB": "The ATM Agreement may be terminated by Cantor or Celsion at any time upon 10 days' notice to the other party, or by Cantor at any time in certain circumstances, including the occurrence of a material adverse change in Celsion.", "type": 1, "words": ["<tag1>", "The", "second", "trigger", "was", "the", "occurrence", "of", "190", "progression-free", "survival", "(PFS)", "events", "in", "the", "study", "population.", "<tag2>", "The", "ATM", "Agreement", "may", "be", "terminated", "by", "Cantor", "or", "Celsion", "at", "any", "time", "upon", "10", "days'", "notice", "to", "the", "other", "party,", "or", "by", "Cantor", "at", "any", "time", "in", "certain", "circumstances,", "including", "the", "occurrence", "of", "a", "material", "adverse", "change", "in", "Celsion.", "<tag3>"], "wordsA": ["The", "second", "trigger", "was", "the", "occurrence", "of", "190", "progression-free", "survival", "(PFS)", "events", "in", "the", "study", "population."], "wordsB": ["The", "ATM", "Agreement", "may", "be", "terminated", "by", "Cantor", "or", "Celsion", "at", "any", "time", "upon", "10", "days'", "notice", "to", "the", "other", "party,", "or", "by", "Cantor", "at", "any", "time", "in", "certain", "circumstances,", "including", "the", "occurrence", "of", "a", "material", "adverse", "change", "in", "Celsion."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item7_p5_s1", "idA": "749647_12_item7_p8_s0", "sentA": "Consistent with our global regulatory strategy, we are continuing to enroll patients in the HEAT study in order to randomize at least 200 patients in the Peoples Republic of China (PRC), a requirement for registrational filing in the PRC.", "sentB": "The Special Protocol Assessment agreed to with the FDA specified Progression Free Survival (PFS) as the HEAT study s primary endpoint.", "type": 1, "words": ["<tag1>", "Consistent", "with", "our", "global", "regulatory", "strategy,", "we", "are", "continuing", "to", "enroll", "patients", "in", "the", "HEAT", "study", "in", "order", "to", "randomize", "at", "least", "200", "patients", "in", "the", "Peoples", "Republic", "of", "China", "(PRC),", "a", "requirement", "for", "registrational", "filing", "in", "the", "PRC.", "<tag2>", "The", "Special", "Protocol", "Assessment", "agreed", "to", "with", "the", "FDA", "specified", "Progression", "Free", "Survival", "(PFS)", "as", "the", "HEAT", "study", "s", "primary", "endpoint.", "<tag3>"], "wordsA": ["Consistent", "with", "our", "global", "regulatory", "strategy,", "we", "are", "continuing", "to", "enroll", "patients", "in", "the", "HEAT", "study", "in", "order", "to", "randomize", "at", "least", "200", "patients", "in", "the", "Peoples", "Republic", "of", "China", "(PRC),", "a", "requirement", "for", "registrational", "filing", "in", "the", "PRC."], "wordsB": ["The", "Special", "Protocol", "Assessment", "agreed", "to", "with", "the", "FDA", "specified", "Progression", "Free", "Survival", "(PFS)", "as", "the", "HEAT", "study", "s", "primary", "endpoint."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item7_p30_s3", "idA": "749647_13_item7_p11_s0", "sentA": "Hisun is also obligated to certain performance requirements under the agreement.", "sentB": "The Company anticipates that it will use any additional funding up to $15 million as provided under the agreement for working capital or in support of its previously announced strategic acquisition initiative, which is designed to identify new technologies and clinical stage products for its development pipeline.", "type": 1, "words": ["<tag1>", "Hisun", "is", "also", "obligated", "to", "certain", "performance", "requirements", "under", "the", "agreement.", "<tag2>", "The", "Company", "anticipates", "that", "it", "will", "use", "any", "additional", "funding", "up", "to", "$15", "million", "as", "provided", "under", "the", "agreement", "for", "working", "capital", "or", "in", "support", "of", "its", "previously", "announced", "strategic", "acquisition", "initiative,", "which", "is", "designed", "to", "identify", "new", "technologies", "and", "clinical", "stage", "products", "for", "its", "development", "pipeline.", "<tag3>"], "wordsA": ["Hisun", "is", "also", "obligated", "to", "certain", "performance", "requirements", "under", "the", "agreement."], "wordsB": ["The", "Company", "anticipates", "that", "it", "will", "use", "any", "additional", "funding", "up", "to", "$15", "million", "as", "provided", "under", "the", "agreement", "for", "working", "capital", "or", "in", "support", "of", "its", "previously", "announced", "strategic", "acquisition", "initiative,", "which", "is", "designed", "to", "identify", "new", "technologies", "and", "clinical", "stage", "products", "for", "its", "development", "pipeline."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item7_p10_s3", "idA": "749647_13_item7_p18_s2", "sentA": "This early phase clinical study is being finalized and will require approval from a local ethics committee.", "sentB": "The OPTIMA study is designed with extensive input from globally recognized HCC researchers and clinicians and after formal consultation with FDA.", "type": 1, "words": ["<tag1>", "This", "early", "phase", "clinical", "study", "is", "being", "finalized", "and", "will", "require", "approval", "from", "a", "local", "ethics", "committee.", "<tag2>", "The", "OPTIMA", "study", "is", "designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and", "after", "formal", "consultation", "with", "FDA.", "<tag3>"], "wordsA": ["This", "early", "phase", "clinical", "study", "is", "being", "finalized", "and", "will", "require", "approval", "from", "a", "local", "ethics", "committee."], "wordsB": ["The", "OPTIMA", "study", "is", "designed", "with", "extensive", "input", "from", "globally", "recognized", "HCC", "researchers", "and", "clinicians", "and", "after", "formal", "consultation", "with", "FDA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item7_p9_s0", "idA": "749647_13_item7_p33_s3", "sentA": "The Company also agreed to reimburse Cantor for legal fees and disbursements, not to exceed $50,000 in the aggregate, in connection with entering into the ATM Agreement.", "sentB": "The Company also completed computational modeling with supplementary preclinical animal studies supporting the relationship between heating duration and clinical outcomes.", "type": 1, "words": ["<tag1>", "The", "Company", "also", "agreed", "to", "reimburse", "Cantor", "for", "legal", "fees", "and", "disbursements,", "not", "to", "exceed", "$50,000", "in", "the", "aggregate,", "in", "connection", "with", "entering", "into", "the", "ATM", "Agreement.", "<tag2>", "The", "Company", "also", "completed", "computational", "modeling", "with", "supplementary", "preclinical", "animal", "studies", "supporting", "the", "relationship", "between", "heating", "duration", "and", "clinical", "outcomes.", "<tag3>"], "wordsA": ["The", "Company", "also", "agreed", "to", "reimburse", "Cantor", "for", "legal", "fees", "and", "disbursements,", "not", "to", "exceed", "$50,000", "in", "the", "aggregate,", "in", "connection", "with", "entering", "into", "the", "ATM", "Agreement."], "wordsB": ["The", "Company", "also", "completed", "computational", "modeling", "with", "supplementary", "preclinical", "animal", "studies", "supporting", "the", "relationship", "between", "heating", "duration", "and", "clinical", "outcomes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item7_p39_s1", "idA": "749647_13_item7_p34_s1", "sentA": "The closing of the Preferred Stock Offering occurred on February 26, 2013, in which the Company received approximately $15.0 million in gross proceeds.", "sentB": "In accordance with ASC 815-40, Derivative Instruments and Hedging - Contracts in Entity s Own Equity, the Waived Warrants were required to be liability classified immediately after the closing of the Common Stock Offering on June 3, 2013 because there were an insufficient number of common shares authorized to permit the full exercise of the warrants.", "type": 1, "words": ["<tag1>", "The", "closing", "of", "the", "Preferred", "Stock", "Offering", "occurred", "on", "February", "26,", "2013,", "in", "which", "the", "Company", "received", "approximately", "$15.0", "million", "in", "gross", "proceeds.", "<tag2>", "In", "accordance", "with", "ASC", "815-40,", "Derivative", "Instruments", "and", "Hedging", "-", "Contracts", "in", "Entity", "s", "Own", "Equity,", "the", "Waived", "Warrants", "were", "required", "to", "be", "liability", "classified", "immediately", "after", "the", "closing", "of", "the", "Common", "Stock", "Offering", "on", "June", "3,", "2013", "because", "there", "were", "an", "insufficient", "number", "of", "common", "shares", "authorized", "to", "permit", "the", "full", "exercise", "of", "the", "warrants.", "<tag3>"], "wordsA": ["The", "closing", "of", "the", "Preferred", "Stock", "Offering", "occurred", "on", "February", "26,", "2013,", "in", "which", "the", "Company", "received", "approximately", "$15.0", "million", "in", "gross", "proceeds."], "wordsB": ["In", "accordance", "with", "ASC", "815-40,", "Derivative", "Instruments", "and", "Hedging", "-", "Contracts", "in", "Entity", "s", "Own", "Equity,", "the", "Waived", "Warrants", "were", "required", "to", "be", "liability", "classified", "immediately", "after", "the", "closing", "of", "the", "Common", "Stock", "Offering", "on", "June", "3,", "2013", "because", "there", "were", "an", "insufficient", "number", "of", "common", "shares", "authorized", "to", "permit", "the", "full", "exercise", "of", "the", "warrants."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item7_p39_s3", "idA": "749647_13_item7_p35_s0", "sentA": "Subject to certain ownership limitations, shares of Series A 0% convertible preferred stock are convertible, at the option of the holder thereof, into an aggregate of up to 12,072,438 shares of common stock, and the warrants are exercisable to purchase an aggregate of up to 6,036,219 shares of common stock.", "sentB": "The Waived Warrants were required to be recorded at fair value at each balance sheet date with changes in fair value recorded in earnings until such time as there were a sufficient number of common shares authorized to permit the full exercise of the warrants (see Note 11).", "type": 1, "words": ["<tag1>", "Subject", "to", "certain", "ownership", "limitations,", "shares", "of", "Series", "A", "0%", "convertible", "preferred", "stock", "are", "convertible,", "at", "the", "option", "of", "the", "holder", "thereof,", "into", "an", "aggregate", "of", "up", "to", "12,072,438", "shares", "of", "common", "stock,", "and", "the", "warrants", "are", "exercisable", "to", "purchase", "an", "aggregate", "of", "up", "to", "6,036,219", "shares", "of", "common", "stock.", "<tag2>", "The", "Waived", "Warrants", "were", "required", "to", "be", "recorded", "at", "fair", "value", "at", "each", "balance", "sheet", "date", "with", "changes", "in", "fair", "value", "recorded", "in", "earnings", "until", "such", "time", "as", "there", "were", "a", "sufficient", "number", "of", "common", "shares", "authorized", "to", "permit", "the", "full", "exercise", "of", "the", "warrants", "(see", "Note", "11).", "<tag3>"], "wordsA": ["Subject", "to", "certain", "ownership", "limitations,", "shares", "of", "Series", "A", "0%", "convertible", "preferred", "stock", "are", "convertible,", "at", "the", "option", "of", "the", "holder", "thereof,", "into", "an", "aggregate", "of", "up", "to", "12,072,438", "shares", "of", "common", "stock,", "and", "the", "warrants", "are", "exercisable", "to", "purchase", "an", "aggregate", "of", "up", "to", "6,036,219", "shares", "of", "common", "stock."], "wordsB": ["The", "Waived", "Warrants", "were", "required", "to", "be", "recorded", "at", "fair", "value", "at", "each", "balance", "sheet", "date", "with", "changes", "in", "fair", "value", "recorded", "in", "earnings", "until", "such", "time", "as", "there", "were", "a", "sufficient", "number", "of", "common", "shares", "authorized", "to", "permit", "the", "full", "exercise", "of", "the", "warrants", "(see", "Note", "11)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item7_p50_s1", "idA": "749647_13_item7_p35_s0", "sentA": "Subject to certain ownership limitations, shares of Series A 0% convertible preferred stock are convertible, at the option of the holder thereof, into an aggregate of up to 12,072,438 shares of common stock, and the warrants are exercisable to purchase an aggregate of up to 6,036,219 shares of common stock.", "sentB": "In accordance with ASC 815-40, Derivative Instruments and Hedging - Contracts in Entity s Own Equity, these warrants were required to be classified as liabilities immediately after the closing of the common stock offering on June 3, 2013 because there were an insufficient number of common shares authorized to permit the full exercise of the warrants if they were exercised.", "type": 1, "words": ["<tag1>", "Subject", "to", "certain", "ownership", "limitations,", "shares", "of", "Series", "A", "0%", "convertible", "preferred", "stock", "are", "convertible,", "at", "the", "option", "of", "the", "holder", "thereof,", "into", "an", "aggregate", "of", "up", "to", "12,072,438", "shares", "of", "common", "stock,", "and", "the", "warrants", "are", "exercisable", "to", "purchase", "an", "aggregate", "of", "up", "to", "6,036,219", "shares", "of", "common", "stock.", "<tag2>", "In", "accordance", "with", "ASC", "815-40,", "Derivative", "Instruments", "and", "Hedging", "-", "Contracts", "in", "Entity", "s", "Own", "Equity,", "these", "warrants", "were", "required", "to", "be", "classified", "as", "liabilities", "immediately", "after", "the", "closing", "of", "the", "common", "stock", "offering", "on", "June", "3,", "2013", "because", "there", "were", "an", "insufficient", "number", "of", "common", "shares", "authorized", "to", "permit", "the", "full", "exercise", "of", "the", "warrants", "if", "they", "were", "exercised.", "<tag3>"], "wordsA": ["Subject", "to", "certain", "ownership", "limitations,", "shares", "of", "Series", "A", "0%", "convertible", "preferred", "stock", "are", "convertible,", "at", "the", "option", "of", "the", "holder", "thereof,", "into", "an", "aggregate", "of", "up", "to", "12,072,438", "shares", "of", "common", "stock,", "and", "the", "warrants", "are", "exercisable", "to", "purchase", "an", "aggregate", "of", "up", "to", "6,036,219", "shares", "of", "common", "stock."], "wordsB": ["In", "accordance", "with", "ASC", "815-40,", "Derivative", "Instruments", "and", "Hedging", "-", "Contracts", "in", "Entity", "s", "Own", "Equity,", "these", "warrants", "were", "required", "to", "be", "classified", "as", "liabilities", "immediately", "after", "the", "closing", "of", "the", "common", "stock", "offering", "on", "June", "3,", "2013", "because", "there", "were", "an", "insufficient", "number", "of", "common", "shares", "authorized", "to", "permit", "the", "full", "exercise", "of", "the", "warrants", "if", "they", "were", "exercised."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item7_p21_s2", "idA": "749647_13_item7_p40_s1", "sentA": "We do not have any committed sources of financing and cannot give assurance that alternate funding will be available in a timely manner, on acceptable terms or at all.", "sentB": "There can be no assurance that the exploration of strategic alternatives will result in any agreements or transactions, or that, if completed, any agreements or transactions will be successful or on attractive terms.", "type": 1, "words": ["<tag1>", "We", "do", "not", "have", "any", "committed", "sources", "of", "financing", "and", "cannot", "give", "assurance", "that", "alternate", "funding", "will", "be", "available", "in", "a", "timely", "manner,", "on", "acceptable", "terms", "or", "at", "all.", "<tag2>", "There", "can", "be", "no", "assurance", "that", "the", "exploration", "of", "strategic", "alternatives", "will", "result", "in", "any", "agreements", "or", "transactions,", "or", "that,", "if", "completed,", "any", "agreements", "or", "transactions", "will", "be", "successful", "or", "on", "attractive", "terms.", "<tag3>"], "wordsA": ["We", "do", "not", "have", "any", "committed", "sources", "of", "financing", "and", "cannot", "give", "assurance", "that", "alternate", "funding", "will", "be", "available", "in", "a", "timely", "manner,", "on", "acceptable", "terms", "or", "at", "all."], "wordsB": ["There", "can", "be", "no", "assurance", "that", "the", "exploration", "of", "strategic", "alternatives", "will", "result", "in", "any", "agreements", "or", "transactions,", "or", "that,", "if", "completed,", "any", "agreements", "or", "transactions", "will", "be", "successful", "or", "on", "attractive", "terms."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item7_p21_s1", "idA": "749647_13_item7_p40_s3", "sentA": "Please refer to Item IA, Risk Factors, including, but not limited to, We will need to raise substantial additional capital to fund our planned future operations, and we may be unable to secure such capital without dilutive financing transactions.", "sentB": "Strategic alternatives we may pursue could include, but are not limited to, continuing its current operating plan, partnering or other collaboration agreements, acquisition of another company s business or assets, or a merger or other strategic transaction.", "type": 1, "words": ["<tag1>", "Please", "refer", "to", "Item", "IA,", "Risk", "Factors,", "including,", "but", "not", "limited", "to,", "We", "will", "need", "to", "raise", "substantial", "additional", "capital", "to", "fund", "our", "planned", "future", "operations,", "and", "we", "may", "be", "unable", "to", "secure", "such", "capital", "without", "dilutive", "financing", "transactions.", "<tag2>", "Strategic", "alternatives", "we", "may", "pursue", "could", "include,", "but", "are", "not", "limited", "to,", "continuing", "its", "current", "operating", "plan,", "partnering", "or", "other", "collaboration", "agreements,", "acquisition", "of", "another", "company", "s", "business", "or", "assets,", "or", "a", "merger", "or", "other", "strategic", "transaction.", "<tag3>"], "wordsA": ["Please", "refer", "to", "Item", "IA,", "Risk", "Factors,", "including,", "but", "not", "limited", "to,", "We", "will", "need", "to", "raise", "substantial", "additional", "capital", "to", "fund", "our", "planned", "future", "operations,", "and", "we", "may", "be", "unable", "to", "secure", "such", "capital", "without", "dilutive", "financing", "transactions."], "wordsB": ["Strategic", "alternatives", "we", "may", "pursue", "could", "include,", "but", "are", "not", "limited", "to,", "continuing", "its", "current", "operating", "plan,", "partnering", "or", "other", "collaboration", "agreements,", "acquisition", "of", "another", "company", "s", "business", "or", "assets,", "or", "a", "merger", "or", "other", "strategic", "transaction."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item7_p10_s4", "idA": "749647_13_item7_p56_s0", "sentA": "In 2011, we initiated a Phase II study of ThermoDox in combination with radiofrequency ablation (RFA) for the treatment of colorectal liver metastases (CRLM).", "sentB": "The OPTIMA study is expected to enroll 550 patients globally, with up to 100 sites in the United States, Europe, China and Asia Pacific, and will evaluate ThermoDox in combination with RFA, which will be standardized to a minimum of 45 minutes across all investigators and sites for treating lesions 3 to 7 centimeters, versus standardized RFA alone.", "type": 1, "words": ["<tag1>", "In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "radiofrequency", "ablation", "(RFA)", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(CRLM).", "<tag2>", "The", "OPTIMA", "study", "is", "expected", "to", "enroll", "550", "patients", "globally,", "with", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "Asia", "Pacific,", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "RFA,", "which", "will", "be", "standardized", "to", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone.", "<tag3>"], "wordsA": ["In", "2011,", "we", "initiated", "a", "Phase", "II", "study", "of", "ThermoDox", "in", "combination", "with", "radiofrequency", "ablation", "(RFA)", "for", "the", "treatment", "of", "colorectal", "liver", "metastases", "(CRLM)."], "wordsB": ["The", "OPTIMA", "study", "is", "expected", "to", "enroll", "550", "patients", "globally,", "with", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "Asia", "Pacific,", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "RFA,", "which", "will", "be", "standardized", "to", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item7_p68_s2", "idA": "749647_13_item7_p56_s1", "sentA": "Costs associated with the Company s CRLM trial were $0.3 million in 2011.", "sentB": "The Company may request an additional $15 million in up to three advances with each advance in a minimum amount of $5 million, unless otherwise agreed upon by the Company and Hercules, before June 30, 2014 unless extended upon Hercules consent.", "type": 1, "words": ["<tag1>", "Costs", "associated", "with", "the", "Company", "s", "CRLM", "trial", "were", "$0.3", "million", "in", "2011.", "<tag2>", "The", "Company", "may", "request", "an", "additional", "$15", "million", "in", "up", "to", "three", "advances", "with", "each", "advance", "in", "a", "minimum", "amount", "of", "$5", "million,", "unless", "otherwise", "agreed", "upon", "by", "the", "Company", "and", "Hercules,", "before", "June", "30,", "2014", "unless", "extended", "upon", "Hercules", "consent.", "<tag3>"], "wordsA": ["Costs", "associated", "with", "the", "Company", "s", "CRLM", "trial", "were", "$0.3", "million", "in", "2011."], "wordsB": ["The", "Company", "may", "request", "an", "additional", "$15", "million", "in", "up", "to", "three", "advances", "with", "each", "advance", "in", "a", "minimum", "amount", "of", "$5", "million,", "unless", "otherwise", "agreed", "upon", "by", "the", "Company", "and", "Hercules,", "before", "June", "30,", "2014", "unless", "extended", "upon", "Hercules", "consent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item7_p12_s1", "idA": "749647_13_item7_p5_s3", "sentA": "Following review by the DMC, on January 31, 2013, we announced that ThermoDox in combination with RFA did not meet the primary endpoint of the HEAT study in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.", "sentB": "Based on those discussions, we are submitting an application for accelerated approval of the study in China.", "type": 1, "words": ["<tag1>", "Following", "review", "by", "the", "DMC,", "on", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer.", "<tag2>", "Based", "on", "those", "discussions,", "we", "are", "submitting", "an", "application", "for", "accelerated", "approval", "of", "the", "study", "in", "China.", "<tag3>"], "wordsA": ["Following", "review", "by", "the", "DMC,", "on", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "RFA", "did", "not", "meet", "the", "primary", "endpoint", "of", "the", "HEAT", "study", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer."], "wordsB": ["Based", "on", "those", "discussions,", "we", "are", "submitting", "an", "application", "for", "accelerated", "approval", "of", "the", "study", "in", "China."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item7_p21_s0", "idA": "749647_13_item7_p5_s4", "sentA": "Specifically, we determined, after conferring with the DMC, that the HEAT study did not meet the goal of demonstrating persuasive evidence of clinical effectiveness that could form the basis for regulatory approval in the population chosen for the HEAT study.", "sentB": "In April 2013, we engaged Cantor Fitzgerald Co. to conduct a comprehensive review of merger and acquisition opportunities with the goal of identifying novel products with high potential, or companies, for Celsion to acquire.", "type": 1, "words": ["<tag1>", "Specifically,", "we", "determined,", "after", "conferring", "with", "the", "DMC,", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "study.", "<tag2>", "In", "April", "2013,", "we", "engaged", "Cantor", "Fitzgerald", "Co.", "to", "conduct", "a", "comprehensive", "review", "of", "merger", "and", "acquisition", "opportunities", "with", "the", "goal", "of", "identifying", "novel", "products", "with", "high", "potential,", "or", "companies,", "for", "Celsion", "to", "acquire.", "<tag3>"], "wordsA": ["Specifically,", "we", "determined,", "after", "conferring", "with", "the", "DMC,", "that", "the", "HEAT", "study", "did", "not", "meet", "the", "goal", "of", "demonstrating", "persuasive", "evidence", "of", "clinical", "effectiveness", "that", "could", "form", "the", "basis", "for", "regulatory", "approval", "in", "the", "population", "chosen", "for", "the", "HEAT", "study."], "wordsB": ["In", "April", "2013,", "we", "engaged", "Cantor", "Fitzgerald", "Co.", "to", "conduct", "a", "comprehensive", "review", "of", "merger", "and", "acquisition", "opportunities", "with", "the", "goal", "of", "identifying", "novel", "products", "with", "high", "potential,", "or", "companies,", "for", "Celsion", "to", "acquire."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item7_p30_s1", "idA": "749647_13_item7_p69_s0", "sentA": "The obligations under the Credit Agreement are secured by substantially all assets of the Company other than its intellectual property and certain other agreed-upon exclusions.", "sentB": "The Company drew the first tranche of $5 million at the closing under the Hercules Credit Agreement on November 25, 2013 and may request, subject to Hercules consent in its sole discretion, an additional $15 million in up to three advances with each advance in a minimum amount of $5 million, unless otherwise agreed upon by the Company and Hercules, before June 30, 2014 unless extended upon Hercules consent.", "type": 1, "words": ["<tag1>", "The", "obligations", "under", "the", "Credit", "Agreement", "are", "secured", "by", "substantially", "all", "assets", "of", "the", "Company", "other", "than", "its", "intellectual", "property", "and", "certain", "other", "agreed-upon", "exclusions.", "<tag2>", "The", "Company", "drew", "the", "first", "tranche", "of", "$5", "million", "at", "the", "closing", "under", "the", "Hercules", "Credit", "Agreement", "on", "November", "25,", "2013", "and", "may", "request,", "subject", "to", "Hercules", "consent", "in", "its", "sole", "discretion,", "an", "additional", "$15", "million", "in", "up", "to", "three", "advances", "with", "each", "advance", "in", "a", "minimum", "amount", "of", "$5", "million,", "unless", "otherwise", "agreed", "upon", "by", "the", "Company", "and", "Hercules,", "before", "June", "30,", "2014", "unless", "extended", "upon", "Hercules", "consent.", "<tag3>"], "wordsA": ["The", "obligations", "under", "the", "Credit", "Agreement", "are", "secured", "by", "substantially", "all", "assets", "of", "the", "Company", "other", "than", "its", "intellectual", "property", "and", "certain", "other", "agreed-upon", "exclusions."], "wordsB": ["The", "Company", "drew", "the", "first", "tranche", "of", "$5", "million", "at", "the", "closing", "under", "the", "Hercules", "Credit", "Agreement", "on", "November", "25,", "2013", "and", "may", "request,", "subject", "to", "Hercules", "consent", "in", "its", "sole", "discretion,", "an", "additional", "$15", "million", "in", "up", "to", "three", "advances", "with", "each", "advance", "in", "a", "minimum", "amount", "of", "$5", "million,", "unless", "otherwise", "agreed", "upon", "by", "the", "Company", "and", "Hercules,", "before", "June", "30,", "2014", "unless", "extended", "upon", "Hercules", "consent."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item7_p50_s2", "idA": "749647_13_item7_p78_s2", "sentA": "The warrants are immediately exercisable and expire five years after its issuance.", "sentB": "Therefore, these warrants are required to be recorded at fair value at each balance sheet date with changes in fair value recorded in earnings.", "type": 1, "words": ["<tag1>", "The", "warrants", "are", "immediately", "exercisable", "and", "expire", "five", "years", "after", "its", "issuance.", "<tag2>", "Therefore,", "these", "warrants", "are", "required", "to", "be", "recorded", "at", "fair", "value", "at", "each", "balance", "sheet", "date", "with", "changes", "in", "fair", "value", "recorded", "in", "earnings.", "<tag3>"], "wordsA": ["The", "warrants", "are", "immediately", "exercisable", "and", "expire", "five", "years", "after", "its", "issuance."], "wordsB": ["Therefore,", "these", "warrants", "are", "required", "to", "be", "recorded", "at", "fair", "value", "at", "each", "balance", "sheet", "date", "with", "changes", "in", "fair", "value", "recorded", "in", "earnings."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item7_p19_s0", "idA": "749647_13_item7_p7_s2", "sentA": "In addition, we will assess our product pipeline and research and development priorities.", "sentB": "We are engaged in a limited amount of research and development in our own facilities and have sponsored research programs in partnership with various research institutions, including the National Cancer Institute and Duke University.", "type": 1, "words": ["<tag1>", "In", "addition,", "we", "will", "assess", "our", "product", "pipeline", "and", "research", "and", "development", "priorities.", "<tag2>", "We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "have", "sponsored", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "National", "Cancer", "Institute", "and", "Duke", "University.", "<tag3>"], "wordsA": ["In", "addition,", "we", "will", "assess", "our", "product", "pipeline", "and", "research", "and", "development", "priorities."], "wordsB": ["We", "are", "engaged", "in", "a", "limited", "amount", "of", "research", "and", "development", "in", "our", "own", "facilities", "and", "have", "sponsored", "research", "programs", "in", "partnership", "with", "various", "research", "institutions,", "including", "the", "National", "Cancer", "Institute", "and", "Duke", "University."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p28_s0", "idA": "749647_14_item7_p0_s0", "sentA": "-K. The following discussion contains forward-looking statements made pursuant to the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995.", "sentB": "On June 20, 2014, we completed the acquisition of substantially all of the assets of EGEN, Inc., an Alabama Corporation (EGEN) pursuant to an Asset Purchase Agreement (EGEN Purchase Agreement).", "type": 1, "words": ["<tag1>", "-K.", "The", "following", "discussion", "contains", "forward-looking", "statements", "made", "pursuant", "to", "the", "safe", "harbor", "provisions", "of", "Section", "21E", "of", "the", "Securities", "Exchange", "Act", "of", "1934", "and", "the", "Private", "Securities", "Litigation", "Reform", "Act", "of", "1995.", "<tag2>", "On", "June", "20,", "2014,", "we", "completed", "the", "acquisition", "of", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "Inc.,", "an", "Alabama", "Corporation", "(EGEN)", "pursuant", "to", "an", "Asset", "Purchase", "Agreement", "(EGEN", "Purchase", "Agreement).", "<tag3>"], "wordsA": ["-K.", "The", "following", "discussion", "contains", "forward-looking", "statements", "made", "pursuant", "to", "the", "safe", "harbor", "provisions", "of", "Section", "21E", "of", "the", "Securities", "Exchange", "Act", "of", "1934", "and", "the", "Private", "Securities", "Litigation", "Reform", "Act", "of", "1995."], "wordsB": ["On", "June", "20,", "2014,", "we", "completed", "the", "acquisition", "of", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "Inc.,", "an", "Alabama", "Corporation", "(EGEN)", "pursuant", "to", "an", "Asset", "Purchase", "Agreement", "(EGEN", "Purchase", "Agreement)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p34_s4", "idA": "749647_14_item7_p10_s4", "sentA": "The OPTIMA study is expected to enroll 550 patients globally, with up to 100 sites in the United States, Europe, China and Asia Pacific, and will evaluate ThermoDox in combination with RFA, which will be standardized to a minimum of 45 minutes across all investigators and sites for treating lesions 3 to 7 centimeters, versus standardized RFA alone.", "sentB": "The trial is designed to enroll three to six patients per dose level and will evaluate safety and efficacy and attempt to define an optimal dose to carry forward into a Phase II trial.", "type": 1, "words": ["<tag1>", "The", "OPTIMA", "study", "is", "expected", "to", "enroll", "550", "patients", "globally,", "with", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "Asia", "Pacific,", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "RFA,", "which", "will", "be", "standardized", "to", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone.", "<tag2>", "The", "trial", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "to", "carry", "forward", "into", "a", "Phase", "II", "trial.", "<tag3>"], "wordsA": ["The", "OPTIMA", "study", "is", "expected", "to", "enroll", "550", "patients", "globally,", "with", "up", "to", "100", "sites", "in", "the", "United", "States,", "Europe,", "China", "and", "Asia", "Pacific,", "and", "will", "evaluate", "ThermoDox", "in", "combination", "with", "RFA,", "which", "will", "be", "standardized", "to", "a", "minimum", "of", "45", "minutes", "across", "all", "investigators", "and", "sites", "for", "treating", "lesions", "3", "to", "7", "centimeters,", "versus", "standardized", "RFA", "alone."], "wordsB": ["The", "trial", "is", "designed", "to", "enroll", "three", "to", "six", "patients", "per", "dose", "level", "and", "will", "evaluate", "safety", "and", "efficacy", "and", "attempt", "to", "define", "an", "optimal", "dose", "to", "carry", "forward", "into", "a", "Phase", "II", "trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p20_s0", "idA": "749647_14_item7_p13_s1", "sentA": "Hisun will be responsible for providing all of the technical and regulatory support services for the manufacture of ThermoDox in the China territory and we will repay Hisun the related development costs and fees, which we expect to be approximately $2.0 million in total, commencing on the successful completion of three registrational batches of ThermoDox .", "sentB": "The primary objectives of the Euro-DIGNITY Study will be (i) to evaluate efficacy in patients after 3 cycles of ThermoDox plus Hyperthermia measuring tumor diameter as a response to therapy and (ii) to evaluate loco-regional breast tumor control in patients who undergo ThermoDox /hyperthermia/radiotherapy as measured by target lesion clinical response rate combining a RECIST criteria with digital photography to gauge response.", "type": 1, "words": ["<tag1>", "Hisun", "will", "be", "responsible", "for", "providing", "all", "of", "the", "technical", "and", "regulatory", "support", "services", "for", "the", "manufacture", "of", "ThermoDox", "in", "the", "China", "territory", "and", "we", "will", "repay", "Hisun", "the", "related", "development", "costs", "and", "fees,", "which", "we", "expect", "to", "be", "approximately", "$2.0", "million", "in", "total,", "commencing", "on", "the", "successful", "completion", "of", "three", "registrational", "batches", "of", "ThermoDox", ".", "<tag2>", "The", "primary", "objectives", "of", "the", "Euro-DIGNITY", "Study", "will", "be", "(i)", "to", "evaluate", "efficacy", "in", "patients", "after", "3", "cycles", "of", "ThermoDox", "plus", "Hyperthermia", "measuring", "tumor", "diameter", "as", "a", "response", "to", "therapy", "and", "(ii)", "to", "evaluate", "loco-regional", "breast", "tumor", "control", "in", "patients", "who", "undergo", "ThermoDox", "/hyperthermia/radiotherapy", "as", "measured", "by", "target", "lesion", "clinical", "response", "rate", "combining", "a", "RECIST", "criteria", "with", "digital", "photography", "to", "gauge", "response.", "<tag3>"], "wordsA": ["Hisun", "will", "be", "responsible", "for", "providing", "all", "of", "the", "technical", "and", "regulatory", "support", "services", "for", "the", "manufacture", "of", "ThermoDox", "in", "the", "China", "territory", "and", "we", "will", "repay", "Hisun", "the", "related", "development", "costs", "and", "fees,", "which", "we", "expect", "to", "be", "approximately", "$2.0", "million", "in", "total,", "commencing", "on", "the", "successful", "completion", "of", "three", "registrational", "batches", "of", "ThermoDox", "."], "wordsB": ["The", "primary", "objectives", "of", "the", "Euro-DIGNITY", "Study", "will", "be", "(i)", "to", "evaluate", "efficacy", "in", "patients", "after", "3", "cycles", "of", "ThermoDox", "plus", "Hyperthermia", "measuring", "tumor", "diameter", "as", "a", "response", "to", "therapy", "and", "(ii)", "to", "evaluate", "loco-regional", "breast", "tumor", "control", "in", "patients", "who", "undergo", "ThermoDox", "/hyperthermia/radiotherapy", "as", "measured", "by", "target", "lesion", "clinical", "response", "rate", "combining", "a", "RECIST", "criteria", "with", "digital", "photography", "to", "gauge", "response."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p45_s0", "idA": "749647_14_item7_p13_s1", "sentA": "Hisun will be responsible for providing all of the technical and regulatory support services for the manufacture of ThermoDox in the China territory and we will repay Hisun the related development costs and fees, which we expect to be approximately $2.0 million in total, commencing on the successful completion of three registrational batches of ThermoDox .", "sentB": "IPR D will be reviewed for possible impairment on an annual basis or more frequently if there appears to be an indication of impairment.", "type": 1, "words": ["<tag1>", "Hisun", "will", "be", "responsible", "for", "providing", "all", "of", "the", "technical", "and", "regulatory", "support", "services", "for", "the", "manufacture", "of", "ThermoDox", "in", "the", "China", "territory", "and", "we", "will", "repay", "Hisun", "the", "related", "development", "costs", "and", "fees,", "which", "we", "expect", "to", "be", "approximately", "$2.0", "million", "in", "total,", "commencing", "on", "the", "successful", "completion", "of", "three", "registrational", "batches", "of", "ThermoDox", ".", "<tag2>", "IPR", "D", "will", "be", "reviewed", "for", "possible", "impairment", "on", "an", "annual", "basis", "or", "more", "frequently", "if", "there", "appears", "to", "be", "an", "indication", "of", "impairment.", "<tag3>"], "wordsA": ["Hisun", "will", "be", "responsible", "for", "providing", "all", "of", "the", "technical", "and", "regulatory", "support", "services", "for", "the", "manufacture", "of", "ThermoDox", "in", "the", "China", "territory", "and", "we", "will", "repay", "Hisun", "the", "related", "development", "costs", "and", "fees,", "which", "we", "expect", "to", "be", "approximately", "$2.0", "million", "in", "total,", "commencing", "on", "the", "successful", "completion", "of", "three", "registrational", "batches", "of", "ThermoDox", "."], "wordsB": ["IPR", "D", "will", "be", "reviewed", "for", "possible", "impairment", "on", "an", "annual", "basis", "or", "more", "frequently", "if", "there", "appears", "to", "be", "an", "indication", "of", "impairment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p43_s6", "idA": "749647_14_item7_p15_s2", "sentA": "While our estimated future capital requirements are uncertain and could increase or decrease as a result of many factors, including the extent to which we choose to advance our research, development activities, preclinical studies and clinical trials, or if we are in a position to pursue manufacturing or commercialization activities, we will need significant additional capital to develop our product candidates through development and clinical trials, obtain regulatory approvals and manufacture and commercialized approved products, if any.", "sentB": "The projected cash flows were based on significant assumptions, including the indication in which we will pursue development of IPR D programs, the time and resources needed to complete the development and regulatory approval of IPR D programs, estimates of revenue and operating profit related to the program considering its stage of development, the life of the potential commercialized product, market penetration and competition, and risks associated with achieving commercialization, including delay or failure to obtain regulatory approvals to conduct clinical studies, failure of clinical studies, delay or failure to obtain required market clearances, and intellectual property litigation.", "type": 1, "words": ["<tag1>", "While", "our", "estimated", "future", "capital", "requirements", "are", "uncertain", "and", "could", "increase", "or", "decrease", "as", "a", "result", "of", "many", "factors,", "including", "the", "extent", "to", "which", "we", "choose", "to", "advance", "our", "research,", "development", "activities,", "preclinical", "studies", "and", "clinical", "trials,", "or", "if", "we", "are", "in", "a", "position", "to", "pursue", "manufacturing", "or", "commercialization", "activities,", "we", "will", "need", "significant", "additional", "capital", "to", "develop", "our", "product", "candidates", "through", "development", "and", "clinical", "trials,", "obtain", "regulatory", "approvals", "and", "manufacture", "and", "commercialized", "approved", "products,", "if", "any.", "<tag2>", "The", "projected", "cash", "flows", "were", "based", "on", "significant", "assumptions,", "including", "the", "indication", "in", "which", "we", "will", "pursue", "development", "of", "IPR", "D", "programs,", "the", "time", "and", "resources", "needed", "to", "complete", "the", "development", "and", "regulatory", "approval", "of", "IPR", "D", "programs,", "estimates", "of", "revenue", "and", "operating", "profit", "related", "to", "the", "program", "considering", "its", "stage", "of", "development,", "the", "life", "of", "the", "potential", "commercialized", "product,", "market", "penetration", "and", "competition,", "and", "risks", "associated", "with", "achieving", "commercialization,", "including", "delay", "or", "failure", "to", "obtain", "regulatory", "approvals", "to", "conduct", "clinical", "studies,", "failure", "of", "clinical", "studies,", "delay", "or", "failure", "to", "obtain", "required", "market", "clearances,", "and", "intellectual", "property", "litigation.", "<tag3>"], "wordsA": ["While", "our", "estimated", "future", "capital", "requirements", "are", "uncertain", "and", "could", "increase", "or", "decrease", "as", "a", "result", "of", "many", "factors,", "including", "the", "extent", "to", "which", "we", "choose", "to", "advance", "our", "research,", "development", "activities,", "preclinical", "studies", "and", "clinical", "trials,", "or", "if", "we", "are", "in", "a", "position", "to", "pursue", "manufacturing", "or", "commercialization", "activities,", "we", "will", "need", "significant", "additional", "capital", "to", "develop", "our", "product", "candidates", "through", "development", "and", "clinical", "trials,", "obtain", "regulatory", "approvals", "and", "manufacture", "and", "commercialized", "approved", "products,", "if", "any."], "wordsB": ["The", "projected", "cash", "flows", "were", "based", "on", "significant", "assumptions,", "including", "the", "indication", "in", "which", "we", "will", "pursue", "development", "of", "IPR", "D", "programs,", "the", "time", "and", "resources", "needed", "to", "complete", "the", "development", "and", "regulatory", "approval", "of", "IPR", "D", "programs,", "estimates", "of", "revenue", "and", "operating", "profit", "related", "to", "the", "program", "considering", "its", "stage", "of", "development,", "the", "life", "of", "the", "potential", "commercialized", "product,", "market", "penetration", "and", "competition,", "and", "risks", "associated", "with", "achieving", "commercialization,", "including", "delay", "or", "failure", "to", "obtain", "regulatory", "approvals", "to", "conduct", "clinical", "studies,", "failure", "of", "clinical", "studies,", "delay", "or", "failure", "to", "obtain", "required", "market", "clearances,", "and", "intellectual", "property", "litigation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p56_s0", "idA": "749647_14_item7_p17_s3", "sentA": "Enrollment of the first patient in this clinical study is targeted for 2014.", "sentB": "On June 20, 2014, we completed the acquisition of substantially all of the assets of EGEN.", "type": 1, "words": ["<tag1>", "Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "2014.", "<tag2>", "On", "June", "20,", "2014,", "we", "completed", "the", "acquisition", "of", "substantially", "all", "of", "the", "assets", "of", "EGEN.", "<tag3>"], "wordsA": ["Enrollment", "of", "the", "first", "patient", "in", "this", "clinical", "study", "is", "targeted", "for", "2014."], "wordsB": ["On", "June", "20,", "2014,", "we", "completed", "the", "acquisition", "of", "substantially", "all", "of", "the", "assets", "of", "EGEN."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p22_s1", "idA": "749647_14_item7_p18_s0", "sentA": "We are also working with the Focused Ultrasound Foundation in preclinical studies designed to explore the use of ThermoDox in combination with MR-guided HIFU for the treatment of pancreatic cancer.", "sentB": "Under the early access program, Impatients will engage in activities to secure authorization, exemption or waiver from regulatory authorities for patient use of ThermoDox that may otherwise be subject to approvals from such regulatory authorities before the sale and distribution of ThermoDox in the relevant territories.", "type": 1, "words": ["<tag1>", "We", "are", "also", "working", "with", "the", "Focused", "Ultrasound", "Foundation", "in", "preclinical", "studies", "designed", "to", "explore", "the", "use", "of", "ThermoDox", "in", "combination", "with", "MR-guided", "HIFU", "for", "the", "treatment", "of", "pancreatic", "cancer.", "<tag2>", "Under", "the", "early", "access", "program,", "Impatients", "will", "engage", "in", "activities", "to", "secure", "authorization,", "exemption", "or", "waiver", "from", "regulatory", "authorities", "for", "patient", "use", "of", "ThermoDox", "that", "may", "otherwise", "be", "subject", "to", "approvals", "from", "such", "regulatory", "authorities", "before", "the", "sale", "and", "distribution", "of", "ThermoDox", "in", "the", "relevant", "territories.", "<tag3>"], "wordsA": ["We", "are", "also", "working", "with", "the", "Focused", "Ultrasound", "Foundation", "in", "preclinical", "studies", "designed", "to", "explore", "the", "use", "of", "ThermoDox", "in", "combination", "with", "MR-guided", "HIFU", "for", "the", "treatment", "of", "pancreatic", "cancer."], "wordsB": ["Under", "the", "early", "access", "program,", "Impatients", "will", "engage", "in", "activities", "to", "secure", "authorization,", "exemption", "or", "waiver", "from", "regulatory", "authorities", "for", "patient", "use", "of", "ThermoDox", "that", "may", "otherwise", "be", "subject", "to", "approvals", "from", "such", "regulatory", "authorities", "before", "the", "sale", "and", "distribution", "of", "ThermoDox", "in", "the", "relevant", "territories."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p100_s1", "idA": "749647_14_item7_p25_s1", "sentA": "On October 28, 2013, we effected a 4.5-to-1 reverse split of our common stock.", "sentB": "Under the ATM Agreement, Cantor may sell ATM Shares by any method deemed to be an at-the-market offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, including sales made directly on The NASDAQ Capital Market, on any other existing trading market for the our common stock or to or through a market maker.", "type": 1, "words": ["<tag1>", "On", "October", "28,", "2013,", "we", "effected", "a", "4.5-to-1", "reverse", "split", "of", "our", "common", "stock.", "<tag2>", "Under", "the", "ATM", "Agreement,", "Cantor", "may", "sell", "ATM", "Shares", "by", "any", "method", "deemed", "to", "be", "an", "at-the-market", "offering", "as", "defined", "in", "Rule", "415", "promulgated", "under", "the", "Securities", "Act", "of", "1933,", "as", "amended,", "including", "sales", "made", "directly", "on", "The", "NASDAQ", "Capital", "Market,", "on", "any", "other", "existing", "trading", "market", "for", "the", "our", "common", "stock", "or", "to", "or", "through", "a", "market", "maker.", "<tag3>"], "wordsA": ["On", "October", "28,", "2013,", "we", "effected", "a", "4.5-to-1", "reverse", "split", "of", "our", "common", "stock."], "wordsB": ["Under", "the", "ATM", "Agreement,", "Cantor", "may", "sell", "ATM", "Shares", "by", "any", "method", "deemed", "to", "be", "an", "at-the-market", "offering", "as", "defined", "in", "Rule", "415", "promulgated", "under", "the", "Securities", "Act", "of", "1933,", "as", "amended,", "including", "sales", "made", "directly", "on", "The", "NASDAQ", "Capital", "Market,", "on", "any", "other", "existing", "trading", "market", "for", "the", "our", "common", "stock", "or", "to", "or", "through", "a", "market", "maker."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p100_s2", "idA": "749647_14_item7_p26_s1", "sentA": "From February 1, 2013 through February 25, 2013, we sold and issued an aggregate of 1,195,923 shares of common stock under such agreement for approximately $6.8 million in aggregate gross proceeds.", "sentB": "We will pay Cantor a commission of three percent of the aggregate gross proceeds from each sale of ATM Shares.", "type": 1, "words": ["<tag1>", "From", "February", "1,", "2013", "through", "February", "25,", "2013,", "we", "sold", "and", "issued", "an", "aggregate", "of", "1,195,923", "shares", "of", "common", "stock", "under", "such", "agreement", "for", "approximately", "$6.8", "million", "in", "aggregate", "gross", "proceeds.", "<tag2>", "We", "will", "pay", "Cantor", "a", "commission", "of", "three", "percent", "of", "the", "aggregate", "gross", "proceeds", "from", "each", "sale", "of", "ATM", "Shares.", "<tag3>"], "wordsA": ["From", "February", "1,", "2013", "through", "February", "25,", "2013,", "we", "sold", "and", "issued", "an", "aggregate", "of", "1,195,923", "shares", "of", "common", "stock", "under", "such", "agreement", "for", "approximately", "$6.8", "million", "in", "aggregate", "gross", "proceeds."], "wordsB": ["We", "will", "pay", "Cantor", "a", "commission", "of", "three", "percent", "of", "the", "aggregate", "gross", "proceeds", "from", "each", "sale", "of", "ATM", "Shares."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p17_s2", "idA": "749647_14_item7_p27_s0", "sentA": "On February 22, 2013, we entered into a Securities Purchase Agreement with certain institutional investors, pursuant to which the we sold, in a registered direct offering, an aggregate of 15,000.00422 shares of our Series A 0% convertible preferred stock and warrants to purchase up to 1,341,382 shares of common stock, for an aggregate purchase price of approximately $15.0 million in gross proceeds.", "sentB": "Of the 14 patients enrolled and treated, ten were eligible for evaluation of efficacy.", "type": 1, "words": ["<tag1>", "On", "February", "22,", "2013,", "we", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "we", "sold,", "in", "a", "registered", "direct", "offering,", "an", "aggregate", "of", "15,000.00422", "shares", "of", "our", "Series", "A", "0%", "convertible", "preferred", "stock", "and", "warrants", "to", "purchase", "up", "to", "1,341,382", "shares", "of", "common", "stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15.0", "million", "in", "gross", "proceeds.", "<tag2>", "Of", "the", "14", "patients", "enrolled", "and", "treated,", "ten", "were", "eligible", "for", "evaluation", "of", "efficacy.", "<tag3>"], "wordsA": ["On", "February", "22,", "2013,", "we", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "we", "sold,", "in", "a", "registered", "direct", "offering,", "an", "aggregate", "of", "15,000.00422", "shares", "of", "our", "Series", "A", "0%", "convertible", "preferred", "stock", "and", "warrants", "to", "purchase", "up", "to", "1,341,382", "shares", "of", "common", "stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15.0", "million", "in", "gross", "proceeds."], "wordsB": ["Of", "the", "14", "patients", "enrolled", "and", "treated,", "ten", "were", "eligible", "for", "evaluation", "of", "efficacy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p18_s3", "idA": "749647_14_item7_p27_s0", "sentA": "On February 22, 2013, we entered into a Securities Purchase Agreement with certain institutional investors, pursuant to which the we sold, in a registered direct offering, an aggregate of 15,000.00422 shares of our Series A 0% convertible preferred stock and warrants to purchase up to 1,341,382 shares of common stock, for an aggregate purchase price of approximately $15.0 million in gross proceeds.", "sentB": "Of the 29 patients treated, 23 were eligible for evaluation of efficacy.", "type": 1, "words": ["<tag1>", "On", "February", "22,", "2013,", "we", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "we", "sold,", "in", "a", "registered", "direct", "offering,", "an", "aggregate", "of", "15,000.00422", "shares", "of", "our", "Series", "A", "0%", "convertible", "preferred", "stock", "and", "warrants", "to", "purchase", "up", "to", "1,341,382", "shares", "of", "common", "stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15.0", "million", "in", "gross", "proceeds.", "<tag2>", "Of", "the", "29", "patients", "treated,", "23", "were", "eligible", "for", "evaluation", "of", "efficacy.", "<tag3>"], "wordsA": ["On", "February", "22,", "2013,", "we", "entered", "into", "a", "Securities", "Purchase", "Agreement", "with", "certain", "institutional", "investors,", "pursuant", "to", "which", "the", "we", "sold,", "in", "a", "registered", "direct", "offering,", "an", "aggregate", "of", "15,000.00422", "shares", "of", "our", "Series", "A", "0%", "convertible", "preferred", "stock", "and", "warrants", "to", "purchase", "up", "to", "1,341,382", "shares", "of", "common", "stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15.0", "million", "in", "gross", "proceeds."], "wordsB": ["Of", "the", "29", "patients", "treated,", "23", "were", "eligible", "for", "evaluation", "of", "efficacy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p42_s0", "idA": "749647_14_item7_p2_s2", "sentA": "The promise of this drug technology is to maximize efficacy while minimizing side-effects common to cancer treatments.", "sentB": "Acquired IPR D consists of EGEN s drug technology platforms: TheraPlas and TheraSilence .", "type": 1, "words": ["<tag1>", "The", "promise", "of", "this", "drug", "technology", "is", "to", "maximize", "efficacy", "while", "minimizing", "side-effects", "common", "to", "cancer", "treatments.", "<tag2>", "Acquired", "IPR", "D", "consists", "of", "EGEN", "s", "drug", "technology", "platforms:", "TheraPlas", "and", "TheraSilence", ".", "<tag3>"], "wordsA": ["The", "promise", "of", "this", "drug", "technology", "is", "to", "maximize", "efficacy", "while", "minimizing", "side-effects", "common", "to", "cancer", "treatments."], "wordsB": ["Acquired", "IPR", "D", "consists", "of", "EGEN", "s", "drug", "technology", "platforms:", "TheraPlas", "and", "TheraSilence", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p28_s2", "idA": "749647_14_item7_p37_s0", "sentA": "Prior to the closing of the Common Stock Offering on June 3, 2013, there were an insufficient number of authorized shares to complete the transaction.", "sentB": "In addition, CLSN Laboratories assumed certain specified liabilities of EGEN, including the liabilities arising out of the acquired contracts and other assets relating to periods after the closing date.", "type": 1, "words": ["<tag1>", "Prior", "to", "the", "closing", "of", "the", "Common", "Stock", "Offering", "on", "June", "3,", "2013,", "there", "were", "an", "insufficient", "number", "of", "authorized", "shares", "to", "complete", "the", "transaction.", "<tag2>", "In", "addition,", "CLSN", "Laboratories", "assumed", "certain", "specified", "liabilities", "of", "EGEN,", "including", "the", "liabilities", "arising", "out", "of", "the", "acquired", "contracts", "and", "other", "assets", "relating", "to", "periods", "after", "the", "closing", "date.", "<tag3>"], "wordsA": ["Prior", "to", "the", "closing", "of", "the", "Common", "Stock", "Offering", "on", "June", "3,", "2013,", "there", "were", "an", "insufficient", "number", "of", "authorized", "shares", "to", "complete", "the", "transaction."], "wordsB": ["In", "addition,", "CLSN", "Laboratories", "assumed", "certain", "specified", "liabilities", "of", "EGEN,", "including", "the", "liabilities", "arising", "out", "of", "the", "acquired", "contracts", "and", "other", "assets", "relating", "to", "periods", "after", "the", "closing", "date."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p18_s1", "idA": "749647_14_item7_p39_s0", "sentA": "The warrants described above were originally recorded as equity at the fair value on the date of issuance.", "sentB": "The two similarly designed Phase I studies enrolled patients with highly resistant tumors found on the chest wall and who had progressed on previous therapy including chemotherapy, radiation therapy and hormone therapy.", "type": 1, "words": ["<tag1>", "The", "warrants", "described", "above", "were", "originally", "recorded", "as", "equity", "at", "the", "fair", "value", "on", "the", "date", "of", "issuance.", "<tag2>", "The", "two", "similarly", "designed", "Phase", "I", "studies", "enrolled", "patients", "with", "highly", "resistant", "tumors", "found", "on", "the", "chest", "wall", "and", "who", "had", "progressed", "on", "previous", "therapy", "including", "chemotherapy,", "radiation", "therapy", "and", "hormone", "therapy.", "<tag3>"], "wordsA": ["The", "warrants", "described", "above", "were", "originally", "recorded", "as", "equity", "at", "the", "fair", "value", "on", "the", "date", "of", "issuance."], "wordsB": ["The", "two", "similarly", "designed", "Phase", "I", "studies", "enrolled", "patients", "with", "highly", "resistant", "tumors", "found", "on", "the", "chest", "wall", "and", "who", "had", "progressed", "on", "previous", "therapy", "including", "chemotherapy,", "radiation", "therapy", "and", "hormone", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p28_s1", "idA": "749647_14_item7_p40_s1", "sentA": "As part of the process, the Company reviews the selection, application and communication of critical accounting policies and financial disclosures.", "sentB": "CLSN Laboratories, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (CLSN Laboratories), acquired all of EGEN s right, title and interest in and to substantially all of the assets of EGEN, including cash and cash equivalents, patents, trademarks and other intellectual property rights, clinical data, certain contracts, licenses and permits, equipment, furniture, office equipment, furnishings, supplies and other tangible personal property.", "type": 1, "words": ["<tag1>", "As", "part", "of", "the", "process,", "the", "Company", "reviews", "the", "selection,", "application", "and", "communication", "of", "critical", "accounting", "policies", "and", "financial", "disclosures.", "<tag2>", "CLSN", "Laboratories,", "Inc.,", "a", "Delaware", "corporation", "and", "a", "wholly-owned", "subsidiary", "of", "the", "Company", "(CLSN", "Laboratories),", "acquired", "all", "of", "EGEN", "s", "right,", "title", "and", "interest", "in", "and", "to", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "including", "cash", "and", "cash", "equivalents,", "patents,", "trademarks", "and", "other", "intellectual", "property", "rights,", "clinical", "data,", "certain", "contracts,", "licenses", "and", "permits,", "equipment,", "furniture,", "office", "equipment,", "furnishings,", "supplies", "and", "other", "tangible", "personal", "property.", "<tag3>"], "wordsA": ["As", "part", "of", "the", "process,", "the", "Company", "reviews", "the", "selection,", "application", "and", "communication", "of", "critical", "accounting", "policies", "and", "financial", "disclosures."], "wordsB": ["CLSN", "Laboratories,", "Inc.,", "a", "Delaware", "corporation", "and", "a", "wholly-owned", "subsidiary", "of", "the", "Company", "(CLSN", "Laboratories),", "acquired", "all", "of", "EGEN", "s", "right,", "title", "and", "interest", "in", "and", "to", "substantially", "all", "of", "the", "assets", "of", "EGEN,", "including", "cash", "and", "cash", "equivalents,", "patents,", "trademarks", "and", "other", "intellectual", "property", "rights,", "clinical", "data,", "certain", "contracts,", "licenses", "and", "permits,", "equipment,", "furniture,", "office", "equipment,", "furnishings,", "supplies", "and", "other", "tangible", "personal", "property."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p40_s0", "idA": "749647_14_item7_p41_s0", "sentA": "The preparation of our financial statements in conformity with accounting principles generally accepted in the United States requires that our management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.", "sentB": "Under the acquisition method of accounting, the total purchase price is allocated to EGEN s net tangible and intangible assets and liabilities based on their estimated fair values as of the acquisition date.", "type": 1, "words": ["<tag1>", "The", "preparation", "of", "our", "financial", "statements", "in", "conformity", "with", "accounting", "principles", "generally", "accepted", "in", "the", "United", "States", "requires", "that", "our", "management", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period.", "<tag2>", "Under", "the", "acquisition", "method", "of", "accounting,", "the", "total", "purchase", "price", "is", "allocated", "to", "EGEN", "s", "net", "tangible", "and", "intangible", "assets", "and", "liabilities", "based", "on", "their", "estimated", "fair", "values", "as", "of", "the", "acquisition", "date.", "<tag3>"], "wordsA": ["The", "preparation", "of", "our", "financial", "statements", "in", "conformity", "with", "accounting", "principles", "generally", "accepted", "in", "the", "United", "States", "requires", "that", "our", "management", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period."], "wordsB": ["Under", "the", "acquisition", "method", "of", "accounting,", "the", "total", "purchase", "price", "is", "allocated", "to", "EGEN", "s", "net", "tangible", "and", "intangible", "assets", "and", "liabilities", "based", "on", "their", "estimated", "fair", "values", "as", "of", "the", "acquisition", "date."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p40_s1", "idA": "749647_14_item7_p41_s0", "sentA": "The preparation of our financial statements in conformity with accounting principles generally accepted in the United States requires that our management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.", "sentB": "The table below summarizes the preliminary estimated fair values of EGEN s net tangible and intangible assets and liabilities on the acquisition date.", "type": 1, "words": ["<tag1>", "The", "preparation", "of", "our", "financial", "statements", "in", "conformity", "with", "accounting", "principles", "generally", "accepted", "in", "the", "United", "States", "requires", "that", "our", "management", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period.", "<tag2>", "The", "table", "below", "summarizes", "the", "preliminary", "estimated", "fair", "values", "of", "EGEN", "s", "net", "tangible", "and", "intangible", "assets", "and", "liabilities", "on", "the", "acquisition", "date.", "<tag3>"], "wordsA": ["The", "preparation", "of", "our", "financial", "statements", "in", "conformity", "with", "accounting", "principles", "generally", "accepted", "in", "the", "United", "States", "requires", "that", "our", "management", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period."], "wordsB": ["The", "table", "below", "summarizes", "the", "preliminary", "estimated", "fair", "values", "of", "EGEN", "s", "net", "tangible", "and", "intangible", "assets", "and", "liabilities", "on", "the", "acquisition", "date."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p43_s1", "idA": "749647_14_item7_p41_s0", "sentA": "The preparation of our financial statements in conformity with accounting principles generally accepted in the United States requires that our management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.", "sentB": "Cash flows were calculated based on estimated projections of revenues and expenses related to the IPR D programs and then reduced by a contributory charge on requisite assets employed.", "type": 1, "words": ["<tag1>", "The", "preparation", "of", "our", "financial", "statements", "in", "conformity", "with", "accounting", "principles", "generally", "accepted", "in", "the", "United", "States", "requires", "that", "our", "management", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period.", "<tag2>", "Cash", "flows", "were", "calculated", "based", "on", "estimated", "projections", "of", "revenues", "and", "expenses", "related", "to", "the", "IPR", "D", "programs", "and", "then", "reduced", "by", "a", "contributory", "charge", "on", "requisite", "assets", "employed.", "<tag3>"], "wordsA": ["The", "preparation", "of", "our", "financial", "statements", "in", "conformity", "with", "accounting", "principles", "generally", "accepted", "in", "the", "United", "States", "requires", "that", "our", "management", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period."], "wordsB": ["Cash", "flows", "were", "calculated", "based", "on", "estimated", "projections", "of", "revenues", "and", "expenses", "related", "to", "the", "IPR", "D", "programs", "and", "then", "reduced", "by", "a", "contributory", "charge", "on", "requisite", "assets", "employed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p43_s2", "idA": "749647_14_item7_p41_s0", "sentA": "The preparation of our financial statements in conformity with accounting principles generally accepted in the United States requires that our management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.", "sentB": "Contributory assets included debt-free working capital, net fixed assets and assembled workforce.", "type": 1, "words": ["<tag1>", "The", "preparation", "of", "our", "financial", "statements", "in", "conformity", "with", "accounting", "principles", "generally", "accepted", "in", "the", "United", "States", "requires", "that", "our", "management", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period.", "<tag2>", "Contributory", "assets", "included", "debt-free", "working", "capital,", "net", "fixed", "assets", "and", "assembled", "workforce.", "<tag3>"], "wordsA": ["The", "preparation", "of", "our", "financial", "statements", "in", "conformity", "with", "accounting", "principles", "generally", "accepted", "in", "the", "United", "States", "requires", "that", "our", "management", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period."], "wordsB": ["Contributory", "assets", "included", "debt-free", "working", "capital,", "net", "fixed", "assets", "and", "assembled", "workforce."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p67_s0", "idA": "749647_14_item7_p41_s0", "sentA": "The preparation of our financial statements in conformity with accounting principles generally accepted in the United States requires that our management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.", "sentB": "Under the acquisition method of accounting, the total purchase price is allocated to net tangible and intangible assets and liabilities based on their estimated fair values as of the acquisition date.", "type": 1, "words": ["<tag1>", "The", "preparation", "of", "our", "financial", "statements", "in", "conformity", "with", "accounting", "principles", "generally", "accepted", "in", "the", "United", "States", "requires", "that", "our", "management", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period.", "<tag2>", "Under", "the", "acquisition", "method", "of", "accounting,", "the", "total", "purchase", "price", "is", "allocated", "to", "net", "tangible", "and", "intangible", "assets", "and", "liabilities", "based", "on", "their", "estimated", "fair", "values", "as", "of", "the", "acquisition", "date.", "<tag3>"], "wordsA": ["The", "preparation", "of", "our", "financial", "statements", "in", "conformity", "with", "accounting", "principles", "generally", "accepted", "in", "the", "United", "States", "requires", "that", "our", "management", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period."], "wordsB": ["Under", "the", "acquisition", "method", "of", "accounting,", "the", "total", "purchase", "price", "is", "allocated", "to", "net", "tangible", "and", "intangible", "assets", "and", "liabilities", "based", "on", "their", "estimated", "fair", "values", "as", "of", "the", "acquisition", "date."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p31_s0", "idA": "749647_14_item7_p47_s0", "sentA": "General and administrative expenses increased slightly to $6.5 million in 2013 compared to $6.4 million in 2012.", "sentB": "A self-liquidating payment of 50% of all fees received from the licensing of TherSilence (up to $6.0 million).", "type": 1, "words": ["<tag1>", "General", "and", "administrative", "expenses", "increased", "slightly", "to", "$6.5", "million", "in", "2013", "compared", "to", "$6.4", "million", "in", "2012.", "<tag2>", "A", "self-liquidating", "payment", "of", "50%", "of", "all", "fees", "received", "from", "the", "licensing", "of", "TherSilence", "(up", "to", "$6.0", "million).", "<tag3>"], "wordsA": ["General", "and", "administrative", "expenses", "increased", "slightly", "to", "$6.5", "million", "in", "2013", "compared", "to", "$6.4", "million", "in", "2012."], "wordsB": ["A", "self-liquidating", "payment", "of", "50%", "of", "all", "fees", "received", "from", "the", "licensing", "of", "TherSilence", "(up", "to", "$6.0", "million)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p18_s4", "idA": "749647_14_item7_p4_s0", "sentA": "On January 31, 2013, we announced that ThermoDox in combination with radio frequency ablation (RFA) did not meet the primary endpoint of Progression Free Survival (PFS) of the 701 patient clinical trial (the HEAT Study) in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.", "sentB": "A local response rate of over 60 percent was reported in 14 of the 23 evaluable patients with five complete responses and nine partial responses.", "type": 1, "words": ["<tag1>", "On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "radio", "frequency", "ablation", "(RFA)", "did", "not", "meet", "the", "primary", "endpoint", "of", "Progression", "Free", "Survival", "(PFS)", "of", "the", "701", "patient", "clinical", "trial", "(the", "HEAT", "Study)", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer.", "<tag2>", "A", "local", "response", "rate", "of", "over", "60", "percent", "was", "reported", "in", "14", "of", "the", "23", "evaluable", "patients", "with", "five", "complete", "responses", "and", "nine", "partial", "responses.", "<tag3>"], "wordsA": ["On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "radio", "frequency", "ablation", "(RFA)", "did", "not", "meet", "the", "primary", "endpoint", "of", "Progression", "Free", "Survival", "(PFS)", "of", "the", "701", "patient", "clinical", "trial", "(the", "HEAT", "Study)", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer."], "wordsB": ["A", "local", "response", "rate", "of", "over", "60", "percent", "was", "reported", "in", "14", "of", "the", "23", "evaluable", "patients", "with", "five", "complete", "responses", "and", "nine", "partial", "responses."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p21_s0", "idA": "749647_14_item7_p4_s0", "sentA": "On January 31, 2013, we announced that ThermoDox in combination with radio frequency ablation (RFA) did not meet the primary endpoint of Progression Free Survival (PFS) of the 701 patient clinical trial (the HEAT Study) in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer.", "sentB": "Secondary objectives of the Euro-DIGNITY Study will be (i) to evaluate the safety of the combination of ThermoDox/Hyperthermia/Radiotherapy among patients with LRR breast cancer, (ii) to evaluate the duration of local control complete response (CR), partial response (PR) and stable disease (SD) following treatment with ThermoDox/Hyperthermia/Radiotherapy up to 24 months among patients with LRR breast cancer and (iii) to assess Patient Reported Quality of Life using the FACT-B and Brief Pain Inventory (BPI) following treatment with ThermoDox/Hyperthermia/Radiotherapy among patients with LRR breast cancer.", "type": 1, "words": ["<tag1>", "On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "radio", "frequency", "ablation", "(RFA)", "did", "not", "meet", "the", "primary", "endpoint", "of", "Progression", "Free", "Survival", "(PFS)", "of", "the", "701", "patient", "clinical", "trial", "(the", "HEAT", "Study)", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer.", "<tag2>", "Secondary", "objectives", "of", "the", "Euro-DIGNITY", "Study", "will", "be", "(i)", "to", "evaluate", "the", "safety", "of", "the", "combination", "of", "ThermoDox/Hyperthermia/Radiotherapy", "among", "patients", "with", "LRR", "breast", "cancer,", "(ii)", "to", "evaluate", "the", "duration", "of", "local", "control", "complete", "response", "(CR),", "partial", "response", "(PR)", "and", "stable", "disease", "(SD)", "following", "treatment", "with", "ThermoDox/Hyperthermia/Radiotherapy", "up", "to", "24", "months", "among", "patients", "with", "LRR", "breast", "cancer", "and", "(iii)", "to", "assess", "Patient", "Reported", "Quality", "of", "Life", "using", "the", "FACT-B", "and", "Brief", "Pain", "Inventory", "(BPI)", "following", "treatment", "with", "ThermoDox/Hyperthermia/Radiotherapy", "among", "patients", "with", "LRR", "breast", "cancer.", "<tag3>"], "wordsA": ["On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "radio", "frequency", "ablation", "(RFA)", "did", "not", "meet", "the", "primary", "endpoint", "of", "Progression", "Free", "Survival", "(PFS)", "of", "the", "701", "patient", "clinical", "trial", "(the", "HEAT", "Study)", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer."], "wordsB": ["Secondary", "objectives", "of", "the", "Euro-DIGNITY", "Study", "will", "be", "(i)", "to", "evaluate", "the", "safety", "of", "the", "combination", "of", "ThermoDox/Hyperthermia/Radiotherapy", "among", "patients", "with", "LRR", "breast", "cancer,", "(ii)", "to", "evaluate", "the", "duration", "of", "local", "control", "complete", "response", "(CR),", "partial", "response", "(PR)", "and", "stable", "disease", "(SD)", "following", "treatment", "with", "ThermoDox/Hyperthermia/Radiotherapy", "up", "to", "24", "months", "among", "patients", "with", "LRR", "breast", "cancer", "and", "(iii)", "to", "assess", "Patient", "Reported", "Quality", "of", "Life", "using", "the", "FACT-B", "and", "Brief", "Pain", "Inventory", "(BPI)", "following", "treatment", "with", "ThermoDox/Hyperthermia/Radiotherapy", "among", "patients", "with", "LRR", "breast", "cancer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p23_s1", "idA": "749647_14_item7_p50_s4", "sentA": "The change in the fair value of the warrants which were waived from the time they were liability classified to the time they were equity reclassified resulted in a non-cash benefit of $3.8 million in 2013.", "sentB": "In addition, we granted to Impatients an option to negotiate an exclusive license to distribute ThermoDox in the Territory after ThermoDox receives regulatory approval in a country within the Territory.", "type": 1, "words": ["<tag1>", "The", "change", "in", "the", "fair", "value", "of", "the", "warrants", "which", "were", "waived", "from", "the", "time", "they", "were", "liability", "classified", "to", "the", "time", "they", "were", "equity", "reclassified", "resulted", "in", "a", "non-cash", "benefit", "of", "$3.8", "million", "in", "2013.", "<tag2>", "In", "addition,", "we", "granted", "to", "Impatients", "an", "option", "to", "negotiate", "an", "exclusive", "license", "to", "distribute", "ThermoDox", "in", "the", "Territory", "after", "ThermoDox", "receives", "regulatory", "approval", "in", "a", "country", "within", "the", "Territory.", "<tag3>"], "wordsA": ["The", "change", "in", "the", "fair", "value", "of", "the", "warrants", "which", "were", "waived", "from", "the", "time", "they", "were", "liability", "classified", "to", "the", "time", "they", "were", "equity", "reclassified", "resulted", "in", "a", "non-cash", "benefit", "of", "$3.8", "million", "in", "2013."], "wordsB": ["In", "addition,", "we", "granted", "to", "Impatients", "an", "option", "to", "negotiate", "an", "exclusive", "license", "to", "distribute", "ThermoDox", "in", "the", "Territory", "after", "ThermoDox", "receives", "regulatory", "approval", "in", "a", "country", "within", "the", "Territory."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p35_s1", "idA": "749647_14_item7_p50_s4", "sentA": "The change in the fair value of the warrants which were waived from the time they were liability classified to the time they were equity reclassified resulted in a non-cash benefit of $3.8 million in 2013.", "sentB": "Preclinical data indicate that in a mouse lung tumor model, intravenous (IV) delivery of RNA inhibiting VEGFR-2, a tumor angiogenesis factor, via the TheraSilence delivery system resulted in significant knockdown of VEGFR-2 transcript in lungs, reduction in tumor blood vessel density and inhibition of tumor growth.", "type": 1, "words": ["<tag1>", "The", "change", "in", "the", "fair", "value", "of", "the", "warrants", "which", "were", "waived", "from", "the", "time", "they", "were", "liability", "classified", "to", "the", "time", "they", "were", "equity", "reclassified", "resulted", "in", "a", "non-cash", "benefit", "of", "$3.8", "million", "in", "2013.", "<tag2>", "Preclinical", "data", "indicate", "that", "in", "a", "mouse", "lung", "tumor", "model,", "intravenous", "(IV)", "delivery", "of", "RNA", "inhibiting", "VEGFR-2,", "a", "tumor", "angiogenesis", "factor,", "via", "the", "TheraSilence", "delivery", "system", "resulted", "in", "significant", "knockdown", "of", "VEGFR-2", "transcript", "in", "lungs,", "reduction", "in", "tumor", "blood", "vessel", "density", "and", "inhibition", "of", "tumor", "growth.", "<tag3>"], "wordsA": ["The", "change", "in", "the", "fair", "value", "of", "the", "warrants", "which", "were", "waived", "from", "the", "time", "they", "were", "liability", "classified", "to", "the", "time", "they", "were", "equity", "reclassified", "resulted", "in", "a", "non-cash", "benefit", "of", "$3.8", "million", "in", "2013."], "wordsB": ["Preclinical", "data", "indicate", "that", "in", "a", "mouse", "lung", "tumor", "model,", "intravenous", "(IV)", "delivery", "of", "RNA", "inhibiting", "VEGFR-2,", "a", "tumor", "angiogenesis", "factor,", "via", "the", "TheraSilence", "delivery", "system", "resulted", "in", "significant", "knockdown", "of", "VEGFR-2", "transcript", "in", "lungs,", "reduction", "in", "tumor", "blood", "vessel", "density", "and", "inhibition", "of", "tumor", "growth."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p14_s0", "idA": "749647_14_item7_p55_s0", "sentA": "We had no licensing revenue for the year ended December 31, 2012.", "sentB": "We have filed a request for a Voluntary Harmonization Procedure (VHP) in Europe, which provides for the assessment of multinational clinical trial applications across several European countries, including Germany, Italy and Spain.", "type": 1, "words": ["<tag1>", "We", "had", "no", "licensing", "revenue", "for", "the", "year", "ended", "December", "31,", "2012.", "<tag2>", "We", "have", "filed", "a", "request", "for", "a", "Voluntary", "Harmonization", "Procedure", "(VHP)", "in", "Europe,", "which", "provides", "for", "the", "assessment", "of", "multinational", "clinical", "trial", "applications", "across", "several", "European", "countries,", "including", "Germany,", "Italy", "and", "Spain.", "<tag3>"], "wordsA": ["We", "had", "no", "licensing", "revenue", "for", "the", "year", "ended", "December", "31,", "2012."], "wordsB": ["We", "have", "filed", "a", "request", "for", "a", "Voluntary", "Harmonization", "Procedure", "(VHP)", "in", "Europe,", "which", "provides", "for", "the", "assessment", "of", "multinational", "clinical", "trial", "applications", "across", "several", "European", "countries,", "including", "Germany,", "Italy", "and", "Spain."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p34_s3", "idA": "749647_14_item7_p57_s0", "sentA": "Costs associated with our recurrent chest wall breast cancer clinical trial (RCW) remained relatively unchanged at $0.4 million in 2012 and 2011.", "sentB": "The clinical trial will identify a safe, tolerable and potentially therapeutically active dose of GEN-1 while maximizing an immune response.", "type": 1, "words": ["<tag1>", "Costs", "associated", "with", "our", "recurrent", "chest", "wall", "breast", "cancer", "clinical", "trial", "(RCW)", "remained", "relatively", "unchanged", "at", "$0.4", "million", "in", "2012", "and", "2011.", "<tag2>", "The", "clinical", "trial", "will", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "while", "maximizing", "an", "immune", "response.", "<tag3>"], "wordsA": ["Costs", "associated", "with", "our", "recurrent", "chest", "wall", "breast", "cancer", "clinical", "trial", "(RCW)", "remained", "relatively", "unchanged", "at", "$0.4", "million", "in", "2012", "and", "2011."], "wordsB": ["The", "clinical", "trial", "will", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "while", "maximizing", "an", "immune", "response."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p35_s2", "idA": "749647_14_item7_p57_s1", "sentA": "Costs associated with the Company s CRLM trial were $0.2 million in 2012 compared to $0.3 million in 2011.", "sentB": "Preclinical studies also demonstrated the ability of anti-miRNA delivered via the TheraSilence delivery system to inhibit miRNA-145, which is associated with the pathogenesis of pulmonary arterial hypertension.", "type": 1, "words": ["<tag1>", "Costs", "associated", "with", "the", "Company", "s", "CRLM", "trial", "were", "$0.2", "million", "in", "2012", "compared", "to", "$0.3", "million", "in", "2011.", "<tag2>", "Preclinical", "studies", "also", "demonstrated", "the", "ability", "of", "anti-miRNA", "delivered", "via", "the", "TheraSilence", "delivery", "system", "to", "inhibit", "miRNA-145,", "which", "is", "associated", "with", "the", "pathogenesis", "of", "pulmonary", "arterial", "hypertension.", "<tag3>"], "wordsA": ["Costs", "associated", "with", "the", "Company", "s", "CRLM", "trial", "were", "$0.2", "million", "in", "2012", "compared", "to", "$0.3", "million", "in", "2011."], "wordsB": ["Preclinical", "studies", "also", "demonstrated", "the", "ability", "of", "anti-miRNA", "delivered", "via", "the", "TheraSilence", "delivery", "system", "to", "inhibit", "miRNA-145,", "which", "is", "associated", "with", "the", "pathogenesis", "of", "pulmonary", "arterial", "hypertension."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p35_s3", "idA": "749647_14_item7_p59_s1", "sentA": "This liability is calculated at its fair market value using the Black-Scholes option-pricing model and is adjusted at the end of each quarter.", "sentB": "Systemically administered RNA complexes using the TheraSilence delivery system demonstrated a good tolerability profile.", "type": 1, "words": ["<tag1>", "This", "liability", "is", "calculated", "at", "its", "fair", "market", "value", "using", "the", "Black-Scholes", "option-pricing", "model", "and", "is", "adjusted", "at", "the", "end", "of", "each", "quarter.", "<tag2>", "Systemically", "administered", "RNA", "complexes", "using", "the", "TheraSilence", "delivery", "system", "demonstrated", "a", "good", "tolerability", "profile.", "<tag3>"], "wordsA": ["This", "liability", "is", "calculated", "at", "its", "fair", "market", "value", "using", "the", "Black-Scholes", "option-pricing", "model", "and", "is", "adjusted", "at", "the", "end", "of", "each", "quarter."], "wordsB": ["Systemically", "administered", "RNA", "complexes", "using", "the", "TheraSilence", "delivery", "system", "demonstrated", "a", "good", "tolerability", "profile."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p43_s5", "idA": "749647_14_item7_p59_s1", "sentA": "This liability is calculated at its fair market value using the Black-Scholes option-pricing model and is adjusted at the end of each quarter.", "sentB": "The resultant cash flows were then discounted to present value using a weighted-average cost of equity capital for companies with profiles substantially similar to that of Celsion, which we believe represents the rate that market participants would use to value the assets.", "type": 1, "words": ["<tag1>", "This", "liability", "is", "calculated", "at", "its", "fair", "market", "value", "using", "the", "Black-Scholes", "option-pricing", "model", "and", "is", "adjusted", "at", "the", "end", "of", "each", "quarter.", "<tag2>", "The", "resultant", "cash", "flows", "were", "then", "discounted", "to", "present", "value", "using", "a", "weighted-average", "cost", "of", "equity", "capital", "for", "companies", "with", "profiles", "substantially", "similar", "to", "that", "of", "Celsion,", "which", "we", "believe", "represents", "the", "rate", "that", "market", "participants", "would", "use", "to", "value", "the", "assets.", "<tag3>"], "wordsA": ["This", "liability", "is", "calculated", "at", "its", "fair", "market", "value", "using", "the", "Black-Scholes", "option-pricing", "model", "and", "is", "adjusted", "at", "the", "end", "of", "each", "quarter."], "wordsB": ["The", "resultant", "cash", "flows", "were", "then", "discounted", "to", "present", "value", "using", "a", "weighted-average", "cost", "of", "equity", "capital", "for", "companies", "with", "profiles", "substantially", "similar", "to", "that", "of", "Celsion,", "which", "we", "believe", "represents", "the", "rate", "that", "market", "participants", "would", "use", "to", "value", "the", "assets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p43_s4", "idA": "749647_14_item7_p6_s2", "sentA": "In January 2014, we announced that the latest overall survival data from its post-hoc analysis of results from the HEAT Study supports continued clinical development through a prospective pivotal Phase III Study.", "sentB": "Cash flows were assumed to extend through a seven-year market exclusivity period.", "type": 1, "words": ["<tag1>", "In", "January", "2014,", "we", "announced", "that", "the", "latest", "overall", "survival", "data", "from", "its", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "Study", "supports", "continued", "clinical", "development", "through", "a", "prospective", "pivotal", "Phase", "III", "Study.", "<tag2>", "Cash", "flows", "were", "assumed", "to", "extend", "through", "a", "seven-year", "market", "exclusivity", "period.", "<tag3>"], "wordsA": ["In", "January", "2014,", "we", "announced", "that", "the", "latest", "overall", "survival", "data", "from", "its", "post-hoc", "analysis", "of", "results", "from", "the", "HEAT", "Study", "supports", "continued", "clinical", "development", "through", "a", "prospective", "pivotal", "Phase", "III", "Study."], "wordsB": ["Cash", "flows", "were", "assumed", "to", "extend", "through", "a", "seven-year", "market", "exclusivity", "period."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p66_s0", "idA": "749647_14_item7_p70_s0", "sentA": "In January 2014, the Company sold in a registered direct offering, an aggregate of 3,603,604 shares of common stock and warrants to purchase up to 1,801,802 shares of Common Stock, for an aggregate purchase price of approximately $15 million.", "sentB": "During 2014, the Company acquired certain assets of EGEN, Inc.", "type": 1, "words": ["<tag1>", "In", "January", "2014,", "the", "Company", "sold", "in", "a", "registered", "direct", "offering,", "an", "aggregate", "of", "3,603,604", "shares", "of", "common", "stock", "and", "warrants", "to", "purchase", "up", "to", "1,801,802", "shares", "of", "Common", "Stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15", "million.", "<tag2>", "During", "2014,", "the", "Company", "acquired", "certain", "assets", "of", "EGEN,", "Inc.", "<tag3>"], "wordsA": ["In", "January", "2014,", "the", "Company", "sold", "in", "a", "registered", "direct", "offering,", "an", "aggregate", "of", "3,603,604", "shares", "of", "common", "stock", "and", "warrants", "to", "purchase", "up", "to", "1,801,802", "shares", "of", "Common", "Stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15", "million."], "wordsB": ["During", "2014,", "the", "Company", "acquired", "certain", "assets", "of", "EGEN,", "Inc."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p79_s0", "idA": "749647_14_item7_p70_s0", "sentA": "In January 2014, the Company sold in a registered direct offering, an aggregate of 3,603,604 shares of common stock and warrants to purchase up to 1,801,802 shares of Common Stock, for an aggregate purchase price of approximately $15 million.", "sentB": "The total aggregate purchase price for the acquisition of assets from EGEN Acquisition included potential future earn-out payments contingent upon achievement of certain milestones.", "type": 1, "words": ["<tag1>", "In", "January", "2014,", "the", "Company", "sold", "in", "a", "registered", "direct", "offering,", "an", "aggregate", "of", "3,603,604", "shares", "of", "common", "stock", "and", "warrants", "to", "purchase", "up", "to", "1,801,802", "shares", "of", "Common", "Stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15", "million.", "<tag2>", "The", "total", "aggregate", "purchase", "price", "for", "the", "acquisition", "of", "assets", "from", "EGEN", "Acquisition", "included", "potential", "future", "earn-out", "payments", "contingent", "upon", "achievement", "of", "certain", "milestones.", "<tag3>"], "wordsA": ["In", "January", "2014,", "the", "Company", "sold", "in", "a", "registered", "direct", "offering,", "an", "aggregate", "of", "3,603,604", "shares", "of", "common", "stock", "and", "warrants", "to", "purchase", "up", "to", "1,801,802", "shares", "of", "Common", "Stock,", "for", "an", "aggregate", "purchase", "price", "of", "approximately", "$15", "million."], "wordsB": ["The", "total", "aggregate", "purchase", "price", "for", "the", "acquisition", "of", "assets", "from", "EGEN", "Acquisition", "included", "potential", "future", "earn-out", "payments", "contingent", "upon", "achievement", "of", "certain", "milestones."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p39_s0", "idA": "749647_14_item7_p70_s1", "sentA": "The net proceeds from this offering to the Company were approximately $13.8 million.", "sentB": "The acquisition of EGEN was accounted for under the acquisition method of accounting which required the Company to perform an allocation of the purchase price to the assets acquired and liabilities assumed.", "type": 1, "words": ["<tag1>", "The", "net", "proceeds", "from", "this", "offering", "to", "the", "Company", "were", "approximately", "$13.8", "million.", "<tag2>", "The", "acquisition", "of", "EGEN", "was", "accounted", "for", "under", "the", "acquisition", "method", "of", "accounting", "which", "required", "the", "Company", "to", "perform", "an", "allocation", "of", "the", "purchase", "price", "to", "the", "assets", "acquired", "and", "liabilities", "assumed.", "<tag3>"], "wordsA": ["The", "net", "proceeds", "from", "this", "offering", "to", "the", "Company", "were", "approximately", "$13.8", "million."], "wordsB": ["The", "acquisition", "of", "EGEN", "was", "accounted", "for", "under", "the", "acquisition", "method", "of", "accounting", "which", "required", "the", "Company", "to", "perform", "an", "allocation", "of", "the", "purchase", "price", "to", "the", "assets", "acquired", "and", "liabilities", "assumed."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item7_p17_s3", "idA": "749647_14_item7_p7_s0", "sentA": "As reported in January 2014, post-hoc data from the HEAT Study demonstrate that the patient subgroup in the ThermoDox arm whose RFA procedure lasted longer than 45 minutes (285 patients or 63% of single lesion patients), experienced a 55% improvement in overall survival, with a Hazard Ratio of 0.64 (95% CI 0.41 - 1.00) and a P-value = 0.0495.", "sentB": "Based on data available to date, 60 percent of patients experienced a stabilization of their highly refractory disease with a local response rate of 50 percent observed in the ten evaluable patients, notably three complete responses, two partial responses and one patient with stable disease.", "type": 1, "words": ["<tag1>", "As", "reported", "in", "January", "2014,", "post-hoc", "data", "from", "the", "HEAT", "Study", "demonstrate", "that", "the", "patient", "subgroup", "in", "the", "ThermoDox", "arm", "whose", "RFA", "procedure", "lasted", "longer", "than", "45", "minutes", "(285", "patients", "or", "63%", "of", "single", "lesion", "patients),", "experienced", "a", "55%", "improvement", "in", "overall", "survival,", "with", "a", "Hazard", "Ratio", "of", "0.64", "(95%", "CI", "0.41", "-", "1.00)", "and", "a", "P-value", "=", "0.0495.", "<tag2>", "Based", "on", "data", "available", "to", "date,", "60", "percent", "of", "patients", "experienced", "a", "stabilization", "of", "their", "highly", "refractory", "disease", "with", "a", "local", "response", "rate", "of", "50", "percent", "observed", "in", "the", "ten", "evaluable", "patients,", "notably", "three", "complete", "responses,", "two", "partial", "responses", "and", "one", "patient", "with", "stable", "disease.", "<tag3>"], "wordsA": ["As", "reported", "in", "January", "2014,", "post-hoc", "data", "from", "the", "HEAT", "Study", "demonstrate", "that", "the", "patient", "subgroup", "in", "the", "ThermoDox", "arm", "whose", "RFA", "procedure", "lasted", "longer", "than", "45", "minutes", "(285", "patients", "or", "63%", "of", "single", "lesion", "patients),", "experienced", "a", "55%", "improvement", "in", "overall", "survival,", "with", "a", "Hazard", "Ratio", "of", "0.64", "(95%", "CI", "0.41", "-", "1.00)", "and", "a", "P-value", "=", "0.0495."], "wordsB": ["Based", "on", "data", "available", "to", "date,", "60", "percent", "of", "patients", "experienced", "a", "stabilization", "of", "their", "highly", "refractory", "disease", "with", "a", "local", "response", "rate", "of", "50", "percent", "observed", "in", "the", "ten", "evaluable", "patients,", "notably", "three", "complete", "responses,", "two", "partial", "responses", "and", "one", "patient", "with", "stable", "disease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_16_item7_p35_s4", "idA": "749647_15_item7_p17_s1", "sentA": "The trial is designed to enroll up to 20 patients at several U.S. clinical sites and is evaluating ThermoDox in combination with mild hyperthermia.", "sentB": "The study is designed to characterize the nature of the immune response triggered by GEN-1 at various levels of the patients immune system, including:", "type": 1, "words": ["<tag1>", "The", "trial", "is", "designed", "to", "enroll", "up", "to", "20", "patients", "at", "several", "U.S.", "clinical", "sites", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia.", "<tag2>", "The", "study", "is", "designed", "to", "characterize", "the", "nature", "of", "the", "immune", "response", "triggered", "by", "GEN-1", "at", "various", "levels", "of", "the", "patients", "immune", "system,", "including:", "<tag3>"], "wordsA": ["The", "trial", "is", "designed", "to", "enroll", "up", "to", "20", "patients", "at", "several", "U.S.", "clinical", "sites", "and", "is", "evaluating", "ThermoDox", "in", "combination", "with", "mild", "hyperthermia."], "wordsB": ["The", "study", "is", "designed", "to", "characterize", "the", "nature", "of", "the", "immune", "response", "triggered", "by", "GEN-1", "at", "various", "levels", "of", "the", "patients", "immune", "system,", "including:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_16_item7_p40_s1", "idA": "749647_15_item7_p18_s0", "sentA": "These data are consistent with the combined clinical data from two Phase I trials, our Phase I DIGNITY Study and the Duke University sponsored Phase I trial of ThermoDox plus hyperthermia in RCW breast cancer in December 2013.", "sentB": "The preclinical data are also consistent with the mechanism of action for GEN-1, which exhibits certain anti-angiogenic properties and suggests that combining GEN-1 with lower doses of Avastin may enhance efficacy and help reduce the known toxicities associated with this anti-VEGF drug.", "type": 1, "words": ["<tag1>", "These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "two", "Phase", "I", "trials,", "our", "Phase", "I", "DIGNITY", "Study", "and", "the", "Duke", "University", "sponsored", "Phase", "I", "trial", "of", "ThermoDox", "plus", "hyperthermia", "in", "RCW", "breast", "cancer", "in", "December", "2013.", "<tag2>", "The", "preclinical", "data", "are", "also", "consistent", "with", "the", "mechanism", "of", "action", "for", "GEN-1,", "which", "exhibits", "certain", "anti-angiogenic", "properties", "and", "suggests", "that", "combining", "GEN-1", "with", "lower", "doses", "of", "Avastin", "may", "enhance", "efficacy", "and", "help", "reduce", "the", "known", "toxicities", "associated", "with", "this", "anti-VEGF", "drug.", "<tag3>"], "wordsA": ["These", "data", "are", "consistent", "with", "the", "combined", "clinical", "data", "from", "two", "Phase", "I", "trials,", "our", "Phase", "I", "DIGNITY", "Study", "and", "the", "Duke", "University", "sponsored", "Phase", "I", "trial", "of", "ThermoDox", "plus", "hyperthermia", "in", "RCW", "breast", "cancer", "in", "December", "2013."], "wordsB": ["The", "preclinical", "data", "are", "also", "consistent", "with", "the", "mechanism", "of", "action", "for", "GEN-1,", "which", "exhibits", "certain", "anti-angiogenic", "properties", "and", "suggests", "that", "combining", "GEN-1", "with", "lower", "doses", "of", "Avastin", "may", "enhance", "efficacy", "and", "help", "reduce", "the", "known", "toxicities", "associated", "with", "this", "anti-VEGF", "drug."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_16_item7_p41_s1", "idA": "749647_15_item7_p34_s3", "sentA": "The clinical trial will identify a safe, tolerable and potentially therapeutically active dose of GEN-1 while maximizing an immune response.", "sentB": "Additionally, the anti-angiogenic activity of GEN-1 mediated through up regulation of the interferon gamma (IFN-g) pathway may help to explain the remarkable synergy between GEN-1 and Avastin and potentially addresses the VEGF escape mechanisms associated with resistance to Avastin therapy.", "type": 1, "words": ["<tag1>", "The", "clinical", "trial", "will", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "while", "maximizing", "an", "immune", "response.", "<tag2>", "Additionally,", "the", "anti-angiogenic", "activity", "of", "GEN-1", "mediated", "through", "up", "regulation", "of", "the", "interferon", "gamma", "(IFN-g)", "pathway", "may", "help", "to", "explain", "the", "remarkable", "synergy", "between", "GEN-1", "and", "Avastin", "and", "potentially", "addresses", "the", "VEGF", "escape", "mechanisms", "associated", "with", "resistance", "to", "Avastin", "therapy.", "<tag3>"], "wordsA": ["The", "clinical", "trial", "will", "identify", "a", "safe,", "tolerable", "and", "potentially", "therapeutically", "active", "dose", "of", "GEN-1", "while", "maximizing", "an", "immune", "response."], "wordsB": ["Additionally,", "the", "anti-angiogenic", "activity", "of", "GEN-1", "mediated", "through", "up", "regulation", "of", "the", "interferon", "gamma", "(IFN-g)", "pathway", "may", "help", "to", "explain", "the", "remarkable", "synergy", "between", "GEN-1", "and", "Avastin", "and", "potentially", "addresses", "the", "VEGF", "escape", "mechanisms", "associated", "with", "resistance", "to", "Avastin", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_16_item7_p41_s0", "idA": "749647_15_item7_p35_s1", "sentA": "Preclinical data indicate that in a mouse lung tumor model, intravenous (IV) delivery of RNA inhibiting VEGFR-2, a tumor angiogenesis factor, via the TheraSilence delivery system resulted in significant knockdown of VEGFR-2 transcript in lungs, reduction in tumor blood vessel density and inhibition of tumor growth.", "sentB": "The distinct biological activities of GEN-1 (immune stimulation) and Avastin (inhibition of tumor blood vessel formation) makes a sound scientific rationale for this combination approach.", "type": 1, "words": ["<tag1>", "Preclinical", "data", "indicate", "that", "in", "a", "mouse", "lung", "tumor", "model,", "intravenous", "(IV)", "delivery", "of", "RNA", "inhibiting", "VEGFR-2,", "a", "tumor", "angiogenesis", "factor,", "via", "the", "TheraSilence", "delivery", "system", "resulted", "in", "significant", "knockdown", "of", "VEGFR-2", "transcript", "in", "lungs,", "reduction", "in", "tumor", "blood", "vessel", "density", "and", "inhibition", "of", "tumor", "growth.", "<tag2>", "The", "distinct", "biological", "activities", "of", "GEN-1", "(immune", "stimulation)", "and", "Avastin", "(inhibition", "of", "tumor", "blood", "vessel", "formation)", "makes", "a", "sound", "scientific", "rationale", "for", "this", "combination", "approach.", "<tag3>"], "wordsA": ["Preclinical", "data", "indicate", "that", "in", "a", "mouse", "lung", "tumor", "model,", "intravenous", "(IV)", "delivery", "of", "RNA", "inhibiting", "VEGFR-2,", "a", "tumor", "angiogenesis", "factor,", "via", "the", "TheraSilence", "delivery", "system", "resulted", "in", "significant", "knockdown", "of", "VEGFR-2", "transcript", "in", "lungs,", "reduction", "in", "tumor", "blood", "vessel", "density", "and", "inhibition", "of", "tumor", "growth."], "wordsB": ["The", "distinct", "biological", "activities", "of", "GEN-1", "(immune", "stimulation)", "and", "Avastin", "(inhibition", "of", "tumor", "blood", "vessel", "formation)", "makes", "a", "sound", "scientific", "rationale", "for", "this", "combination", "approach."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_16_item7_p35_s3", "idA": "749647_15_item7_p38_s1", "sentA": "The timing and the outcome of clinical results is extremely difficult to predict.", "sentB": "In addition, the OVATION Study establishes a unique opportunity to assess how cytokine-based compounds such as GEN-1, directly affect ovarian cancer cells and the tumor microenvironment in newly diagnosed patients.", "type": 1, "words": ["<tag1>", "The", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict.", "<tag2>", "In", "addition,", "the", "OVATION", "Study", "establishes", "a", "unique", "opportunity", "to", "assess", "how", "cytokine-based", "compounds", "such", "as", "GEN-1,", "directly", "affect", "ovarian", "cancer", "cells", "and", "the", "tumor", "microenvironment", "in", "newly", "diagnosed", "patients.", "<tag3>"], "wordsA": ["The", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict."], "wordsB": ["In", "addition,", "the", "OVATION", "Study", "establishes", "a", "unique", "opportunity", "to", "assess", "how", "cytokine-based", "compounds", "such", "as", "GEN-1,", "directly", "affect", "ovarian", "cancer", "cells", "and", "the", "tumor", "microenvironment", "in", "newly", "diagnosed", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_16_item7_p38_s0", "idA": "749647_15_item7_p38_s1", "sentA": "The timing and the outcome of clinical results is extremely difficult to predict.", "sentB": "GEN-1 Plus Doxil and Avastin Trial.", "type": 1, "words": ["<tag1>", "The", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict.", "<tag2>", "GEN-1", "Plus", "Doxil", "and", "Avastin", "Trial.", "<tag3>"], "wordsA": ["The", "timing", "and", "the", "outcome", "of", "clinical", "results", "is", "extremely", "difficult", "to", "predict."], "wordsB": ["GEN-1", "Plus", "Doxil", "and", "Avastin", "Trial."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_16_item7_p39_s1", "idA": "749647_15_item7_p46_s1", "sentA": "As a result of the reverse stock split, every four and a half shares of common stock outstanding immediately prior to the effectiveness of the reverse stock split were combined and converted into one share of common stock immediately thereafter without any change in the per share par value.", "sentB": "The effectiveness of the combined treatment was seen when GEN-1 was combined with various dose levels of Avastin (low-medium-high).", "type": 1, "words": ["<tag1>", "As", "a", "result", "of", "the", "reverse", "stock", "split,", "every", "four", "and", "a", "half", "shares", "of", "common", "stock", "outstanding", "immediately", "prior", "to", "the", "effectiveness", "of", "the", "reverse", "stock", "split", "were", "combined", "and", "converted", "into", "one", "share", "of", "common", "stock", "immediately", "thereafter", "without", "any", "change", "in", "the", "per", "share", "par", "value.", "<tag2>", "The", "effectiveness", "of", "the", "combined", "treatment", "was", "seen", "when", "GEN-1", "was", "combined", "with", "various", "dose", "levels", "of", "Avastin", "(low-medium-high).", "<tag3>"], "wordsA": ["As", "a", "result", "of", "the", "reverse", "stock", "split,", "every", "four", "and", "a", "half", "shares", "of", "common", "stock", "outstanding", "immediately", "prior", "to", "the", "effectiveness", "of", "the", "reverse", "stock", "split", "were", "combined", "and", "converted", "into", "one", "share", "of", "common", "stock", "immediately", "thereafter", "without", "any", "change", "in", "the", "per", "share", "par", "value."], "wordsB": ["The", "effectiveness", "of", "the", "combined", "treatment", "was", "seen", "when", "GEN-1", "was", "combined", "with", "various", "dose", "levels", "of", "Avastin", "(low-medium-high)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_16_item7_p70_s1", "idA": "749647_15_item7_p65_s0", "sentA": "The warrants described above were originally recorded as equity at the fair value on the date of issuance.", "sentB": "The warrants expired in March 2015.", "type": 1, "words": ["<tag1>", "The", "warrants", "described", "above", "were", "originally", "recorded", "as", "equity", "at", "the", "fair", "value", "on", "the", "date", "of", "issuance.", "<tag2>", "The", "warrants", "expired", "in", "March", "2015.", "<tag3>"], "wordsA": ["The", "warrants", "described", "above", "were", "originally", "recorded", "as", "equity", "at", "the", "fair", "value", "on", "the", "date", "of", "issuance."], "wordsB": ["The", "warrants", "expired", "in", "March", "2015."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_16_item7_p37_s0", "idA": "749647_15_item7_p69_s0", "sentA": "The preparation of our financial statements in conformity with accounting principles generally accepted in the United States requires that our management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.", "sentB": "We have initiated the study at four clinical sites at the University of Alabama at Birmingham, Oklahoma University Medical Center, Washington University in St. Louis and the Medical College of Wisconsin.", "type": 1, "words": ["<tag1>", "The", "preparation", "of", "our", "financial", "statements", "in", "conformity", "with", "accounting", "principles", "generally", "accepted", "in", "the", "United", "States", "requires", "that", "our", "management", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period.", "<tag2>", "We", "have", "initiated", "the", "study", "at", "four", "clinical", "sites", "at", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin.", "<tag3>"], "wordsA": ["The", "preparation", "of", "our", "financial", "statements", "in", "conformity", "with", "accounting", "principles", "generally", "accepted", "in", "the", "United", "States", "requires", "that", "our", "management", "make", "estimates", "and", "assumptions", "that", "affect", "the", "reported", "amounts", "of", "assets", "and", "liabilities", "and", "disclosure", "of", "contingent", "assets", "and", "liabilities", "at", "the", "date", "of", "the", "financial", "statements", "and", "the", "reported", "amounts", "of", "revenues", "and", "expenses", "during", "the", "reporting", "period."], "wordsB": ["We", "have", "initiated", "the", "study", "at", "four", "clinical", "sites", "at", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_16_item7_p36_s0", "idA": "749647_15_item7_p6_s2", "sentA": "We have conducted a comprehensive analysis of the data from the HEAT Study to assess the future strategic value of ThermoDox .", "sentB": "expression profile of a comprehensive panel of immune related genes in pre-treatment and GEN-1-treated tumor tissue.", "type": 1, "words": ["<tag1>", "We", "have", "conducted", "a", "comprehensive", "analysis", "of", "the", "data", "from", "the", "HEAT", "Study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", ".", "<tag2>", "expression", "profile", "of", "a", "comprehensive", "panel", "of", "immune", "related", "genes", "in", "pre-treatment", "and", "GEN-1-treated", "tumor", "tissue.", "<tag3>"], "wordsA": ["We", "have", "conducted", "a", "comprehensive", "analysis", "of", "the", "data", "from", "the", "HEAT", "Study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "."], "wordsB": ["expression", "profile", "of", "a", "comprehensive", "panel", "of", "immune", "related", "genes", "in", "pre-treatment", "and", "GEN-1-treated", "tumor", "tissue."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_16_item7_p69_s1", "idA": "749647_15_item7_p72_s3", "sentA": "Costs associated with our RCW breast cancer clinical trial remained relatively unchanged at $0.4 million in 2014 and 2013.", "sentB": "On March 30, 2015, all remaining warrants associated with this equity offering expired.", "type": 1, "words": ["<tag1>", "Costs", "associated", "with", "our", "RCW", "breast", "cancer", "clinical", "trial", "remained", "relatively", "unchanged", "at", "$0.4", "million", "in", "2014", "and", "2013.", "<tag2>", "On", "March", "30,", "2015,", "all", "remaining", "warrants", "associated", "with", "this", "equity", "offering", "expired.", "<tag3>"], "wordsA": ["Costs", "associated", "with", "our", "RCW", "breast", "cancer", "clinical", "trial", "remained", "relatively", "unchanged", "at", "$0.4", "million", "in", "2014", "and", "2013."], "wordsB": ["On", "March", "30,", "2015,", "all", "remaining", "warrants", "associated", "with", "this", "equity", "offering", "expired."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_16_item7_p14_s2", "idA": "749647_15_item7_p73_s0", "sentA": "As we continue to evaluate ThermoDox in the OPTIMA Study and the DIGNITY Study and plan to initiate the Phase I dose-escalation clinical trial of GEN-1 in the second half of 2015, we expect our research and development costs to increase in 2015 compared to 2014.", "sentB": "The DIGNITY Study is also planned to evaluate kinetics in ThermoDox produced from more than one manufacturing site.", "type": 1, "words": ["<tag1>", "As", "we", "continue", "to", "evaluate", "ThermoDox", "in", "the", "OPTIMA", "Study", "and", "the", "DIGNITY", "Study", "and", "plan", "to", "initiate", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "the", "second", "half", "of", "2015,", "we", "expect", "our", "research", "and", "development", "costs", "to", "increase", "in", "2015", "compared", "to", "2014.", "<tag2>", "The", "DIGNITY", "Study", "is", "also", "planned", "to", "evaluate", "kinetics", "in", "ThermoDox", "produced", "from", "more", "than", "one", "manufacturing", "site.", "<tag3>"], "wordsA": ["As", "we", "continue", "to", "evaluate", "ThermoDox", "in", "the", "OPTIMA", "Study", "and", "the", "DIGNITY", "Study", "and", "plan", "to", "initiate", "the", "Phase", "I", "dose-escalation", "clinical", "trial", "of", "GEN-1", "in", "the", "second", "half", "of", "2015,", "we", "expect", "our", "research", "and", "development", "costs", "to", "increase", "in", "2015", "compared", "to", "2014."], "wordsB": ["The", "DIGNITY", "Study", "is", "also", "planned", "to", "evaluate", "kinetics", "in", "ThermoDox", "produced", "from", "more", "than", "one", "manufacturing", "site."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_16_item7_p39_s2", "idA": "749647_15_item7_p78_s2", "sentA": "During 2013, the decrease in the fair value of this liability resulted in the Company recording a non-cash benefit of $8.1 million based on the change in the fair value of the warrants at December 31, 2013.", "sentB": "Additionally, it was shown that GEN-1 treatment alone resulted in anti-tumor activity that was as good as or better than Avastin treatment alone.", "type": 1, "words": ["<tag1>", "During", "2013,", "the", "decrease", "in", "the", "fair", "value", "of", "this", "liability", "resulted", "in", "the", "Company", "recording", "a", "non-cash", "benefit", "of", "$8.1", "million", "based", "on", "the", "change", "in", "the", "fair", "value", "of", "the", "warrants", "at", "December", "31,", "2013.", "<tag2>", "Additionally,", "it", "was", "shown", "that", "GEN-1", "treatment", "alone", "resulted", "in", "anti-tumor", "activity", "that", "was", "as", "good", "as", "or", "better", "than", "Avastin", "treatment", "alone.", "<tag3>"], "wordsA": ["During", "2013,", "the", "decrease", "in", "the", "fair", "value", "of", "this", "liability", "resulted", "in", "the", "Company", "recording", "a", "non-cash", "benefit", "of", "$8.1", "million", "based", "on", "the", "change", "in", "the", "fair", "value", "of", "the", "warrants", "at", "December", "31,", "2013."], "wordsB": ["Additionally,", "it", "was", "shown", "that", "GEN-1", "treatment", "alone", "resulted", "in", "anti-tumor", "activity", "that", "was", "as", "good", "as", "or", "better", "than", "Avastin", "treatment", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_16_item7_p9_s4", "idA": "749647_15_item7_p7_s3", "sentA": "This information should be viewed with caution since it is based on a retrospective analysis of a subgroup that has not reached its median point for the overall survival analysis.", "sentB": "Median overall survival for the ThermoDox group has been reached in this subgroup which translates into a 25.4 month (2.1 year) survival benefit over the optimized RFA only group (79 months for the ThermoDox plus optimized RFA group versus 53.6 months for the optimized RFA only group).", "type": 1, "words": ["<tag1>", "This", "information", "should", "be", "viewed", "with", "caution", "since", "it", "is", "based", "on", "a", "retrospective", "analysis", "of", "a", "subgroup", "that", "has", "not", "reached", "its", "median", "point", "for", "the", "overall", "survival", "analysis.", "<tag2>", "Median", "overall", "survival", "for", "the", "ThermoDox", "group", "has", "been", "reached", "in", "this", "subgroup", "which", "translates", "into", "a", "25.4", "month", "(2.1", "year)", "survival", "benefit", "over", "the", "optimized", "RFA", "only", "group", "(79", "months", "for", "the", "ThermoDox", "plus", "optimized", "RFA", "group", "versus", "53.6", "months", "for", "the", "optimized", "RFA", "only", "group).", "<tag3>"], "wordsA": ["This", "information", "should", "be", "viewed", "with", "caution", "since", "it", "is", "based", "on", "a", "retrospective", "analysis", "of", "a", "subgroup", "that", "has", "not", "reached", "its", "median", "point", "for", "the", "overall", "survival", "analysis."], "wordsB": ["Median", "overall", "survival", "for", "the", "ThermoDox", "group", "has", "been", "reached", "in", "this", "subgroup", "which", "translates", "into", "a", "25.4", "month", "(2.1", "year)", "survival", "benefit", "over", "the", "optimized", "RFA", "only", "group", "(79", "months", "for", "the", "ThermoDox", "plus", "optimized", "RFA", "group", "versus", "53.6", "months", "for", "the", "optimized", "RFA", "only", "group)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p41_s2", "idA": "749647_16_item7_p11_s1", "sentA": "The OPTIMA Study trial design is based on the comprehensive analysis of data from the HEAT study, which, as described previously, demonstrated that treatment with ThermoDox resulted in a 58% improvement in overall survival in a large number of HCC patients that received an optimized RFA treatment for longer than 45 minutes.", "sentB": "cPRs have been associated with a median overall survival of 72 months, which is more than three years longer than those who do not experience a cPR.", "type": 1, "words": ["<tag1>", "The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "the", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "study,", "which,", "as", "described", "previously,", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "58%", "improvement", "in", "overall", "survival", "in", "a", "large", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment", "for", "longer", "than", "45", "minutes.", "<tag2>", "cPRs", "have", "been", "associated", "with", "a", "median", "overall", "survival", "of", "72", "months,", "which", "is", "more", "than", "three", "years", "longer", "than", "those", "who", "do", "not", "experience", "a", "cPR.", "<tag3>"], "wordsA": ["The", "OPTIMA", "Study", "trial", "design", "is", "based", "on", "the", "comprehensive", "analysis", "of", "data", "from", "the", "HEAT", "study,", "which,", "as", "described", "previously,", "demonstrated", "that", "treatment", "with", "ThermoDox", "resulted", "in", "a", "58%", "improvement", "in", "overall", "survival", "in", "a", "large", "number", "of", "HCC", "patients", "that", "received", "an", "optimized", "RFA", "treatment", "for", "longer", "than", "45", "minutes."], "wordsB": ["cPRs", "have", "been", "associated", "with", "a", "median", "overall", "survival", "of", "72", "months,", "which", "is", "more", "than", "three", "years", "longer", "than", "those", "who", "do", "not", "experience", "a", "cPR."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p46_s2", "idA": "749647_16_item7_p15_s1", "sentA": "Approximately 62% of evaluable patients experienced a local response, including six complete responses and seven partial responses.", "sentB": "The ratio of CD8+/FoxP3+ cells was increased in all four evaluable patients.", "type": 1, "words": ["<tag1>", "Approximately", "62%", "of", "evaluable", "patients", "experienced", "a", "local", "response,", "including", "six", "complete", "responses", "and", "seven", "partial", "responses.", "<tag2>", "The", "ratio", "of", "CD8+/FoxP3+", "cells", "was", "increased", "in", "all", "four", "evaluable", "patients.", "<tag3>"], "wordsA": ["Approximately", "62%", "of", "evaluable", "patients", "experienced", "a", "local", "response,", "including", "six", "complete", "responses", "and", "seven", "partial", "responses."], "wordsB": ["The", "ratio", "of", "CD8+/FoxP3+", "cells", "was", "increased", "in", "all", "four", "evaluable", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p41_s0", "idA": "749647_16_item7_p16_s3", "sentA": "Of the 29 patients treated, 23 were eligible for evaluation of efficacy.", "sentB": "Of the eleven surgically treated and evaluable patients, one patient demonstrated a complete pathological response ( cPR ), five (5) patients demonstrated a micro pathological response ( microPR ), and five (5) patients demonstrated a macroPR.", "type": 1, "words": ["<tag1>", "Of", "the", "29", "patients", "treated,", "23", "were", "eligible", "for", "evaluation", "of", "efficacy.", "<tag2>", "Of", "the", "eleven", "surgically", "treated", "and", "evaluable", "patients,", "one", "patient", "demonstrated", "a", "complete", "pathological", "response", "(", "cPR", "),", "five", "(5)", "patients", "demonstrated", "a", "micro", "pathological", "response", "(", "microPR", "),", "and", "five", "(5)", "patients", "demonstrated", "a", "macroPR.", "<tag3>"], "wordsA": ["Of", "the", "29", "patients", "treated,", "23", "were", "eligible", "for", "evaluation", "of", "efficacy."], "wordsB": ["Of", "the", "eleven", "surgically", "treated", "and", "evaluable", "patients,", "one", "patient", "demonstrated", "a", "complete", "pathological", "response", "(", "cPR", "),", "five", "(5)", "patients", "demonstrated", "a", "micro", "pathological", "response", "(", "microPR", "),", "and", "five", "(5)", "patients", "demonstrated", "a", "macroPR."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p39_s1", "idA": "749647_16_item7_p16_s4", "sentA": "A local response rate of over 60 percent was reported in 14 of the 23 evaluable patients with five complete responses and nine partial responses.", "sentB": "This translates to a 100% disease control rate ( DCR ) and 75% objective response rate ( ORR ).", "type": 1, "words": ["<tag1>", "A", "local", "response", "rate", "of", "over", "60", "percent", "was", "reported", "in", "14", "of", "the", "23", "evaluable", "patients", "with", "five", "complete", "responses", "and", "nine", "partial", "responses.", "<tag2>", "This", "translates", "to", "a", "100%", "disease", "control", "rate", "(", "DCR", ")", "and", "75%", "objective", "response", "rate", "(", "ORR", ").", "<tag3>"], "wordsA": ["A", "local", "response", "rate", "of", "over", "60", "percent", "was", "reported", "in", "14", "of", "the", "23", "evaluable", "patients", "with", "five", "complete", "responses", "and", "nine", "partial", "responses."], "wordsB": ["This", "translates", "to", "a", "100%", "disease", "control", "rate", "(", "DCR", ")", "and", "75%", "objective", "response", "rate", "(", "ORR", ")."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p39_s0", "idA": "749647_16_item7_p18_s0", "sentA": "The primary objectives of the Euro-DIGNITY Study will be (i) to evaluate efficacy in patients after 3 cycles of ThermoDox plus Hyperthermia measuring tumor diameter as a response to therapy and (ii) to evaluate loco-regional breast tumor control in patients who undergo ThermoDox /hyperthermia/radiotherapy as measured by target lesion clinical response rate combining a RECIST criteria with digital photography to gauge response.", "sentB": "Of the first twelve patients dosed, one (1) patient demonstrated a complete response ( CR ), eight (8) patients demonstrated partial response ( PR ) and three patients demonstrated stable disease ( SD ), as measured by RECIST criteria.", "type": 1, "words": ["<tag1>", "The", "primary", "objectives", "of", "the", "Euro-DIGNITY", "Study", "will", "be", "(i)", "to", "evaluate", "efficacy", "in", "patients", "after", "3", "cycles", "of", "ThermoDox", "plus", "Hyperthermia", "measuring", "tumor", "diameter", "as", "a", "response", "to", "therapy", "and", "(ii)", "to", "evaluate", "loco-regional", "breast", "tumor", "control", "in", "patients", "who", "undergo", "ThermoDox", "/hyperthermia/radiotherapy", "as", "measured", "by", "target", "lesion", "clinical", "response", "rate", "combining", "a", "RECIST", "criteria", "with", "digital", "photography", "to", "gauge", "response.", "<tag2>", "Of", "the", "first", "twelve", "patients", "dosed,", "one", "(1)", "patient", "demonstrated", "a", "complete", "response", "(", "CR", "),", "eight", "(8)", "patients", "demonstrated", "partial", "response", "(", "PR", ")", "and", "three", "patients", "demonstrated", "stable", "disease", "(", "SD", "),", "as", "measured", "by", "RECIST", "criteria.", "<tag3>"], "wordsA": ["The", "primary", "objectives", "of", "the", "Euro-DIGNITY", "Study", "will", "be", "(i)", "to", "evaluate", "efficacy", "in", "patients", "after", "3", "cycles", "of", "ThermoDox", "plus", "Hyperthermia", "measuring", "tumor", "diameter", "as", "a", "response", "to", "therapy", "and", "(ii)", "to", "evaluate", "loco-regional", "breast", "tumor", "control", "in", "patients", "who", "undergo", "ThermoDox", "/hyperthermia/radiotherapy", "as", "measured", "by", "target", "lesion", "clinical", "response", "rate", "combining", "a", "RECIST", "criteria", "with", "digital", "photography", "to", "gauge", "response."], "wordsB": ["Of", "the", "first", "twelve", "patients", "dosed,", "one", "(1)", "patient", "demonstrated", "a", "complete", "response", "(", "CR", "),", "eight", "(8)", "patients", "demonstrated", "partial", "response", "(", "PR", ")", "and", "three", "patients", "demonstrated", "stable", "disease", "(", "SD", "),", "as", "measured", "by", "RECIST", "criteria."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p46_s1", "idA": "749647_16_item7_p23_s2", "sentA": "In addition, CLSN Laboratories assumed certain specified liabilities of EGEN, including the liabilities arising out of the acquired contracts and other assets relating to periods after the closing date.", "sentB": "There was a decrease in immunosuppressive FoxP3+ T-cells in two out of those 4 patients.", "type": 1, "words": ["<tag1>", "In", "addition,", "CLSN", "Laboratories", "assumed", "certain", "specified", "liabilities", "of", "EGEN,", "including", "the", "liabilities", "arising", "out", "of", "the", "acquired", "contracts", "and", "other", "assets", "relating", "to", "periods", "after", "the", "closing", "date.", "<tag2>", "There", "was", "a", "decrease", "in", "immunosuppressive", "FoxP3+", "T-cells", "in", "two", "out", "of", "those", "4", "patients.", "<tag3>"], "wordsA": ["In", "addition,", "CLSN", "Laboratories", "assumed", "certain", "specified", "liabilities", "of", "EGEN,", "including", "the", "liabilities", "arising", "out", "of", "the", "acquired", "contracts", "and", "other", "assets", "relating", "to", "periods", "after", "the", "closing", "date."], "wordsB": ["There", "was", "a", "decrease", "in", "immunosuppressive", "FoxP3+", "T-cells", "in", "two", "out", "of", "those", "4", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p43_s2", "idA": "749647_16_item7_p33_s0", "sentA": "As of the closing of the acquisition, the IPR D is considered indefinite lived intangible assets and will not be amortized.", "sentB": "A 50% reduction in CA-125 levels is considered meaningful.", "type": 1, "words": ["<tag1>", "As", "of", "the", "closing", "of", "the", "acquisition,", "the", "IPR", "D", "is", "considered", "indefinite", "lived", "intangible", "assets", "and", "will", "not", "be", "amortized.", "<tag2>", "A", "50%", "reduction", "in", "CA-125", "levels", "is", "considered", "meaningful.", "<tag3>"], "wordsA": ["As", "of", "the", "closing", "of", "the", "acquisition,", "the", "IPR", "D", "is", "considered", "indefinite", "lived", "intangible", "assets", "and", "will", "not", "be", "amortized."], "wordsB": ["A", "50%", "reduction", "in", "CA-125", "levels", "is", "considered", "meaningful."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p60_s2", "idA": "749647_16_item7_p33_s0", "sentA": "As of the closing of the acquisition, the IPR D is considered indefinite lived intangible assets and will not be amortized.", "sentB": "As of March 15, 2017, the Pre-funded Series B Warrants were fully exercised.", "type": 1, "words": ["<tag1>", "As", "of", "the", "closing", "of", "the", "acquisition,", "the", "IPR", "D", "is", "considered", "indefinite", "lived", "intangible", "assets", "and", "will", "not", "be", "amortized.", "<tag2>", "As", "of", "March", "15,", "2017,", "the", "Pre-funded", "Series", "B", "Warrants", "were", "fully", "exercised.", "<tag3>"], "wordsA": ["As", "of", "the", "closing", "of", "the", "acquisition,", "the", "IPR", "D", "is", "considered", "indefinite", "lived", "intangible", "assets", "and", "will", "not", "be", "amortized."], "wordsB": ["As", "of", "March", "15,", "2017,", "the", "Pre-funded", "Series", "B", "Warrants", "were", "fully", "exercised."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p38_s0", "idA": "749647_16_item7_p35_s3", "sentA": "In addition, the OVATION Study establishes a unique opportunity to assess how cytokine-based compounds such as GEN-1, directly affect ovarian cancer cells and the tumor microenvironment in newly diagnosed patients.", "sentB": "The first four cohorts each enrolled three patients.", "type": 1, "words": ["<tag1>", "In", "addition,", "the", "OVATION", "Study", "establishes", "a", "unique", "opportunity", "to", "assess", "how", "cytokine-based", "compounds", "such", "as", "GEN-1,", "directly", "affect", "ovarian", "cancer", "cells", "and", "the", "tumor", "microenvironment", "in", "newly", "diagnosed", "patients.", "<tag2>", "The", "first", "four", "cohorts", "each", "enrolled", "three", "patients.", "<tag3>"], "wordsA": ["In", "addition,", "the", "OVATION", "Study", "establishes", "a", "unique", "opportunity", "to", "assess", "how", "cytokine-based", "compounds", "such", "as", "GEN-1,", "directly", "affect", "ovarian", "cancer", "cells", "and", "the", "tumor", "microenvironment", "in", "newly", "diagnosed", "patients."], "wordsB": ["The", "first", "four", "cohorts", "each", "enrolled", "three", "patients."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p47_s1", "idA": "749647_16_item7_p36_s0", "sentA": "expression profile of a comprehensive panel of immune related genes in pre-treatment and GEN-1-treated tumor tissue.", "sentB": "In one of those two patients there was complete pathological response hence no tumor tissue was present to provide a post-treatment comparison.", "type": 1, "words": ["<tag1>", "expression", "profile", "of", "a", "comprehensive", "panel", "of", "immune", "related", "genes", "in", "pre-treatment", "and", "GEN-1-treated", "tumor", "tissue.", "<tag2>", "In", "one", "of", "those", "two", "patients", "there", "was", "complete", "pathological", "response", "hence", "no", "tumor", "tissue", "was", "present", "to", "provide", "a", "post-treatment", "comparison.", "<tag3>"], "wordsA": ["expression", "profile", "of", "a", "comprehensive", "panel", "of", "immune", "related", "genes", "in", "pre-treatment", "and", "GEN-1-treated", "tumor", "tissue."], "wordsB": ["In", "one", "of", "those", "two", "patients", "there", "was", "complete", "pathological", "response", "hence", "no", "tumor", "tissue", "was", "present", "to", "provide", "a", "post-treatment", "comparison."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p43_s0", "idA": "749647_16_item7_p37_s0", "sentA": "We have initiated the study at four clinical sites at the University of Alabama at Birmingham, Oklahoma University Medical Center, Washington University in St. Louis and the Medical College of Wisconsin.", "sentB": "CA-125 is used to monitor certain cancers during and after treatment.", "type": 1, "words": ["<tag1>", "We", "have", "initiated", "the", "study", "at", "four", "clinical", "sites", "at", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin.", "<tag2>", "CA-125", "is", "used", "to", "monitor", "certain", "cancers", "during", "and", "after", "treatment.", "<tag3>"], "wordsA": ["We", "have", "initiated", "the", "study", "at", "four", "clinical", "sites", "at", "the", "University", "of", "Alabama", "at", "Birmingham,", "Oklahoma", "University", "Medical", "Center,", "Washington", "University", "in", "St.", "Louis", "and", "the", "Medical", "College", "of", "Wisconsin."], "wordsB": ["CA-125", "is", "used", "to", "monitor", "certain", "cancers", "during", "and", "after", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p46_s3", "idA": "749647_16_item7_p39_s0", "sentA": "In two preclinical studies using an animal model of disseminated ovarian cancer, GEN-1 in combination with Avastin led to a significant reduction in tumor burden and disease progression.", "sentB": "High tumor infiltrating CD8+ T-cell density, low FoxP3+ T-cell density or high CD8+/FoxP3+ ratio demonstrate a potential shift in tumor environment to favoring immune stimulation following NACT + GEN-1 therapy.", "type": 1, "words": ["<tag1>", "In", "two", "preclinical", "studies", "using", "an", "animal", "model", "of", "disseminated", "ovarian", "cancer,", "GEN-1", "in", "combination", "with", "Avastin", "led", "to", "a", "significant", "reduction", "in", "tumor", "burden", "and", "disease", "progression.", "<tag2>", "High", "tumor", "infiltrating", "CD8+", "T-cell", "density,", "low", "FoxP3+", "T-cell", "density", "or", "high", "CD8+/FoxP3+", "ratio", "demonstrate", "a", "potential", "shift", "in", "tumor", "environment", "to", "favoring", "immune", "stimulation", "following", "NACT", "+", "GEN-1", "therapy.", "<tag3>"], "wordsA": ["In", "two", "preclinical", "studies", "using", "an", "animal", "model", "of", "disseminated", "ovarian", "cancer,", "GEN-1", "in", "combination", "with", "Avastin", "led", "to", "a", "significant", "reduction", "in", "tumor", "burden", "and", "disease", "progression."], "wordsB": ["High", "tumor", "infiltrating", "CD8+", "T-cell", "density,", "low", "FoxP3+", "T-cell", "density", "or", "high", "CD8+/FoxP3+", "ratio", "demonstrate", "a", "potential", "shift", "in", "tumor", "environment", "to", "favoring", "immune", "stimulation", "following", "NACT", "+", "GEN-1", "therapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p57_s5", "idA": "749647_16_item7_p42_s0", "sentA": "Business As a clinical stage biopharmaceutical company, our business and our ability to execute our strategy to achieve our corporate goals are subject to numerous risks and uncertainties.", "sentB": "Based on the above, management has determined there is substantial doubt regarding our ability to continue as a going concern.", "type": 1, "words": ["<tag1>", "Business", "As", "a", "clinical", "stage", "biopharmaceutical", "company,", "our", "business", "and", "our", "ability", "to", "execute", "our", "strategy", "to", "achieve", "our", "corporate", "goals", "are", "subject", "to", "numerous", "risks", "and", "uncertainties.", "<tag2>", "Based", "on", "the", "above,", "management", "has", "determined", "there", "is", "substantial", "doubt", "regarding", "our", "ability", "to", "continue", "as", "a", "going", "concern.", "<tag3>"], "wordsA": ["Business", "As", "a", "clinical", "stage", "biopharmaceutical", "company,", "our", "business", "and", "our", "ability", "to", "execute", "our", "strategy", "to", "achieve", "our", "corporate", "goals", "are", "subject", "to", "numerous", "risks", "and", "uncertainties."], "wordsB": ["Based", "on", "the", "above,", "management", "has", "determined", "there", "is", "substantial", "doubt", "regarding", "our", "ability", "to", "continue", "as", "a", "going", "concern."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p93_s0", "idA": "749647_16_item7_p42_s0", "sentA": "Business As a clinical stage biopharmaceutical company, our business and our ability to execute our strategy to achieve our corporate goals are subject to numerous risks and uncertainties.", "sentB": "Based on the above, Management has determined there is substantial doubt as to our ability to continue as a going concern.", "type": 1, "words": ["<tag1>", "Business", "As", "a", "clinical", "stage", "biopharmaceutical", "company,", "our", "business", "and", "our", "ability", "to", "execute", "our", "strategy", "to", "achieve", "our", "corporate", "goals", "are", "subject", "to", "numerous", "risks", "and", "uncertainties.", "<tag2>", "Based", "on", "the", "above,", "Management", "has", "determined", "there", "is", "substantial", "doubt", "as", "to", "our", "ability", "to", "continue", "as", "a", "going", "concern.", "<tag3>"], "wordsA": ["Business", "As", "a", "clinical", "stage", "biopharmaceutical", "company,", "our", "business", "and", "our", "ability", "to", "execute", "our", "strategy", "to", "achieve", "our", "corporate", "goals", "are", "subject", "to", "numerous", "risks", "and", "uncertainties."], "wordsB": ["Based", "on", "the", "above,", "Management", "has", "determined", "there", "is", "substantial", "doubt", "as", "to", "our", "ability", "to", "continue", "as", "a", "going", "concern."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p48_s1", "idA": "749647_16_item7_p69_s1", "sentA": "On March 30, 2015, all remaining warrants associated with this equity offering expired.", "sentB": "The density of myeloid derived suppressor cells that are associated with immunosuppression in ovarian cancer were either decreased or did not increase in post-treatment samples.", "type": 1, "words": ["<tag1>", "On", "March", "30,", "2015,", "all", "remaining", "warrants", "associated", "with", "this", "equity", "offering", "expired.", "<tag2>", "The", "density", "of", "myeloid", "derived", "suppressor", "cells", "that", "are", "associated", "with", "immunosuppression", "in", "ovarian", "cancer", "were", "either", "decreased", "or", "did", "not", "increase", "in", "post-treatment", "samples.", "<tag3>"], "wordsA": ["On", "March", "30,", "2015,", "all", "remaining", "warrants", "associated", "with", "this", "equity", "offering", "expired."], "wordsB": ["The", "density", "of", "myeloid", "derived", "suppressor", "cells", "that", "are", "associated", "with", "immunosuppression", "in", "ovarian", "cancer", "were", "either", "decreased", "or", "did", "not", "increase", "in", "post-treatment", "samples."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p48_s0", "idA": "749647_16_item7_p70_s3", "sentA": "Therefore, no change in warrant liability was required to be recorded or reclassified during 2015.", "sentB": "In plasma samples, there was no significant change in T-cell density following the treatment.", "type": 1, "words": ["<tag1>", "Therefore,", "no", "change", "in", "warrant", "liability", "was", "required", "to", "be", "recorded", "or", "reclassified", "during", "2015.", "<tag2>", "In", "plasma", "samples,", "there", "was", "no", "significant", "change", "in", "T-cell", "density", "following", "the", "treatment.", "<tag3>"], "wordsA": ["Therefore,", "no", "change", "in", "warrant", "liability", "was", "required", "to", "be", "recorded", "or", "reclassified", "during", "2015."], "wordsB": ["In", "plasma", "samples,", "there", "was", "no", "significant", "change", "in", "T-cell", "density", "following", "the", "treatment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p66_s0", "idA": "749647_16_item7_p71_s0", "sentA": "In addition, we issued warrants for 194,986 shares of the Company s common stock in connection with the Hercules Credit Agreement in November 2013 and June 2014.", "sentB": "The obligations under the Hercules Credit Agreement are in the form of secured indebtedness bearing interest at a calculated prime-based variable rate (11.25% per annum since inception through December 17, 2015, 11.50% from December 18, 2015 through December 15, 2016 and 11.75% since).", "type": 1, "words": ["<tag1>", "In", "addition,", "we", "issued", "warrants", "for", "194,986", "shares", "of", "the", "Company", "s", "common", "stock", "in", "connection", "with", "the", "Hercules", "Credit", "Agreement", "in", "November", "2013", "and", "June", "2014.", "<tag2>", "The", "obligations", "under", "the", "Hercules", "Credit", "Agreement", "are", "in", "the", "form", "of", "secured", "indebtedness", "bearing", "interest", "at", "a", "calculated", "prime-based", "variable", "rate", "(11.25%", "per", "annum", "since", "inception", "through", "December", "17,", "2015,", "11.50%", "from", "December", "18,", "2015", "through", "December", "15,", "2016", "and", "11.75%", "since).", "<tag3>"], "wordsA": ["In", "addition,", "we", "issued", "warrants", "for", "194,986", "shares", "of", "the", "Company", "s", "common", "stock", "in", "connection", "with", "the", "Hercules", "Credit", "Agreement", "in", "November", "2013", "and", "June", "2014."], "wordsB": ["The", "obligations", "under", "the", "Hercules", "Credit", "Agreement", "are", "in", "the", "form", "of", "secured", "indebtedness", "bearing", "interest", "at", "a", "calculated", "prime-based", "variable", "rate", "(11.25%", "per", "annum", "since", "inception", "through", "December", "17,", "2015,", "11.50%", "from", "December", "18,", "2015", "through", "December", "15,", "2016", "and", "11.75%", "since)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p63_s2", "idA": "749647_16_item7_p71_s2", "sentA": "As discussed in Note 8 of the financial statements, the Company concluded in the second quarter of 2015 that the warrant provision, which required the exercise price of the warrant to be adjusted downward to a lower price at which the Company would sell and issue shares in a financing for cash during the one-year anniversary of the warrant, had expired.", "sentB": "The Series AA Warrants have an exercise price of $0.23 per share, have a five year life and are immediately exercisable.", "type": 1, "words": ["<tag1>", "As", "discussed", "in", "Note", "8", "of", "the", "financial", "statements,", "the", "Company", "concluded", "in", "the", "second", "quarter", "of", "2015", "that", "the", "warrant", "provision,", "which", "required", "the", "exercise", "price", "of", "the", "warrant", "to", "be", "adjusted", "downward", "to", "a", "lower", "price", "at", "which", "the", "Company", "would", "sell", "and", "issue", "shares", "in", "a", "financing", "for", "cash", "during", "the", "one-year", "anniversary", "of", "the", "warrant,", "had", "expired.", "<tag2>", "The", "Series", "AA", "Warrants", "have", "an", "exercise", "price", "of", "$0.23", "per", "share,", "have", "a", "five", "year", "life", "and", "are", "immediately", "exercisable.", "<tag3>"], "wordsA": ["As", "discussed", "in", "Note", "8", "of", "the", "financial", "statements,", "the", "Company", "concluded", "in", "the", "second", "quarter", "of", "2015", "that", "the", "warrant", "provision,", "which", "required", "the", "exercise", "price", "of", "the", "warrant", "to", "be", "adjusted", "downward", "to", "a", "lower", "price", "at", "which", "the", "Company", "would", "sell", "and", "issue", "shares", "in", "a", "financing", "for", "cash", "during", "the", "one-year", "anniversary", "of", "the", "warrant,", "had", "expired."], "wordsB": ["The", "Series", "AA", "Warrants", "have", "an", "exercise", "price", "of", "$0.23", "per", "share,", "have", "a", "five", "year", "life", "and", "are", "immediately", "exercisable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p47_s2", "idA": "749647_16_item7_p73_s0", "sentA": "Other (expense) income for 2014 and 2013 was not significant.", "sentB": "In the other patient the debulking surgery was not performed due to disease related complications.", "type": 1, "words": ["<tag1>", "Other", "(expense)", "income", "for", "2014", "and", "2013", "was", "not", "significant.", "<tag2>", "In", "the", "other", "patient", "the", "debulking", "surgery", "was", "not", "performed", "due", "to", "disease", "related", "complications.", "<tag3>"], "wordsA": ["Other", "(expense)", "income", "for", "2014", "and", "2013", "was", "not", "significant."], "wordsB": ["In", "the", "other", "patient", "the", "debulking", "surgery", "was", "not", "performed", "due", "to", "disease", "related", "complications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p57_s6", "idA": "749647_16_item7_p76_s9", "sentA": "Costs associated with CLSN Laboratories were $2.3 million for the period from the date of acquisition on June 20, 2014 through December 31, 2014.", "sentB": "The report of our independent registered public accounting firm for the year ended December 31, 2016 includes an explanatory paragraph which expresses substantial doubt about our ability to continue as a going concern.", "type": 1, "words": ["<tag1>", "Costs", "associated", "with", "CLSN", "Laboratories", "were", "$2.3", "million", "for", "the", "period", "from", "the", "date", "of", "acquisition", "on", "June", "20,", "2014", "through", "December", "31,", "2014.", "<tag2>", "The", "report", "of", "our", "independent", "registered", "public", "accounting", "firm", "for", "the", "year", "ended", "December", "31,", "2016", "includes", "an", "explanatory", "paragraph", "which", "expresses", "substantial", "doubt", "about", "our", "ability", "to", "continue", "as", "a", "going", "concern.", "<tag3>"], "wordsA": ["Costs", "associated", "with", "CLSN", "Laboratories", "were", "$2.3", "million", "for", "the", "period", "from", "the", "date", "of", "acquisition", "on", "June", "20,", "2014", "through", "December", "31,", "2014."], "wordsB": ["The", "report", "of", "our", "independent", "registered", "public", "accounting", "firm", "for", "the", "year", "ended", "December", "31,", "2016", "includes", "an", "explanatory", "paragraph", "which", "expresses", "substantial", "doubt", "about", "our", "ability", "to", "continue", "as", "a", "going", "concern."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p93_s1", "idA": "749647_16_item7_p76_s9", "sentA": "Costs associated with CLSN Laboratories were $2.3 million for the period from the date of acquisition on June 20, 2014 through December 31, 2014.", "sentB": "The report of our independent registered public accounting firm for the year ended December 31, 2016 includes an explanatory paragraph which expresses substantial doubt about our ability to continue as a going concern.", "type": 1, "words": ["<tag1>", "Costs", "associated", "with", "CLSN", "Laboratories", "were", "$2.3", "million", "for", "the", "period", "from", "the", "date", "of", "acquisition", "on", "June", "20,", "2014", "through", "December", "31,", "2014.", "<tag2>", "The", "report", "of", "our", "independent", "registered", "public", "accounting", "firm", "for", "the", "year", "ended", "December", "31,", "2016", "includes", "an", "explanatory", "paragraph", "which", "expresses", "substantial", "doubt", "about", "our", "ability", "to", "continue", "as", "a", "going", "concern.", "<tag3>"], "wordsA": ["Costs", "associated", "with", "CLSN", "Laboratories", "were", "$2.3", "million", "for", "the", "period", "from", "the", "date", "of", "acquisition", "on", "June", "20,", "2014", "through", "December", "31,", "2014."], "wordsB": ["The", "report", "of", "our", "independent", "registered", "public", "accounting", "firm", "for", "the", "year", "ended", "December", "31,", "2016", "includes", "an", "explanatory", "paragraph", "which", "expresses", "substantial", "doubt", "about", "our", "ability", "to", "continue", "as", "a", "going", "concern."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p40_s0", "idA": "749647_16_item7_p79_s2", "sentA": "In addition, in connection with a common stock offering in the second quarter of 2013, the investors in the offering agreed to waive their rights to exercise the warrants to purchase 1,398,816 shares of common stock of the Company until the Company affected a reverse stock split and increased the number of its authorized shares of common stock.", "sentB": "Eleven patients had successful resections of their tumors, with six (6) patients having an R0 resection, which indicates a microscopically margin-negative resection in which no gross or microscopic tumor remains in the tumor bed, and four (4) patients with a R1 resection, indicating microscopic residual tumor.", "type": 1, "words": ["<tag1>", "In", "addition,", "in", "connection", "with", "a", "common", "stock", "offering", "in", "the", "second", "quarter", "of", "2013,", "the", "investors", "in", "the", "offering", "agreed", "to", "waive", "their", "rights", "to", "exercise", "the", "warrants", "to", "purchase", "1,398,816", "shares", "of", "common", "stock", "of", "the", "Company", "until", "the", "Company", "affected", "a", "reverse", "stock", "split", "and", "increased", "the", "number", "of", "its", "authorized", "shares", "of", "common", "stock.", "<tag2>", "Eleven", "patients", "had", "successful", "resections", "of", "their", "tumors,", "with", "six", "(6)", "patients", "having", "an", "R0", "resection,", "which", "indicates", "a", "microscopically", "margin-negative", "resection", "in", "which", "no", "gross", "or", "microscopic", "tumor", "remains", "in", "the", "tumor", "bed,", "and", "four", "(4)", "patients", "with", "a", "R1", "resection,", "indicating", "microscopic", "residual", "tumor.", "<tag3>"], "wordsA": ["In", "addition,", "in", "connection", "with", "a", "common", "stock", "offering", "in", "the", "second", "quarter", "of", "2013,", "the", "investors", "in", "the", "offering", "agreed", "to", "waive", "their", "rights", "to", "exercise", "the", "warrants", "to", "purchase", "1,398,816", "shares", "of", "common", "stock", "of", "the", "Company", "until", "the", "Company", "affected", "a", "reverse", "stock", "split", "and", "increased", "the", "number", "of", "its", "authorized", "shares", "of", "common", "stock."], "wordsB": ["Eleven", "patients", "had", "successful", "resections", "of", "their", "tumors,", "with", "six", "(6)", "patients", "having", "an", "R0", "resection,", "which", "indicates", "a", "microscopically", "margin-negative", "resection", "in", "which", "no", "gross", "or", "microscopic", "tumor", "remains", "in", "the", "tumor", "bed,", "and", "four", "(4)", "patients", "with", "a", "R1", "resection,", "indicating", "microscopic", "residual", "tumor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p40_s1", "idA": "749647_16_item7_p86_s2", "sentA": "Our expenses have significantly and regularly exceeded our revenue, and we had an accumulated deficit of $218 million at December 31, 2015.", "sentB": "One patient had an R2, indicating macroscopic residual tumor.", "type": 1, "words": ["<tag1>", "Our", "expenses", "have", "significantly", "and", "regularly", "exceeded", "our", "revenue,", "and", "we", "had", "an", "accumulated", "deficit", "of", "$218", "million", "at", "December", "31,", "2015.", "<tag2>", "One", "patient", "had", "an", "R2,", "indicating", "macroscopic", "residual", "tumor.", "<tag3>"], "wordsA": ["Our", "expenses", "have", "significantly", "and", "regularly", "exceeded", "our", "revenue,", "and", "we", "had", "an", "accumulated", "deficit", "of", "$218", "million", "at", "December", "31,", "2015."], "wordsB": ["One", "patient", "had", "an", "R2,", "indicating", "macroscopic", "residual", "tumor."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p41_s3", "idA": "749647_16_item7_p95_s2", "sentA": "The lease has a remaining term of 16 months.", "sentB": "In addition, microPRs are seen in approximately 30% of patients, and are associated with a median overall survival of 38 months.", "type": 1, "words": ["<tag1>", "The", "lease", "has", "a", "remaining", "term", "of", "16", "months.", "<tag2>", "In", "addition,", "microPRs", "are", "seen", "in", "approximately", "30%", "of", "patients,", "and", "are", "associated", "with", "a", "median", "overall", "survival", "of", "38", "months.", "<tag3>"], "wordsA": ["The", "lease", "has", "a", "remaining", "term", "of", "16", "months."], "wordsB": ["In", "addition,", "microPRs", "are", "seen", "in", "approximately", "30%", "of", "patients,", "and", "are", "associated", "with", "a", "median", "overall", "survival", "of", "38", "months."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p95_s0", "idA": "749647_16_item7_p95_s4", "sentA": "The lease stipulated standby letter of credit will be reduced by $50,000 on each of the 19th, 31st and 43rd months from the initial term, with the remaining $100,000 amount remaining until the term of the lease has expired.", "sentB": "In late 2015, Lenox Drive Office Park LLC, purchased the real estate and office building and assumed the lease.", "type": 1, "words": ["<tag1>", "The", "lease", "stipulated", "standby", "letter", "of", "credit", "will", "be", "reduced", "by", "$50,000", "on", "each", "of", "the", "19th,", "31st", "and", "43rd", "months", "from", "the", "initial", "term,", "with", "the", "remaining", "$100,000", "amount", "remaining", "until", "the", "term", "of", "the", "lease", "has", "expired.", "<tag2>", "In", "late", "2015,", "Lenox", "Drive", "Office", "Park", "LLC,", "purchased", "the", "real", "estate", "and", "office", "building", "and", "assumed", "the", "lease.", "<tag3>"], "wordsA": ["The", "lease", "stipulated", "standby", "letter", "of", "credit", "will", "be", "reduced", "by", "$50,000", "on", "each", "of", "the", "19th,", "31st", "and", "43rd", "months", "from", "the", "initial", "term,", "with", "the", "remaining", "$100,000", "amount", "remaining", "until", "the", "term", "of", "the", "lease", "has", "expired."], "wordsB": ["In", "late", "2015,", "Lenox", "Drive", "Office", "Park", "LLC,", "purchased", "the", "real", "estate", "and", "office", "building", "and", "assumed", "the", "lease."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p95_s1", "idA": "749647_16_item7_p95_s4", "sentA": "The lease stipulated standby letter of credit will be reduced by $50,000 on each of the 19th, 31st and 43rd months from the initial term, with the remaining $100,000 amount remaining until the term of the lease has expired.", "sentB": "The Company is currently in negotiations with the landlord to extend the lease term and to reduce the square footage by approximately 30%.", "type": 1, "words": ["<tag1>", "The", "lease", "stipulated", "standby", "letter", "of", "credit", "will", "be", "reduced", "by", "$50,000", "on", "each", "of", "the", "19th,", "31st", "and", "43rd", "months", "from", "the", "initial", "term,", "with", "the", "remaining", "$100,000", "amount", "remaining", "until", "the", "term", "of", "the", "lease", "has", "expired.", "<tag2>", "The", "Company", "is", "currently", "in", "negotiations", "with", "the", "landlord", "to", "extend", "the", "lease", "term", "and", "to", "reduce", "the", "square", "footage", "by", "approximately", "30%.", "<tag3>"], "wordsA": ["The", "lease", "stipulated", "standby", "letter", "of", "credit", "will", "be", "reduced", "by", "$50,000", "on", "each", "of", "the", "19th,", "31st", "and", "43rd", "months", "from", "the", "initial", "term,", "with", "the", "remaining", "$100,000", "amount", "remaining", "until", "the", "term", "of", "the", "lease", "has", "expired."], "wordsB": ["The", "Company", "is", "currently", "in", "negotiations", "with", "the", "landlord", "to", "extend", "the", "lease", "term", "and", "to", "reduce", "the", "square", "footage", "by", "approximately", "30%."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p14_s1", "idA": "749647_16_item7_p9_s2", "sentA": "The most recent post-hoc OS analysis data from the HEAT Study as of July 15, 2015 showed that in a large, well bounded, subgroup of patients (n=285, 41% of the study patients), the combination of ThermoDox and optimized RFA provided a 58% improvement in OS compared to optimized RFA alone.", "sentB": "The NIH analysis, which sought to evaluate the correlation between RFA burn time per tumor volume (min/ml) and clinical outcome, concluded that increased burn time per tumor volume significantly improved overall survival in patients treated with RFA plus ThermoDox compared to patients treated with RFA alone.", "type": 1, "words": ["<tag1>", "The", "most", "recent", "post-hoc", "OS", "analysis", "data", "from", "the", "HEAT", "Study", "as", "of", "July", "15,", "2015", "showed", "that", "in", "a", "large,", "well", "bounded,", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "optimized", "RFA", "provided", "a", "58%", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone.", "<tag2>", "The", "NIH", "analysis,", "which", "sought", "to", "evaluate", "the", "correlation", "between", "RFA", "burn", "time", "per", "tumor", "volume", "(min/ml)", "and", "clinical", "outcome,", "concluded", "that", "increased", "burn", "time", "per", "tumor", "volume", "significantly", "improved", "overall", "survival", "in", "patients", "treated", "with", "RFA", "plus", "ThermoDox", "compared", "to", "patients", "treated", "with", "RFA", "alone.", "<tag3>"], "wordsA": ["The", "most", "recent", "post-hoc", "OS", "analysis", "data", "from", "the", "HEAT", "Study", "as", "of", "July", "15,", "2015", "showed", "that", "in", "a", "large,", "well", "bounded,", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "optimized", "RFA", "provided", "a", "58%", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone."], "wordsB": ["The", "NIH", "analysis,", "which", "sought", "to", "evaluate", "the", "correlation", "between", "RFA", "burn", "time", "per", "tumor", "volume", "(min/ml)", "and", "clinical", "outcome,", "concluded", "that", "increased", "burn", "time", "per", "tumor", "volume", "significantly", "improved", "overall", "survival", "in", "patients", "treated", "with", "RFA", "plus", "ThermoDox", "compared", "to", "patients", "treated", "with", "RFA", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p42_s0", "idA": "749647_16_item7_p9_s2", "sentA": "The most recent post-hoc OS analysis data from the HEAT Study as of July 15, 2015 showed that in a large, well bounded, subgroup of patients (n=285, 41% of the study patients), the combination of ThermoDox and optimized RFA provided a 58% improvement in OS compared to optimized RFA alone.", "sentB": "All eleven patients who completed treatment follow-up experienced a dramatic (greater than 90%) drop in their CA-125 protein levels as of their most recent study visit.", "type": 1, "words": ["<tag1>", "The", "most", "recent", "post-hoc", "OS", "analysis", "data", "from", "the", "HEAT", "Study", "as", "of", "July", "15,", "2015", "showed", "that", "in", "a", "large,", "well", "bounded,", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "optimized", "RFA", "provided", "a", "58%", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone.", "<tag2>", "All", "eleven", "patients", "who", "completed", "treatment", "follow-up", "experienced", "a", "dramatic", "(greater", "than", "90%)", "drop", "in", "their", "CA-125", "protein", "levels", "as", "of", "their", "most", "recent", "study", "visit.", "<tag3>"], "wordsA": ["The", "most", "recent", "post-hoc", "OS", "analysis", "data", "from", "the", "HEAT", "Study", "as", "of", "July", "15,", "2015", "showed", "that", "in", "a", "large,", "well", "bounded,", "subgroup", "of", "patients", "(n=285,", "41%", "of", "the", "study", "patients),", "the", "combination", "of", "ThermoDox", "and", "optimized", "RFA", "provided", "a", "58%", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone."], "wordsB": ["All", "eleven", "patients", "who", "completed", "treatment", "follow-up", "experienced", "a", "dramatic", "(greater", "than", "90%)", "drop", "in", "their", "CA-125", "protein", "levels", "as", "of", "their", "most", "recent", "study", "visit."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item7_p41_s1", "idA": "749647_16_item7_p9_s5", "sentA": "These data continue to support the protocol for the Phase III OPTIMA Study, as described below.", "sentB": "These data compare favorably to historical data, which indicate that cPRs are typically seen in less than 7% of patients receiving neoadjuvant chemotherapy followed by surgical resection.", "type": 1, "words": ["<tag1>", "These", "data", "continue", "to", "support", "the", "protocol", "for", "the", "Phase", "III", "OPTIMA", "Study,", "as", "described", "below.", "<tag2>", "These", "data", "compare", "favorably", "to", "historical", "data,", "which", "indicate", "that", "cPRs", "are", "typically", "seen", "in", "less", "than", "7%", "of", "patients", "receiving", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection.", "<tag3>"], "wordsA": ["These", "data", "continue", "to", "support", "the", "protocol", "for", "the", "Phase", "III", "OPTIMA", "Study,", "as", "described", "below."], "wordsB": ["These", "data", "compare", "favorably", "to", "historical", "data,", "which", "indicate", "that", "cPRs", "are", "typically", "seen", "in", "less", "than", "7%", "of", "patients", "receiving", "neoadjuvant", "chemotherapy", "followed", "by", "surgical", "resection."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p61_s2", "idA": "749647_17_item7_p32_s1", "sentA": "At December 31, 2016, the Company determined one of the IPR D assets related to the development of its RNA delivery system being developed with collaborators using their RNA product candidates, valued at $1.4 million, was impaired.", "sentB": "The Company will be required to obtain additional funding in order to continue the development of its current product candidates within the anticipated time periods, if at all, and to continue to fund operations.", "type": 1, "words": ["<tag1>", "At", "December", "31,", "2016,", "the", "Company", "determined", "one", "of", "the", "IPR", "D", "assets", "related", "to", "the", "development", "of", "its", "RNA", "delivery", "system", "being", "developed", "with", "collaborators", "using", "their", "RNA", "product", "candidates,", "valued", "at", "$1.4", "million,", "was", "impaired.", "<tag2>", "The", "Company", "will", "be", "required", "to", "obtain", "additional", "funding", "in", "order", "to", "continue", "the", "development", "of", "its", "current", "product", "candidates", "within", "the", "anticipated", "time", "periods,", "if", "at", "all,", "and", "to", "continue", "to", "fund", "operations.", "<tag3>"], "wordsA": ["At", "December", "31,", "2016,", "the", "Company", "determined", "one", "of", "the", "IPR", "D", "assets", "related", "to", "the", "development", "of", "its", "RNA", "delivery", "system", "being", "developed", "with", "collaborators", "using", "their", "RNA", "product", "candidates,", "valued", "at", "$1.4", "million,", "was", "impaired."], "wordsB": ["The", "Company", "will", "be", "required", "to", "obtain", "additional", "funding", "in", "order", "to", "continue", "the", "development", "of", "its", "current", "product", "candidates", "within", "the", "anticipated", "time", "periods,", "if", "at", "all,", "and", "to", "continue", "to", "fund", "operations."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p106_s2", "idA": "749647_17_item7_p35_s1", "sentA": "On September 30, 2015, we announced enrollment of the first patient in the OVATION Study.", "sentB": "Under the current terms of the lease, which was amended effective May 1, 2017 and is set to expire on September 1, 2022, we reduced the size of the premises to 7,565 square feet and are paying a monthly rent that ranges from approximately $18,900 in the first year to approximately $20,500 in the final year of the amendment.", "type": 1, "words": ["<tag1>", "On", "September", "30,", "2015,", "we", "announced", "enrollment", "of", "the", "first", "patient", "in", "the", "OVATION", "Study.", "<tag2>", "Under", "the", "current", "terms", "of", "the", "lease,", "which", "was", "amended", "effective", "May", "1,", "2017", "and", "is", "set", "to", "expire", "on", "September", "1,", "2022,", "we", "reduced", "the", "size", "of", "the", "premises", "to", "7,565", "square", "feet", "and", "are", "paying", "a", "monthly", "rent", "that", "ranges", "from", "approximately", "$18,900", "in", "the", "first", "year", "to", "approximately", "$20,500", "in", "the", "final", "year", "of", "the", "amendment.", "<tag3>"], "wordsA": ["On", "September", "30,", "2015,", "we", "announced", "enrollment", "of", "the", "first", "patient", "in", "the", "OVATION", "Study."], "wordsB": ["Under", "the", "current", "terms", "of", "the", "lease,", "which", "was", "amended", "effective", "May", "1,", "2017", "and", "is", "set", "to", "expire", "on", "September", "1,", "2022,", "we", "reduced", "the", "size", "of", "the", "premises", "to", "7,565", "square", "feet", "and", "are", "paying", "a", "monthly", "rent", "that", "ranges", "from", "approximately", "$18,900", "in", "the", "first", "year", "to", "approximately", "$20,500", "in", "the", "final", "year", "of", "the", "amendment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p25_s2", "idA": "749647_17_item7_p38_s1", "sentA": "Enrollment of three additional patients in the fourth cohort is ongoing, and Celsion expects to complete the OVATION Study in the first half of 2017.", "sentB": "These shares were issued on June 16, 2017.", "type": 1, "words": ["<tag1>", "Enrollment", "of", "three", "additional", "patients", "in", "the", "fourth", "cohort", "is", "ongoing,", "and", "Celsion", "expects", "to", "complete", "the", "OVATION", "Study", "in", "the", "first", "half", "of", "2017.", "<tag2>", "These", "shares", "were", "issued", "on", "June", "16,", "2017.", "<tag3>"], "wordsA": ["Enrollment", "of", "three", "additional", "patients", "in", "the", "fourth", "cohort", "is", "ongoing,", "and", "Celsion", "expects", "to", "complete", "the", "OVATION", "Study", "in", "the", "first", "half", "of", "2017."], "wordsB": ["These", "shares", "were", "issued", "on", "June", "16,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p64_s6", "idA": "749647_17_item7_p38_s1", "sentA": "Enrollment of three additional patients in the fourth cohort is ongoing, and Celsion expects to complete the OVATION Study in the first half of 2017.", "sentB": "The October 2017 Offering closed on October 31, 2017.", "type": 1, "words": ["<tag1>", "Enrollment", "of", "three", "additional", "patients", "in", "the", "fourth", "cohort", "is", "ongoing,", "and", "Celsion", "expects", "to", "complete", "the", "OVATION", "Study", "in", "the", "first", "half", "of", "2017.", "<tag2>", "The", "October", "2017", "Offering", "closed", "on", "October", "31,", "2017.", "<tag3>"], "wordsA": ["Enrollment", "of", "three", "additional", "patients", "in", "the", "fourth", "cohort", "is", "ongoing,", "and", "Celsion", "expects", "to", "complete", "the", "OVATION", "Study", "in", "the", "first", "half", "of", "2017."], "wordsB": ["The", "October", "2017", "Offering", "closed", "on", "October", "31,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p71_s3", "idA": "749647_17_item7_p38_s1", "sentA": "Enrollment of three additional patients in the fourth cohort is ongoing, and Celsion expects to complete the OVATION Study in the first half of 2017.", "sentB": "These shares were issued on June 16, 2017.", "type": 1, "words": ["<tag1>", "Enrollment", "of", "three", "additional", "patients", "in", "the", "fourth", "cohort", "is", "ongoing,", "and", "Celsion", "expects", "to", "complete", "the", "OVATION", "Study", "in", "the", "first", "half", "of", "2017.", "<tag2>", "These", "shares", "were", "issued", "on", "June", "16,", "2017.", "<tag3>"], "wordsA": ["Enrollment", "of", "three", "additional", "patients", "in", "the", "fourth", "cohort", "is", "ongoing,", "and", "Celsion", "expects", "to", "complete", "the", "OVATION", "Study", "in", "the", "first", "half", "of", "2017."], "wordsB": ["These", "shares", "were", "issued", "on", "June", "16,", "2017."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p10_s1", "idA": "749647_17_item7_p38_s3", "sentA": "The results of the OVATION Study to date are as follows:", "sentB": "The article reports on one of the largest controlled studies in hepatocellular carcinoma.", "type": 1, "words": ["<tag1>", "The", "results", "of", "the", "OVATION", "Study", "to", "date", "are", "as", "follows:", "<tag2>", "The", "article", "reports", "on", "one", "of", "the", "largest", "controlled", "studies", "in", "hepatocellular", "carcinoma.", "<tag3>"], "wordsA": ["The", "results", "of", "the", "OVATION", "Study", "to", "date", "are", "as", "follows:"], "wordsB": ["The", "article", "reports", "on", "one", "of", "the", "largest", "controlled", "studies", "in", "hepatocellular", "carcinoma."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p45_s0", "idA": "749647_17_item7_p45_s0", "sentA": "Tumor and blood samples collected before the start of the neoadjuvant chemotherapy ( NACT ) and after the completion of GEN-1 treatment at debulking surgery are being analyzed for immune cell populations.", "sentB": "The intraperitoneal treatment of GEN-1 in conjunction with neoadjuvant chemotherapy resulted in dose dependent increases in IL-12 and Interferon-gamma (IFN-g) levels that were predominantly in the peritoneal fluid compartment with little to no changes observed in the patients systemic circulation.", "type": 1, "words": ["<tag1>", "Tumor", "and", "blood", "samples", "collected", "before", "the", "start", "of", "the", "neoadjuvant", "chemotherapy", "(", "NACT", ")", "and", "after", "the", "completion", "of", "GEN-1", "treatment", "at", "debulking", "surgery", "are", "being", "analyzed", "for", "immune", "cell", "populations.", "<tag2>", "The", "intraperitoneal", "treatment", "of", "GEN-1", "in", "conjunction", "with", "neoadjuvant", "chemotherapy", "resulted", "in", "dose", "dependent", "increases", "in", "IL-12", "and", "Interferon-gamma", "(IFN-g)", "levels", "that", "were", "predominantly", "in", "the", "peritoneal", "fluid", "compartment", "with", "little", "to", "no", "changes", "observed", "in", "the", "patients", "systemic", "circulation.", "<tag3>"], "wordsA": ["Tumor", "and", "blood", "samples", "collected", "before", "the", "start", "of", "the", "neoadjuvant", "chemotherapy", "(", "NACT", ")", "and", "after", "the", "completion", "of", "GEN-1", "treatment", "at", "debulking", "surgery", "are", "being", "analyzed", "for", "immune", "cell", "populations."], "wordsB": ["The", "intraperitoneal", "treatment", "of", "GEN-1", "in", "conjunction", "with", "neoadjuvant", "chemotherapy", "resulted", "in", "dose", "dependent", "increases", "in", "IL-12", "and", "Interferon-gamma", "(IFN-g)", "levels", "that", "were", "predominantly", "in", "the", "peritoneal", "fluid", "compartment", "with", "little", "to", "no", "changes", "observed", "in", "the", "patients", "systemic", "circulation."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p48_s0", "idA": "749647_17_item7_p45_s1", "sentA": "Top line data demonstrates intriguing immunological changes in the tumor that are consistent with the activation of the immune system.", "sentB": "Analysis of peritoneal fluid by cell sorting, not reported before, shows treatment-related decrease in the percentage of immunosuppressive T-cell (Foxp3+), which is consistent with the reduction of Foxp3+ T-cells in the primary tumor tissue, and a shift in tumor na ve CD8+ cell population to more efficient tumor killing memory effector CD8+ cells .", "type": 1, "words": ["<tag1>", "Top", "line", "data", "demonstrates", "intriguing", "immunological", "changes", "in", "the", "tumor", "that", "are", "consistent", "with", "the", "activation", "of", "the", "immune", "system.", "<tag2>", "Analysis", "of", "peritoneal", "fluid", "by", "cell", "sorting,", "not", "reported", "before,", "shows", "treatment-related", "decrease", "in", "the", "percentage", "of", "immunosuppressive", "T-cell", "(Foxp3+),", "which", "is", "consistent", "with", "the", "reduction", "of", "Foxp3+", "T-cells", "in", "the", "primary", "tumor", "tissue,", "and", "a", "shift", "in", "tumor", "na", "ve", "CD8+", "cell", "population", "to", "more", "efficient", "tumor", "killing", "memory", "effector", "CD8+", "cells", ".", "<tag3>"], "wordsA": ["Top", "line", "data", "demonstrates", "intriguing", "immunological", "changes", "in", "the", "tumor", "that", "are", "consistent", "with", "the", "activation", "of", "the", "immune", "system."], "wordsB": ["Analysis", "of", "peritoneal", "fluid", "by", "cell", "sorting,", "not", "reported", "before,", "shows", "treatment-related", "decrease", "in", "the", "percentage", "of", "immunosuppressive", "T-cell", "(Foxp3+),", "which", "is", "consistent", "with", "the", "reduction", "of", "Foxp3+", "T-cells", "in", "the", "primary", "tumor", "tissue,", "and", "a", "shift", "in", "tumor", "na", "ve", "CD8+", "cell", "population", "to", "more", "efficient", "tumor", "killing", "memory", "effector", "CD8+", "cells", "."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p100_s4", "idA": "749647_17_item7_p60_s2", "sentA": "As of March 15, 2017, the Pre-funded Series B Warrants were fully exercised.", "sentB": "The Series AAA Warrants were initially exercisable six months following issuance, and terminate five and one-half years following issuance.", "type": 1, "words": ["<tag1>", "As", "of", "March", "15,", "2017,", "the", "Pre-funded", "Series", "B", "Warrants", "were", "fully", "exercised.", "<tag2>", "The", "Series", "AAA", "Warrants", "were", "initially", "exercisable", "six", "months", "following", "issuance,", "and", "terminate", "five", "and", "one-half", "years", "following", "issuance.", "<tag3>"], "wordsA": ["As", "of", "March", "15,", "2017,", "the", "Pre-funded", "Series", "B", "Warrants", "were", "fully", "exercised."], "wordsB": ["The", "Series", "AAA", "Warrants", "were", "initially", "exercisable", "six", "months", "following", "issuance,", "and", "terminate", "five", "and", "one-half", "years", "following", "issuance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p66_s1", "idA": "749647_17_item7_p63_s2", "sentA": "The Series AA Warrants have an exercise price of $0.23 per share, have a five year life and are immediately exercisable.", "sentB": "The Series AAA Warrants are initially exercisable six months following issuance, and terminate five and one-half years following issuance.", "type": 1, "words": ["<tag1>", "The", "Series", "AA", "Warrants", "have", "an", "exercise", "price", "of", "$0.23", "per", "share,", "have", "a", "five", "year", "life", "and", "are", "immediately", "exercisable.", "<tag2>", "The", "Series", "AAA", "Warrants", "are", "initially", "exercisable", "six", "months", "following", "issuance,", "and", "terminate", "five", "and", "one-half", "years", "following", "issuance.", "<tag3>"], "wordsA": ["The", "Series", "AA", "Warrants", "have", "an", "exercise", "price", "of", "$0.23", "per", "share,", "have", "a", "five", "year", "life", "and", "are", "immediately", "exercisable."], "wordsB": ["The", "Series", "AAA", "Warrants", "are", "initially", "exercisable", "six", "months", "following", "issuance,", "and", "terminate", "five", "and", "one-half", "years", "following", "issuance."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p57_s0", "idA": "749647_17_item7_p6_s0", "sentA": "On January 31, 2013, we announced that ThermoDox in combination with radio frequency ablation ( RFA ) did not meet the primary endpoint of progression free survival ( PFS ) for the 701 patient clinical trial in patients with hepatocellular carcinoma (HCC), also known as primary liver cancer (the HEAT Study).", "sentB": "GEN-1 has demonstrated positive safety and efficacy data in the recently completed dose escalation Phase IB trial in combination with neoadjuvant chemotherapy.", "type": 1, "words": ["<tag1>", "On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "radio", "frequency", "ablation", "(", "RFA", ")", "did", "not", "meet", "the", "primary", "endpoint", "of", "progression", "free", "survival", "(", "PFS", ")", "for", "the", "701", "patient", "clinical", "trial", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer", "(the", "HEAT", "Study).", "<tag2>", "GEN-1", "has", "demonstrated", "positive", "safety", "and", "efficacy", "data", "in", "the", "recently", "completed", "dose", "escalation", "Phase", "IB", "trial", "in", "combination", "with", "neoadjuvant", "chemotherapy.", "<tag3>"], "wordsA": ["On", "January", "31,", "2013,", "we", "announced", "that", "ThermoDox", "in", "combination", "with", "radio", "frequency", "ablation", "(", "RFA", ")", "did", "not", "meet", "the", "primary", "endpoint", "of", "progression", "free", "survival", "(", "PFS", ")", "for", "the", "701", "patient", "clinical", "trial", "in", "patients", "with", "hepatocellular", "carcinoma", "(HCC),", "also", "known", "as", "primary", "liver", "cancer", "(the", "HEAT", "Study)."], "wordsB": ["GEN-1", "has", "demonstrated", "positive", "safety", "and", "efficacy", "data", "in", "the", "recently", "completed", "dose", "escalation", "Phase", "IB", "trial", "in", "combination", "with", "neoadjuvant", "chemotherapy."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p47_s1", "idA": "749647_17_item7_p76_s4", "sentA": "Costs associated with the HEAT Study are expected to be minimal as the Company has completed its final post-hoc overall survival analysis in 2016 and is in the process of closing out the study.", "sentB": "An increase in CD8+ to immunosuppressive T-cell populations is a leading indicator and believed to be a good predictor of improved overall survival.", "type": 1, "words": ["<tag1>", "Costs", "associated", "with", "the", "HEAT", "Study", "are", "expected", "to", "be", "minimal", "as", "the", "Company", "has", "completed", "its", "final", "post-hoc", "overall", "survival", "analysis", "in", "2016", "and", "is", "in", "the", "process", "of", "closing", "out", "the", "study.", "<tag2>", "An", "increase", "in", "CD8+", "to", "immunosuppressive", "T-cell", "populations", "is", "a", "leading", "indicator", "and", "believed", "to", "be", "a", "good", "predictor", "of", "improved", "overall", "survival.", "<tag3>"], "wordsA": ["Costs", "associated", "with", "the", "HEAT", "Study", "are", "expected", "to", "be", "minimal", "as", "the", "Company", "has", "completed", "its", "final", "post-hoc", "overall", "survival", "analysis", "in", "2016", "and", "is", "in", "the", "process", "of", "closing", "out", "the", "study."], "wordsB": ["An", "increase", "in", "CD8+", "to", "immunosuppressive", "T-cell", "populations", "is", "a", "leading", "indicator", "and", "believed", "to", "be", "a", "good", "predictor", "of", "improved", "overall", "survival."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p49_s1", "idA": "749647_17_item7_p7_s0", "sentA": "In the trial, ThermoDox was well-tolerated with no unexpected serious adverse events.", "sentB": "GEN-1 plus standard chemotherapy produced positive clinical results, with no dose limiting toxicities and positive dose dependent efficacy signals which correlate well with positive surgical outcomes as summarized below:", "type": 1, "words": ["<tag1>", "In", "the", "trial,", "ThermoDox", "was", "well-tolerated", "with", "no", "unexpected", "serious", "adverse", "events.", "<tag2>", "GEN-1", "plus", "standard", "chemotherapy", "produced", "positive", "clinical", "results,", "with", "no", "dose", "limiting", "toxicities", "and", "positive", "dose", "dependent", "efficacy", "signals", "which", "correlate", "well", "with", "positive", "surgical", "outcomes", "as", "summarized", "below:", "<tag3>"], "wordsA": ["In", "the", "trial,", "ThermoDox", "was", "well-tolerated", "with", "no", "unexpected", "serious", "adverse", "events."], "wordsB": ["GEN-1", "plus", "standard", "chemotherapy", "produced", "positive", "clinical", "results,", "with", "no", "dose", "limiting", "toxicities", "and", "positive", "dose", "dependent", "efficacy", "signals", "which", "correlate", "well", "with", "positive", "surgical", "outcomes", "as", "summarized", "below:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p19_s0", "idA": "749647_17_item7_p80_s3", "sentA": "The Company concluded none of the other IPR D assets were impaired at December 31, 2016.", "sentB": "The Company hosted an Investigators Meeting with physicians in South East Asia and key opinion leaders on July 22-23, 2017 in Bangkok, Thailand.", "type": 1, "words": ["<tag1>", "The", "Company", "concluded", "none", "of", "the", "other", "IPR", "D", "assets", "were", "impaired", "at", "December", "31,", "2016.", "<tag2>", "The", "Company", "hosted", "an", "Investigators", "Meeting", "with", "physicians", "in", "South", "East", "Asia", "and", "key", "opinion", "leaders", "on", "July", "22-23,", "2017", "in", "Bangkok,", "Thailand.", "<tag3>"], "wordsA": ["The", "Company", "concluded", "none", "of", "the", "other", "IPR", "D", "assets", "were", "impaired", "at", "December", "31,", "2016."], "wordsB": ["The", "Company", "hosted", "an", "Investigators", "Meeting", "with", "physicians", "in", "South", "East", "Asia", "and", "key", "opinion", "leaders", "on", "July", "22-23,", "2017", "in", "Bangkok,", "Thailand."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p28_s2", "idA": "749647_17_item7_p95_s1", "sentA": "The Company is currently in negotiations with the landlord to extend the lease term and to reduce the square footage by approximately 30%.", "sentB": "The Company is continuing to evaluate the development of GEN-1 in glioblastoma multiforme brain cancer in light of other substantial competitive development programs in this indication.", "type": 1, "words": ["<tag1>", "The", "Company", "is", "currently", "in", "negotiations", "with", "the", "landlord", "to", "extend", "the", "lease", "term", "and", "to", "reduce", "the", "square", "footage", "by", "approximately", "30%.", "<tag2>", "The", "Company", "is", "continuing", "to", "evaluate", "the", "development", "of", "GEN-1", "in", "glioblastoma", "multiforme", "brain", "cancer", "in", "light", "of", "other", "substantial", "competitive", "development", "programs", "in", "this", "indication.", "<tag3>"], "wordsA": ["The", "Company", "is", "currently", "in", "negotiations", "with", "the", "landlord", "to", "extend", "the", "lease", "term", "and", "to", "reduce", "the", "square", "footage", "by", "approximately", "30%."], "wordsB": ["The", "Company", "is", "continuing", "to", "evaluate", "the", "development", "of", "GEN-1", "in", "glioblastoma", "multiforme", "brain", "cancer", "in", "light", "of", "other", "substantial", "competitive", "development", "programs", "in", "this", "indication."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p10_s3", "idA": "749647_17_item7_p9_s2", "sentA": "On August 15, 2016, the Company announced the most recent post-hoc OS analysis from the HEAT Study.", "sentB": "The article details learnings from the Company s 701 patient HEAT Study and includes results from computer simulation studies and includes findings from a post hoc subgroup analysis, all of which are consistent with each other and which - when examined together - suggests a clearer understanding of a key ThermoDox heat-based mechanism of action: the longer the target tissue is heated, the greater the doxorubicin tissue concentration.", "type": 1, "words": ["<tag1>", "On", "August", "15,", "2016,", "the", "Company", "announced", "the", "most", "recent", "post-hoc", "OS", "analysis", "from", "the", "HEAT", "Study.", "<tag2>", "The", "article", "details", "learnings", "from", "the", "Company", "s", "701", "patient", "HEAT", "Study", "and", "includes", "results", "from", "computer", "simulation", "studies", "and", "includes", "findings", "from", "a", "post", "hoc", "subgroup", "analysis,", "all", "of", "which", "are", "consistent", "with", "each", "other", "and", "which", "-", "when", "examined", "together", "-", "suggests", "a", "clearer", "understanding", "of", "a", "key", "ThermoDox", "heat-based", "mechanism", "of", "action:", "the", "longer", "the", "target", "tissue", "is", "heated,", "the", "greater", "the", "doxorubicin", "tissue", "concentration.", "<tag3>"], "wordsA": ["On", "August", "15,", "2016,", "the", "Company", "announced", "the", "most", "recent", "post-hoc", "OS", "analysis", "from", "the", "HEAT", "Study."], "wordsB": ["The", "article", "details", "learnings", "from", "the", "Company", "s", "701", "patient", "HEAT", "Study", "and", "includes", "results", "from", "computer", "simulation", "studies", "and", "includes", "findings", "from", "a", "post", "hoc", "subgroup", "analysis,", "all", "of", "which", "are", "consistent", "with", "each", "other", "and", "which", "-", "when", "examined", "together", "-", "suggests", "a", "clearer", "understanding", "of", "a", "key", "ThermoDox", "heat-based", "mechanism", "of", "action:", "the", "longer", "the", "target", "tissue", "is", "heated,", "the", "greater", "the", "doxorubicin", "tissue", "concentration."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p11_s0", "idA": "749647_17_item7_p9_s2", "sentA": "On August 15, 2016, the Company announced the most recent post-hoc OS analysis from the HEAT Study.", "sentB": "The lead author is Won Young Tak, M.D., Ph.D., Professor Internal Medicine, Gastroenterology Hepatology, Kyungpook National University Hospital Daegu, Republic of Korea, and there are 22 HEAT Study co-authors along with Nicholas Borys, M.D., Celsion s senior vice president and chief medical officer.", "type": 1, "words": ["<tag1>", "On", "August", "15,", "2016,", "the", "Company", "announced", "the", "most", "recent", "post-hoc", "OS", "analysis", "from", "the", "HEAT", "Study.", "<tag2>", "The", "lead", "author", "is", "Won", "Young", "Tak,", "M.D.,", "Ph.D.,", "Professor", "Internal", "Medicine,", "Gastroenterology", "Hepatology,", "Kyungpook", "National", "University", "Hospital", "Daegu,", "Republic", "of", "Korea,", "and", "there", "are", "22", "HEAT", "Study", "co-authors", "along", "with", "Nicholas", "Borys,", "M.D.,", "Celsion", "s", "senior", "vice", "president", "and", "chief", "medical", "officer.", "<tag3>"], "wordsA": ["On", "August", "15,", "2016,", "the", "Company", "announced", "the", "most", "recent", "post-hoc", "OS", "analysis", "from", "the", "HEAT", "Study."], "wordsB": ["The", "lead", "author", "is", "Won", "Young", "Tak,", "M.D.,", "Ph.D.,", "Professor", "Internal", "Medicine,", "Gastroenterology", "Hepatology,", "Kyungpook", "National", "University", "Hospital", "Daegu,", "Republic", "of", "Korea,", "and", "there", "are", "22", "HEAT", "Study", "co-authors", "along", "with", "Nicholas", "Borys,", "M.D.,", "Celsion", "s", "senior", "vice", "president", "and", "chief", "medical", "officer."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p76_s0", "idA": "749647_17_item7_p9_s2", "sentA": "On August 15, 2016, the Company announced the most recent post-hoc OS analysis from the HEAT Study.", "sentB": "In March 2016, the FASB issued ASU 2016-09, Compensation - Stock Compensation , which simplifies various aspects of accounting for share-based payments.", "type": 1, "words": ["<tag1>", "On", "August", "15,", "2016,", "the", "Company", "announced", "the", "most", "recent", "post-hoc", "OS", "analysis", "from", "the", "HEAT", "Study.", "<tag2>", "In", "March", "2016,", "the", "FASB", "issued", "ASU", "2016-09,", "Compensation", "-", "Stock", "Compensation", ",", "which", "simplifies", "various", "aspects", "of", "accounting", "for", "share-based", "payments.", "<tag3>"], "wordsA": ["On", "August", "15,", "2016,", "the", "Company", "announced", "the", "most", "recent", "post-hoc", "OS", "analysis", "from", "the", "HEAT", "Study."], "wordsB": ["In", "March", "2016,", "the", "FASB", "issued", "ASU", "2016-09,", "Compensation", "-", "Stock", "Compensation", ",", "which", "simplifies", "various", "aspects", "of", "accounting", "for", "share-based", "payments."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_18_item7_p59_s0", "idA": "749647_17_item7_p9_s3", "sentA": "These results demonstrated that in a large, well bounded subgroup of patients with a single lesion (n=285, 41% of the HEAT Study patients), the combination of ThermoDox and optimized RFA provided an average 54% risk improvement in OS compared to optimized RFA alone.", "sentB": "Primary endpoint of improvement in progression-free survival (PFS) comparing GEN-1 with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone.", "type": 1, "words": ["<tag1>", "These", "results", "demonstrated", "that", "in", "a", "large,", "well", "bounded", "subgroup", "of", "patients", "with", "a", "single", "lesion", "(n=285,", "41%", "of", "the", "HEAT", "Study", "patients),", "the", "combination", "of", "ThermoDox", "and", "optimized", "RFA", "provided", "an", "average", "54%", "risk", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone.", "<tag2>", "Primary", "endpoint", "of", "improvement", "in", "progression-free", "survival", "(PFS)", "comparing", "GEN-1", "with", "neoadjuvant", "chemotherapy", "versus", "neoadjuvant", "chemotherapy", "alone.", "<tag3>"], "wordsA": ["These", "results", "demonstrated", "that", "in", "a", "large,", "well", "bounded", "subgroup", "of", "patients", "with", "a", "single", "lesion", "(n=285,", "41%", "of", "the", "HEAT", "Study", "patients),", "the", "combination", "of", "ThermoDox", "and", "optimized", "RFA", "provided", "an", "average", "54%", "risk", "improvement", "in", "OS", "compared", "to", "optimized", "RFA", "alone."], "wordsB": ["Primary", "endpoint", "of", "improvement", "in", "progression-free", "survival", "(PFS)", "comparing", "GEN-1", "with", "neoadjuvant", "chemotherapy", "versus", "neoadjuvant", "chemotherapy", "alone."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
